,id,cid,dsn,cmpdname,srccmpd,srccmpdname,srccmpdurl,srctarget,srctargetname,srctargeturl,protacxn,protname,geneid,genename,taxid,taxname,action,actname,actvalue,evids,evurls,pmids,dois,citations
0,1488255,74989,Comparative Toxicogenomics Database (CTD),Atovaquone,D053626,Atovaquone,https://ctdbase.org/detail.go?type=chem&acc=D053626,1723,DHODH,https://ctdbase.org/detail.go?type=gene&acc=1723,,,1723.0,DHODH,9606,Homo sapiens (human),Atovaquone results in decreased activity of DHODH protein,,,PMID:10658902,https://www.ncbi.nlm.nih.gov/pubmed/10658902,10658902,,
1,1488437,74989,Comparative Toxicogenomics Database (CTD),Atovaquone,D053626,Atovaquone,https://ctdbase.org/detail.go?type=chem&acc=D053626,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,9606,Homo sapiens (human),"Atovaquone inhibits the reaction [GSTP1 protein results in increased metabolism of 1-chloro-2,4-dinitrobenzene-glutathione conjugate]",,,PMID:23769903,https://www.ncbi.nlm.nih.gov/pubmed/23769903,23769903,,
2,1488438,74989,Drug Gene Interaction database (DGIdb),Atovaquone,,ATOVAQUONE,https://www.dgidb.org/drugs/rxcui:60212,,NFE2L2,https://www.dgidb.org/genes/hgnc:7782,,,4780.0,NFE2L2,9606,Homo sapiens (human),,,,,,,,
3,1488439,75195,Drug Gene Interaction database (DGIdb),Soluble iodophthalein,,IODOPHTHALEIN,https://www.dgidb.org/drugs/chembl:CHEMBL1160008,,HPGD,https://www.dgidb.org/genes/hgnc:5154,,,3248.0,HPGD,9606,Homo sapiens (human),,,,,,,,
4,1488440,75575,Drug Gene Interaction database (DGIdb),"2,2'-Methylenediphenol",,CHEMBL:CHEMBL148831,https://www.dgidb.org/drugs/chembl:CHEMBL148831,,PRDX5,https://www.dgidb.org/genes/hgnc:9355,,,25824.0,PRDX5,9606,Homo sapiens (human),,,,,,,,
5,1488441,75653,Drug Gene Interaction database (DGIdb),"Ethyl 2,4-dihydroxy-6-methylbenzoate",,"ORSELLINIC ACID, ETHYL ESTER",https://www.dgidb.org/drugs/chembl:CHEMBL1601166,,CYP3A4,https://www.dgidb.org/genes/hgnc:2637,,,1576.0,CYP3A4,9606,Homo sapiens (human),,,,,,,,
6,1488442,75846,DrugBank,"4,4'-Dipyridyl disulfide",DB07623,"4,4'-DIPYRIDYL DISULFIDE",https://www.drugbank.ca/drugs/DB07623,BE0003336,Cytochrome P450 2A6,https://www.drugbank.ca/bio_entities/BE0003336,P11509,Cytochrome P450 2A6,1548.0,CYP2A6,9606,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
7,1488443,76223,Toxin and Toxin Target Database (T3DB),Silver trifluoromethanesulfonate,T3D1620,Silver trifluoromethanesulfonate,http://www.t3db.ca/toxins/T3D1620,BE0000820,Epididymal secretory glutathione peroxidase,http://www.t3db.ca/biodb/bio_entities/BE0000820,O75715,Epididymal secretory glutathione peroxidase,2880.0,GPX5,9606,Homo sapiens (human),"The silver ion is known to inhibit glutathione peroxidase activity, disrupting selenium-catalyzed sulfhydryl oxidation-reduction reactions. (A246)",,,PMID:3760861,https://www.ncbi.nlm.nih.gov/pubmed/3760861,3760861,,
8,1488444,76223,Toxin and Toxin Target Database (T3DB),Silver trifluoromethanesulfonate,T3D1620,Silver trifluoromethanesulfonate,http://www.t3db.ca/toxins/T3D1620,BE0000816,Glutathione peroxidase 1,http://www.t3db.ca/biodb/bio_entities/BE0000816,P07203,Glutathione peroxidase 1,2876.0,GPX1,9606,Homo sapiens (human),"The silver ion is known to inhibit glutathione peroxidase activity, disrupting selenium-catalyzed sulfhydryl oxidation-reduction reactions. (A246)",,,PMID:3760861,https://www.ncbi.nlm.nih.gov/pubmed/3760861,3760861,,
9,1488445,76223,Toxin and Toxin Target Database (T3DB),Silver trifluoromethanesulfonate,T3D1620,Silver trifluoromethanesulfonate,http://www.t3db.ca/toxins/T3D1620,BE0000817,Glutathione peroxidase 2,http://www.t3db.ca/biodb/bio_entities/BE0000817,P18283,Glutathione peroxidase 2,2877.0,GPX2,9606,Homo sapiens (human),"The silver ion is known to inhibit glutathione peroxidase activity, disrupting selenium-catalyzed sulfhydryl oxidation-reduction reactions. (A246)",,,PMID:3760861,https://www.ncbi.nlm.nih.gov/pubmed/3760861,3760861,,
10,1488446,76223,Toxin and Toxin Target Database (T3DB),Silver trifluoromethanesulfonate,T3D1620,Silver trifluoromethanesulfonate,http://www.t3db.ca/toxins/T3D1620,BE0000821,Glutathione peroxidase 3,http://www.t3db.ca/biodb/bio_entities/BE0000821,P22352,Glutathione peroxidase 3,2878.0,GPX3,9606,Homo sapiens (human),"The silver ion is known to inhibit glutathione peroxidase activity, disrupting selenium-catalyzed sulfhydryl oxidation-reduction reactions. (A246)",,,PMID:3760861,https://www.ncbi.nlm.nih.gov/pubmed/3760861,3760861,,
11,1489241,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,30845,EHD3,https://ctdbase.org/detail.go?type=gene&acc=30845,,,30845.0,EHD3,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in decreased expression of EHD3 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
12,1489242,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,9451,EIF2AK3,https://ctdbase.org/detail.go?type=gene&acc=9451,,,9451.0,EIF2AK3,10090,Mus musculus (house mouse),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased phosphorylation of EIF2AK3 protein",,,PMID:33771661,https://www.ncbi.nlm.nih.gov/pubmed/33771661,33771661,,
13,1489243,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,321564,EIF2S1B,https://ctdbase.org/detail.go?type=gene&acc=321564,,,321564.0,eif2s1b,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of EIF2S1B protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
14,1489244,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,8668,EIF3I,https://ctdbase.org/detail.go?type=gene&acc=8668,,,8668.0,EIF3I,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of EIF3I protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
15,1489245,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,10480,EIF3M,https://ctdbase.org/detail.go?type=gene&acc=10480,,,10480.0,EIF3M,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of EIF3M protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
16,1489246,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,406402,EIF3S6IP,https://ctdbase.org/detail.go?type=gene&acc=406402,,,406402.0,eif3s6ip,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of EIF3S6IP protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
17,1489247,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,572435,EIF4G1A,https://ctdbase.org/detail.go?type=gene&acc=572435,,,572435.0,eif4g1a,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of EIF4G1A protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
18,1489248,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,255520,ELMOD2,https://ctdbase.org/detail.go?type=gene&acc=255520,,,255520.0,ELMOD2,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of ELMOD2 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
19,1489249,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,334116,ENO1A,https://ctdbase.org/detail.go?type=gene&acc=334116,,,334116.0,eno1a,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in decreased expression of ENO1A protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
20,1493207,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,5862,RAB2A,https://ctdbase.org/detail.go?type=gene&acc=5862,,,5862.0,RAB2A,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of RAB2A protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
21,1493208,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,10567,RABAC1,https://ctdbase.org/detail.go?type=gene&acc=10567,,,10567.0,RABAC1,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of RABAC1 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
22,1494685,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,6194,RPS6,https://ctdbase.org/detail.go?type=gene&acc=6194,,,6194.0,RPS6,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of RPS6 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
23,1494686,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,6202,RPS8,https://ctdbase.org/detail.go?type=gene&acc=6202,,,6202.0,RPS8,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of RPS8 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
24,1494687,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,6203,RPS9,https://ctdbase.org/detail.go?type=gene&acc=6203,,,6203.0,RPS9,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of RPS9 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
25,1494688,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,3921,RPSA,https://ctdbase.org/detail.go?type=gene&acc=3921,,,3921.0,RPSA,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of RPSA protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
26,1494689,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,553448,RRBP1A,https://ctdbase.org/detail.go?type=gene&acc=553448,,,553448.0,rrbp1a,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of RRBP1A protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
27,1494690,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,323706,RTN1A,https://ctdbase.org/detail.go?type=gene&acc=323706,,,323706.0,rtn1a,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of RTN1A protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
28,1494691,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,64755,RUSF1,https://ctdbase.org/detail.go?type=gene&acc=64755,,,64755.0,RUSF1,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of RUSF1 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
29,1494692,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,51128,SAR1B,https://ctdbase.org/detail.go?type=gene&acc=51128,,,51128.0,SAR1B,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in increased expression of SAR1B protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
30,1494693,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,1757,SARDH,https://ctdbase.org/detail.go?type=gene&acc=1757,,,1757.0,SARDH,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in decreased expression of SARDH protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
31,1496656,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,64902,AGXT2,https://ctdbase.org/detail.go?type=gene&acc=64902,,,64902.0,AGXT2,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in decreased expression of AGXT2 protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
32,1496657,83494,Comparative Toxicogenomics Database (CTD),"Phenol, 4,4'-(1,1-dimethyl-3-methylene-1,3-propanediyl)bis-",C504750,"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene",https://ctdbase.org/detail.go?type=chem&acc=C504750,79378,AGXTB,https://ctdbase.org/detail.go?type=gene&acc=79378,,,79378.0,agxtb,28743,Cyprinodon variegatus (sheepshead minnow),"4-methyl-2,4-bis(4-hydroxyphenyl)pent-1-ene results in decreased expression of AGXTB protein",,,PMID:35124124,https://www.ncbi.nlm.nih.gov/pubmed/35124124,35124124,,
33,1498471,83720,Toxin and Toxin Target Database (T3DB),Nickel sulfamate,T3D0699,Nickel sulfamate,http://www.t3db.ca/toxins/T3D0699,BE0005139,Histone H2A type 1-B/E,http://www.t3db.ca/biodb/bio_entities/BE0005139,P04908,Histone H2A type 1-B/E,8335.0,H2AC4,9606,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
34,1498472,83720,Toxin and Toxin Target Database (T3DB),Nickel sulfamate,T3D0699,Nickel sulfamate,http://www.t3db.ca/toxins/T3D0699,BE0005140,Histone H2A type 1-C,http://www.t3db.ca/biodb/bio_entities/BE0005140,Q93077,Histone H2A type 1-C,8334.0,H2AC6,9606,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
35,1498473,83720,Toxin and Toxin Target Database (T3DB),Nickel sulfamate,T3D0699,Nickel sulfamate,http://www.t3db.ca/toxins/T3D0699,BE0005141,Histone H2A type 1-D,http://www.t3db.ca/biodb/bio_entities/BE0005141,P20671,Histone H2A type 1-D,3013.0,H2AC7,9606,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
36,1498474,83720,Toxin and Toxin Target Database (T3DB),Nickel sulfamate,T3D0699,Nickel sulfamate,http://www.t3db.ca/toxins/T3D0699,BE0005148,Histone H2A type 1-H,http://www.t3db.ca/biodb/bio_entities/BE0005148,Q96KK5,Histone H2A type 1-H,85235.0,H2AC12,9606,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
37,1498475,83720,Toxin and Toxin Target Database (T3DB),Nickel sulfamate,T3D0699,Nickel sulfamate,http://www.t3db.ca/toxins/T3D0699,BE0005142,Histone H2A type 1-J,http://www.t3db.ca/biodb/bio_entities/BE0005142,Q99878,Histone H2A type 1-J,8331.0,H2AC14,9606,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
38,1499079,83720,Toxin and Toxin Target Database (T3DB),Nickel sulfamate,T3D0699,Nickel sulfamate,http://www.t3db.ca/toxins/T3D0699,BE0005159,Histone H2B type 1-K,http://www.t3db.ca/biodb/bio_entities/BE0005159,O60814,Histone H2B type 1-K,85236.0,H2BC12,9606,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
39,1499080,83720,Toxin and Toxin Target Database (T3DB),Nickel sulfamate,T3D0699,Nickel sulfamate,http://www.t3db.ca/toxins/T3D0699,BE0005164,Histone H2B type 1-L,http://www.t3db.ca/biodb/bio_entities/BE0005164,Q99880,Histone H2B type 1-L,8340.0,H2BC13,9606,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
40,1499081,83720,Toxin and Toxin Target Database (T3DB),Nickel sulfamate,T3D0699,Nickel sulfamate,http://www.t3db.ca/toxins/T3D0699,BE0005165,Histone H2B type 1-M,http://www.t3db.ca/biodb/bio_entities/BE0005165,Q99879,Histone H2B type 1-M,8342.0,H2BC14,9606,Homo sapiens (human),"Nickel has a high affinity for chromatin proteins, particularly histones and protamines. the complexing of nickel ions with heterochromatin results in a number of alterations including condensation, DNA hypermethylation, gene silencing, and inhibition of histone acetylation, which have been shown to disturb gene expression. (L41)",,,,,,,
41,1489555,83887,IUPHAR/BPS Guide to PHARMACOLOGY,D-Aspartic acid,6511,D-aspartic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6511,459,GluN2D,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=459,O15399,"Glutamate receptor ionotropic, NMDA 2D",2906.0,GRIN2D,9606,Homo sapiens (human),Agonist,,7.11,,,,,
42,1489556,83887,IUPHAR/BPS Guide to PHARMACOLOGY,D-Aspartic acid,6511,D-aspartic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6511,455,GluN1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=455,Q05586,"Glutamate receptor ionotropic, NMDA 1",2902.0,GRIN1,9606,Homo sapiens (human),Agonist,,6.3,,,,,
43,1489557,83887,IUPHAR/BPS Guide to PHARMACOLOGY,D-Aspartic acid,6511,D-aspartic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6511,456,GluN2A,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=456,Q12879,"Glutamate receptor ionotropic, NMDA 2A",2903.0,GRIN2A,9606,Homo sapiens (human),Agonist,,8.52,,,,,
44,1489558,83887,IUPHAR/BPS Guide to PHARMACOLOGY,D-Aspartic acid,6511,D-aspartic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6511,458,GluN2C,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=458,Q14957,"Glutamate receptor ionotropic, NMDA 2C",2905.0,GRIN2C,9606,Homo sapiens (human),Agonist,,5.44,,,,,
45,1489559,83887,IUPHAR/BPS Guide to PHARMACOLOGY,D-Aspartic acid,6511,D-aspartic acid,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6511,457,GluN2B,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=457,Q13224,"Glutamate receptor ionotropic, NMDA 2B",2904.0,GRIN2B,9606,Homo sapiens (human),Agonist,,7.07,,,,,
46,1489560,83887,Comparative Toxicogenomics Database (CTD),D-Aspartic acid,D026603,D-Aspartic Acid,https://ctdbase.org/detail.go?type=chem&acc=D026603,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10090,Mus musculus (house mouse),D-aspartic acid results in increased phosphorylation of AKT1 protein,,,PMID:26189884,https://www.ncbi.nlm.nih.gov/pubmed/26189884,26189884,,
47,1489561,83887,Comparative Toxicogenomics Database (CTD),D-Aspartic acid,D026603,D-Aspartic Acid,https://ctdbase.org/detail.go?type=chem&acc=D026603,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,10116,Rattus norvegicus (Norway rat),D-aspartic acid results in increased phosphorylation of AKT1 protein,,,PMID:31398714,https://www.ncbi.nlm.nih.gov/pubmed/31398714,31398714,,
48,1489562,83887,Comparative Toxicogenomics Database (CTD),D-Aspartic acid,D026603,D-Aspartic Acid,https://ctdbase.org/detail.go?type=chem&acc=D026603,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,10116,Rattus norvegicus (Norway rat),D-aspartic acid affects the expression of AR mRNA,,,PMID:26044185,https://www.ncbi.nlm.nih.gov/pubmed/26044185,26044185,,
49,1489563,83887,Comparative Toxicogenomics Database (CTD),D-Aspartic acid,D026603,D-Aspartic Acid,https://ctdbase.org/detail.go?type=chem&acc=D026603,367,AR,https://ctdbase.org/detail.go?type=gene&acc=367,,,367.0,AR,10116,Rattus norvegicus (Norway rat),D-aspartic acid results in increased expression of AR protein,,,PMID:24439162,https://www.ncbi.nlm.nih.gov/pubmed/24439162,24439162,,
50,1489564,83887,Comparative Toxicogenomics Database (CTD),D-Aspartic acid,D026603,D-Aspartic Acid,https://ctdbase.org/detail.go?type=chem&acc=D026603,9212,AURKB,https://ctdbase.org/detail.go?type=gene&acc=9212,,,9212.0,AURKB,10090,Mus musculus (house mouse),D-aspartic acid results in increased expression of AURKB protein,,,PMID:26189884,https://www.ncbi.nlm.nih.gov/pubmed/26189884,26189884,,
51,1490922,86233,Toxin and Toxin Target Database (T3DB),"5-[(4-Chlorophenyl)methylidene]-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol",T3D4549,Triticonazole,http://www.t3db.ca/toxins/T3D4549,BE0003543,Cytochrome P450 1A1,http://www.t3db.ca/biodb/bio_entities/BE0003543,P04798,Cytochrome P450 1A1,1543.0,CYP1A1,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
52,1490923,86233,Toxin and Toxin Target Database (T3DB),"5-[(4-Chlorophenyl)methylidene]-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol",T3D4549,Triticonazole,http://www.t3db.ca/toxins/T3D4549,BE0000132,Androgen receptor,http://www.t3db.ca/biodb/bio_entities/BE0000132,P10275,Androgen receptor,367.0,AR,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
53,1490924,86233,Toxin and Toxin Target Database (T3DB),"5-[(4-Chlorophenyl)methylidene]-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol",T3D4549,Triticonazole,http://www.t3db.ca/toxins/T3D4549,BE0002638,Cytochrome P450 3A4,http://www.t3db.ca/biodb/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
54,1490925,86233,Toxin and Toxin Target Database (T3DB),"5-[(4-Chlorophenyl)methylidene]-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol",T3D4549,Triticonazole,http://www.t3db.ca/toxins/T3D4549,BE0003549,Cytochrome P450 2B6,http://www.t3db.ca/biodb/bio_entities/BE0003549,P20813,Cytochrome P450 2B6,1555.0,CYP2B6,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
55,1490926,86233,Toxin and Toxin Target Database (T3DB),"5-[(4-Chlorophenyl)methylidene]-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol",T3D4549,Triticonazole,http://www.t3db.ca/toxins/T3D4549,BE0001047,C-C motif chemokine 2,http://www.t3db.ca/biodb/bio_entities/BE0001047,P13500,C-C motif chemokine 2,6347.0,CCL2,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
56,1490927,86233,Toxin and Toxin Target Database (T3DB),"5-[(4-Chlorophenyl)methylidene]-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol",T3D4549,Triticonazole,http://www.t3db.ca/toxins/T3D4549,BE0005460,Early activation antigen CD69,http://www.t3db.ca/biodb/bio_entities/BE0005460,Q07108,Early activation antigen CD69,969.0,CD69,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
57,1490928,86233,Toxin and Toxin Target Database (T3DB),"5-[(4-Chlorophenyl)methylidene]-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol",T3D4549,Triticonazole,http://www.t3db.ca/toxins/T3D4549,BE0000886,Bile salt sulfotransferase,http://www.t3db.ca/biodb/bio_entities/BE0000886,Q06520,Sulfotransferase 2A1,6822.0,SULT2A1,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
58,1490929,86233,Toxin and Toxin Target Database (T3DB),"5-[(4-Chlorophenyl)methylidene]-2,2-dimethyl-1-(1,2,4-triazol-1-ylmethyl)cyclopentan-1-ol",T3D4549,Triticonazole,http://www.t3db.ca/toxins/T3D4549,BE0000956,Nuclear receptor subfamily 1 group I member 2,http://www.t3db.ca/biodb/bio_entities/BE0000956,O75469,Nuclear receptor subfamily 1 group I member 2,8856.0,NR1I2,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
59,1499711,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,393462,ALDH2.1,https://ctdbase.org/detail.go?type=gene&acc=393462,,,393462.0,aldh2.1,7955,Danio rerio (zebrafish),Thifluzamide results in decreased expression of ALDH2.1 mRNA,,,PMID:34635929,https://www.ncbi.nlm.nih.gov/pubmed/34635929,34635929,,
60,1499712,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,501,ALDH7A1,https://ctdbase.org/detail.go?type=gene&acc=501,,,501.0,ALDH7A1,9606,Homo sapiens (human),Thifluzamide results in decreased expression of ALDH7A1 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
61,1499713,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,226,ALDOA,https://ctdbase.org/detail.go?type=gene&acc=226,,,226.0,ALDOA,9606,Homo sapiens (human),Thifluzamide results in increased expression of ALDOA mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
62,1499714,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,302,ANXA2,https://ctdbase.org/detail.go?type=gene&acc=302,,,302.0,ANXA2,9606,Homo sapiens (human),Thifluzamide results in decreased expression of ANXA2 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
63,1499715,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,23779,ARHGAP8,https://ctdbase.org/detail.go?type=gene&acc=23779,,,23779.0,ARHGAP8,9606,Homo sapiens (human),Thifluzamide results in increased expression of ARHGAP8 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
64,1499716,86389,Comparative Toxicogenomics Database (CTD),Thifluzamide,C494892,thifluzamide,https://ctdbase.org/detail.go?type=chem&acc=C494892,64333,ARHGAP9,https://ctdbase.org/detail.go?type=gene&acc=64333,,,64333.0,ARHGAP9,9606,Homo sapiens (human),Thifluzamide results in increased expression of ARHGAP9 mRNA,,,PMID:33512557,https://www.ncbi.nlm.nih.gov/pubmed/33512557,33512557,,
65,1492178,88881,Drug Gene Interaction database (DGIdb),"5,7-Dimethoxyflavone",,CHRYSIN DIMETHYL ETHER,https://www.dgidb.org/drugs/chembl:CHEMBL275391,,BRCA1,https://www.dgidb.org/genes/hgnc:1100,,,672.0,BRCA1,9606,Homo sapiens (human),,,,,,,,
66,1492179,88901,BindingDB,1H-Indazol-7-amine,50271275,1H-Indazol-7-amine,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50271275,50000400,Genome polyprotein [1658-1692],https://www.bindingdb.org/jsp/dbsearch/PrimarySearch_ki.jsp?tag=com&complexid=50000400,P29846,Genome polyprotein,,,31645,Hepatitis C virus (isolate Taiwan),,IC50 (nM),>5.000e+6,PMID:23023261|DOI:10.1038/nchembio.1081,https://www.ncbi.nlm.nih.gov/pubmed/23023261|https://doi.org/10.1038/nchembio.1081,23023261,10.1038/nchembio.1081,
67,1492180,89366,BindingDB,2-Amino-3-(1H-indol-3-yl)propanamide,92688,"L-Tryptophanamide, 9",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=92688,5265,Trp operon repressor,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=5265,P0A881,Trp operon repressor,948917.0,trpR,83333,Escherichia coli K-12,,,,PMID:3549712,https://www.ncbi.nlm.nih.gov/pubmed/3549712,3549712,,
68,1492181,89576,IUPHAR/BPS Guide to PHARMACOLOGY,5-Benzyloxytryptamine,265,5-benzyloxytryptamine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=265,500,TRPM8,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=500,Q7Z2W7,Transient receptor potential cation channel subfamily M member 8,79054.0,TRPM8,9606,Homo sapiens (human),,,5.5,,,,,
69,1492182,89594,IUPHAR/BPS Guide to PHARMACOLOGY,Nicotine,2585,nicotine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2585,485,TRPA1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=485,O75762,Transient receptor potential cation channel subfamily A member 1,8989.0,TRPA1,9606,Homo sapiens (human),Activation,pEC50,4.8,PMID:19749751,https://www.ncbi.nlm.nih.gov/pubmed/19749751,19749751,,
70,1492183,89594,IUPHAR/BPS Guide to PHARMACOLOGY,Nicotine,2585,nicotine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2585,470,nicotinic acetylcholine receptor α10 subunit,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=470,Q9GZZ6,Neuronal acetylcholine receptor subunit alpha-10,57053.0,CHRNA10,9606,Homo sapiens (human),Antagonist,,8.96,,,,,
71,1492184,89594,IUPHAR/BPS Guide to PHARMACOLOGY,Nicotine,2585,nicotine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2585,469,nicotinic acetylcholine receptor α9 subunit,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=469,Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9,55584.0,CHRNA9,9606,Homo sapiens (human),Antagonist,,9.7,,,,,
72,1492185,89594,IUPHAR/BPS Guide to PHARMACOLOGY,Nicotine,2585,nicotine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2585,469,nicotinic acetylcholine receptor α9 subunit,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=469,Q9UGM1,Neuronal acetylcholine receptor subunit alpha-9,55584.0,CHRNA9,9606,Homo sapiens (human),Antagonist,,9.7,,,,,
73,1492186,89594,IUPHAR/BPS Guide to PHARMACOLOGY,Nicotine,2585,nicotine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2585,465,nicotinic acetylcholine receptor α4 subunit,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=465,P43681,Neuronal acetylcholine receptor subunit alpha-4,1137.0,CHRNA4,9606,Homo sapiens (human),Agonist,pKi,8.66,PMID:32026697,https://www.ncbi.nlm.nih.gov/pubmed/32026697,32026697,,
74,1492187,89594,IUPHAR/BPS Guide to PHARMACOLOGY,Nicotine,2585,nicotine,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2585,464,nicotinic acetylcholine receptor α3 subunit,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=464,P32297,Neuronal acetylcholine receptor subunit alpha-3,1136.0,CHRNA3,9606,Homo sapiens (human),Agonist,pKi,5.76,PMID:32026697,https://www.ncbi.nlm.nih.gov/pubmed/32026697,32026697,,
75,1496508,93147,IUPHAR/BPS Guide to PHARMACOLOGY,Tetrahydrocannabivarin,6418,tetrahydrocannabivarin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6418,509,TRPV3,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=509,,,497948.0,Trpv3,10116,Rattus norvegicus (Norway rat),Activation,pEC50,5.42,PMID:21726418,https://www.ncbi.nlm.nih.gov/pubmed/21726418,21726418,,
76,1496509,93147,IUPHAR/BPS Guide to PHARMACOLOGY,Tetrahydrocannabivarin,6418,tetrahydrocannabivarin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6418,511,TRPV5,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=511,Q9NQA5,Transient receptor potential cation channel subfamily V member 5,56302.0,TRPV5,9606,Homo sapiens (human),Inhibition,pIC50,5.4,PMID:30170189,https://www.ncbi.nlm.nih.gov/pubmed/30170189,30170189,,
77,1496510,93147,IUPHAR/BPS Guide to PHARMACOLOGY,Tetrahydrocannabivarin,6418,tetrahydrocannabivarin,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=6418,512,TRPV6,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=512,Q9H1D0,Transient receptor potential cation channel subfamily V member 6,55503.0,TRPV6,9606,Homo sapiens (human),Inhibition,pIC50,5.05,PMID:30170189,https://www.ncbi.nlm.nih.gov/pubmed/30170189,30170189,,
78,1496511,93149,Drug Gene Interaction database (DGIdb),"4-Methyl-1,10-phenanthroline",,CHEMBL:CHEMBL316589,https://www.dgidb.org/drugs/chembl:CHEMBL316589,,BAZ2B,https://www.dgidb.org/genes/hgnc:963,,,29994.0,BAZ2B,9606,Homo sapiens (human),,,,,,,,
79,1496512,93379,Toxin and Toxin Target Database (T3DB),Forchlorfenuron,T3D4513,Forchlorfenuron,http://www.t3db.ca/toxins/T3D4513,BE0003683,Cytochrome P450 2J2,http://www.t3db.ca/biodb/bio_entities/BE0003683,P51589,Cytochrome P450 2J2,1573.0,CYP2J2,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
80,1496513,93379,Toxin and Toxin Target Database (T3DB),Forchlorfenuron,T3D4513,Forchlorfenuron,http://www.t3db.ca/toxins/T3D4513,BE0001047,C-C motif chemokine 2,http://www.t3db.ca/biodb/bio_entities/BE0001047,P13500,C-C motif chemokine 2,6347.0,CCL2,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
81,1496514,93379,Toxin and Toxin Target Database (T3DB),Forchlorfenuron,T3D4513,Forchlorfenuron,http://www.t3db.ca/toxins/T3D4513,BE0001074,E-selectin,http://www.t3db.ca/biodb/bio_entities/BE0001074,P16581,E-selectin,6401.0,SELE,9606,Homo sapiens (human),,,,PMID:23611293,https://www.ncbi.nlm.nih.gov/pubmed/23611293,23611293,,
82,1488265,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,10263,CDK2AP2,https://ctdbase.org/detail.go?type=gene&acc=10263,,,10263.0,CDK2AP2,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of CDK2AP2 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
83,1490039,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,51647,CIAO2B,https://ctdbase.org/detail.go?type=gene&acc=51647,,,51647.0,CIAO2B,10116,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CIAO2B mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
84,1490040,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,57019,CIAPIN1,https://ctdbase.org/detail.go?type=gene&acc=57019,,,57019.0,CIAPIN1,7955,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CIAPIN1 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
85,1490041,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,440836,CIMAP1B,https://ctdbase.org/detail.go?type=gene&acc=440836,,,440836.0,CIMAP1B,10116,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CIMAP1B mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
86,1490042,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1153,CIRBP,https://ctdbase.org/detail.go?type=gene&acc=1153,,,1153.0,CIRBP,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of CIRBP mRNA",,,PMID:19095052,https://www.ncbi.nlm.nih.gov/pubmed/19095052,19095052,,
87,1490791,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1207,CLNS1A,https://ctdbase.org/detail.go?type=gene&acc=1207,,,1207.0,CLNS1A,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of CLNS1A mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
88,1490792,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,10978,CLP1,https://ctdbase.org/detail.go?type=gene&acc=10978,,,10978.0,CLP1,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of CLP1 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
89,1490793,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,8192,CLPP,https://ctdbase.org/detail.go?type=gene&acc=8192,,,8192.0,CLPP,10116,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of CLPP mRNA",,,PMID:21394737,https://www.ncbi.nlm.nih.gov/pubmed/21394737,21394737,,
90,1490794,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,7401,CLRN1,https://ctdbase.org/detail.go?type=gene&acc=7401,,,7401.0,CLRN1,7955,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CLRN1 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
91,1490795,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,9746,CLSTN3,https://ctdbase.org/detail.go?type=gene&acc=9746,,,9746.0,CLSTN3,10116,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CLSTN3 mRNA",,,PMID:21394737,https://www.ncbi.nlm.nih.gov/pubmed/21394737,21394737,,
92,1490796,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1211,CLTA,https://ctdbase.org/detail.go?type=gene&acc=1211,,,1211.0,CLTA,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of CLTA protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
93,1490797,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1211,CLTA,https://ctdbase.org/detail.go?type=gene&acc=1211,,,1211.0,CLTA,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of CLTA mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
94,1490798,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1213,CLTC,https://ctdbase.org/detail.go?type=gene&acc=1213,,,1213.0,CLTC,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of CLTC mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
95,1490799,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1191,CLU,https://ctdbase.org/detail.go?type=gene&acc=1191,,,1191.0,CLU,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of CLU mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
96,1491717,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1289,COL5A1,https://ctdbase.org/detail.go?type=gene&acc=1289,,,1289.0,COL5A1,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of COL5A1 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
97,1491718,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,100463515,COL5A3B,https://ctdbase.org/detail.go?type=gene&acc=100463515,,,100463515.0,col5a3b,7955,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of COL5A3B mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
98,1491719,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1292,COL6A2,https://ctdbase.org/detail.go?type=gene&acc=1292,,,1292.0,COL6A2,7955,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of COL6A2 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
99,1491884,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1292,COL6A2,https://ctdbase.org/detail.go?type=gene&acc=1292,,,1292.0,COL6A2,10116,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of COL6A2 mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
100,1491885,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1293,COL6A3,https://ctdbase.org/detail.go?type=gene&acc=1293,,,1293.0,COL6A3,7955,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of COL6A3 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
101,1491886,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,131873,COL6A6,https://ctdbase.org/detail.go?type=gene&acc=131873,,,131873.0,COL6A6,7955,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of COL6A6 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
102,1491887,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1294,COL7A1,https://ctdbase.org/detail.go?type=gene&acc=1294,,,1294.0,COL7A1,7955,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of COL7A1 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
103,1491888,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1294,COL7A1,https://ctdbase.org/detail.go?type=gene&acc=1294,,,1294.0,COL7A1,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of COL7A1 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
104,1491889,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,562442,COL8A1B,https://ctdbase.org/detail.go?type=gene&acc=562442,,,562442.0,col8a1b,7955,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of COL8A1B mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
105,1492053,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1312,COMT,https://ctdbase.org/detail.go?type=gene&acc=1312,,,1312.0,COMT,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of COMT protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
106,1492054,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1312,COMT,https://ctdbase.org/detail.go?type=gene&acc=1312,,,1312.0,COMT,9823,Sus scrofa (pig),"2,2',4,4'-tetrabromodiphenyl ether results in increased activity of COMT protein",,,PMID:22750137,https://www.ncbi.nlm.nih.gov/pubmed/22750137,22750137,,
107,1496964,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,131118,DNAJC19,https://ctdbase.org/detail.go?type=gene&acc=131118,,,131118.0,DNAJC19,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of DNAJC19 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
108,1496965,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,27000,DNAJC2,https://ctdbase.org/detail.go?type=gene&acc=27000,,,27000.0,DNAJC2,10116,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of DNAJC2 mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
109,1496966,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,134218,DNAJC21,https://ctdbase.org/detail.go?type=gene&acc=134218,,,134218.0,DNAJC21,7955,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of DNAJC21 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
110,1496967,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5611,DNAJC3,https://ctdbase.org/detail.go?type=gene&acc=5611,,,5611.0,DNAJC3,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of DNAJC3 mRNA",,,PMID:19095052,https://www.ncbi.nlm.nih.gov/pubmed/19095052,19095052,,
111,1496968,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,5611,DNAJC3,https://ctdbase.org/detail.go?type=gene&acc=5611,,,5611.0,DNAJC3,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of DNAJC3 mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
112,1496969,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,7266,DNAJC7,https://ctdbase.org/detail.go?type=gene&acc=7266,,,7266.0,DNAJC7,10116,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DNAJC7 mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
113,1496970,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,7802,DNALI1,https://ctdbase.org/detail.go?type=gene&acc=7802,,,7802.0,DNALI1,10116,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DNALI1 mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
114,1496971,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1773,DNASE1,https://ctdbase.org/detail.go?type=gene&acc=1773,,,1773.0,DNASE1,7955,Danio rerio (zebrafish),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DNASE1 mRNA",,,PMID:25614096,https://www.ncbi.nlm.nih.gov/pubmed/25614096,25614096,,
115,1496972,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1759,DNM1,https://ctdbase.org/detail.go?type=gene&acc=1759,,,1759.0,DNM1,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of DNM1 protein",,,PMID:24680724,https://www.ncbi.nlm.nih.gov/pubmed/24680724,24680724,,
116,1496973,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1759,DNM1,https://ctdbase.org/detail.go?type=gene&acc=1759,,,1759.0,DNM1,10116,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DNM1 mRNA",,,PMID:21394737,https://www.ncbi.nlm.nih.gov/pubmed/21394737,21394737,,
117,1497116,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,10059,DNM1L,https://ctdbase.org/detail.go?type=gene&acc=10059,,,10059.0,DNM1L,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of DNM1L mRNA",,,PMID:30714368,https://www.ncbi.nlm.nih.gov/pubmed/30714368,30714368,,
118,1497117,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,10059,DNM1L,https://ctdbase.org/detail.go?type=gene&acc=10059,,,10059.0,DNM1L,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of DNM1L mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
119,1497118,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,10059,DNM1L,https://ctdbase.org/detail.go?type=gene&acc=10059,,,10059.0,DNM1L,10116,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DNM1L mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
120,1497385,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,8189,SYMPK,https://ctdbase.org/detail.go?type=gene&acc=8189,,,8189.0,SYMPK,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of SYMPK mRNA",,,PMID:23146750,https://www.ncbi.nlm.nih.gov/pubmed/23146750,23146750,,
121,1497550,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,10492,SYNCRIP,https://ctdbase.org/detail.go?type=gene&acc=10492,,,10492.0,SYNCRIP,10090,Mus musculus (house mouse),"2,2',4,4'-tetrabromodiphenyl ether affects the expression of SYNCRIP mRNA",,,PMID:30294300,https://www.ncbi.nlm.nih.gov/pubmed/30294300,30294300,,
122,1497551,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,23345,SYNE1,https://ctdbase.org/detail.go?type=gene&acc=23345,,,23345.0,SYNE1,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether analog results in increased expression of SYNE1 mRNA",,,PMID:19095052,https://www.ncbi.nlm.nih.gov/pubmed/19095052,19095052,,
123,1497870,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1819,DRG2,https://ctdbase.org/detail.go?type=gene&acc=1819,,,1819.0,DRG2,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of DRG2 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
124,1497871,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1821,DRP2,https://ctdbase.org/detail.go?type=gene&acc=1821,,,1821.0,DRP2,10116,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of DRP2 mRNA",,,PMID:27291303,https://www.ncbi.nlm.nih.gov/pubmed/27291303,27291303,,
125,1497872,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,57453,DSCAML1,https://ctdbase.org/detail.go?type=gene&acc=57453,,,57453.0,DSCAML1,10116,Rattus norvegicus (Norway rat),"2,2',4,4'-tetrabromodiphenyl ether results in decreased expression of DSCAML1 mRNA",,,PMID:21394737,https://www.ncbi.nlm.nih.gov/pubmed/21394737,21394737,,
126,1497873,95170,Comparative Toxicogenomics Database (CTD),"2,2',4,4'-Tetrabromodiphenyl ether",C511295,"2,2',4,4'-tetrabromodiphenyl ether",https://ctdbase.org/detail.go?type=chem&acc=C511295,1829,DSG2,https://ctdbase.org/detail.go?type=gene&acc=1829,,,1829.0,DSG2,9606,Homo sapiens (human),"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of DSG2 protein",,,PMID:31675489,https://www.ncbi.nlm.nih.gov/pubmed/31675489,31675489,,
127,1488256,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,153020,RASGEF1B,https://ctdbase.org/detail.go?type=gene&acc=153020,,,153020.0,RASGEF1B,10116,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of RASGEF1B mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
128,1488257,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,5947,RBP1,https://ctdbase.org/detail.go?type=gene&acc=5947,,,5947.0,RBP1,10116,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of RBP1 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
129,1488258,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,10231,RCAN2,https://ctdbase.org/detail.go?type=gene&acc=10231,,,10231.0,RCAN2,10116,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of RCAN2 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
130,1488259,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,5959,RDH5,https://ctdbase.org/detail.go?type=gene&acc=5959,,,5959.0,RDH5,10116,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of RDH5 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
131,1488260,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,92840,REEP6,https://ctdbase.org/detail.go?type=gene&acc=92840,,,92840.0,REEP6,10116,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of REEP6 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
132,1488261,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,222546,RFX6,https://ctdbase.org/detail.go?type=gene&acc=222546,,,222546.0,RFX6,10116,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of RFX6 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
133,1488262,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,9104,RGN,https://ctdbase.org/detail.go?type=gene&acc=9104,,,9104.0,RGN,10116,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of RGN mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
134,1488263,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,299021,RPS19-PS18,https://ctdbase.org/detail.go?type=gene&acc=299021,,,299021.0,Rps19-ps18,10116,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of RPS19-PS18 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
135,1488264,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,6299,SALL1,https://ctdbase.org/detail.go?type=gene&acc=6299,,,6299.0,SALL1,10116,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of SALL1 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
136,1488436,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,124925,SEZ6,https://ctdbase.org/detail.go?type=gene&acc=124925,,,124925.0,SEZ6,10116,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of SEZ6 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
137,1488613,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,6446,SGK1,https://ctdbase.org/detail.go?type=gene&acc=6446,,,6446.0,SGK1,10116,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of SGK1 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
138,1488614,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,54847,SIDT1,https://ctdbase.org/detail.go?type=gene&acc=54847,,,54847.0,SIDT1,10116,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of SIDT1 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
139,1488615,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,150094,SIK1,https://ctdbase.org/detail.go?type=gene&acc=150094,,,150094.0,SIK1,10116,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of SIK1 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
140,1488616,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,284111,SLC13A5,https://ctdbase.org/detail.go?type=gene&acc=284111,,,284111.0,SLC13A5,10116,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of SLC13A5 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
141,1488617,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,6567,SLC16A2,https://ctdbase.org/detail.go?type=gene&acc=6567,,,6567.0,SLC16A2,10116,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in decreased expression of SLC16A2 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
142,1488618,99479,Comparative Toxicogenomics Database (CTD),"2,2,5,7,8-Pentamethyl-6-chromanol",C029141,"2,2,5,7,8-pentamethyl-1-hydroxychroman",https://ctdbase.org/detail.go?type=chem&acc=C029141,9120,SLC16A6,https://ctdbase.org/detail.go?type=gene&acc=9120,,,9120.0,SLC16A6,10116,Rattus norvegicus (Norway rat),"2,2,5,7,8-pentamethyl-1-hydroxychroman results in increased expression of SLC16A6 mRNA",,,PMID:21920950,https://www.ncbi.nlm.nih.gov/pubmed/21920950,21920950,,
143,1491584,104850,BindingDB,Rimonabant,21278,"5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21278,9027,Cannabinoid receptor 1 [P221A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9027,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606,Homo sapiens (human),,,,PMID:24092756|DOI:10.1074/jbc.M113.489153,https://www.ncbi.nlm.nih.gov/pubmed/24092756|https://doi.org/10.1074/jbc.M113.489153,24092756,10.1074/jbc.M113.489153,
144,1491585,104850,BindingDB,Rimonabant,21278,"5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21278,9028,Cannabinoid receptor 1 [D338A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9028,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606,Homo sapiens (human),,,,PMID:24092756|DOI:10.1074/jbc.M113.489153,https://www.ncbi.nlm.nih.gov/pubmed/24092756|https://doi.org/10.1074/jbc.M113.489153,24092756,10.1074/jbc.M113.489153,
145,1491586,104850,BindingDB,Rimonabant,21278,"5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21278,9029,Cannabinoid receptor 1 [I339A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9029,P21554,Cannabinoid receptor 1,1268.0,CNR1,9606,Homo sapiens (human),,,,PMID:24092756|DOI:10.1074/jbc.M113.489153,https://www.ncbi.nlm.nih.gov/pubmed/24092756|https://doi.org/10.1074/jbc.M113.489153,24092756,10.1074/jbc.M113.489153,
146,1495176,104930,Comparative Toxicogenomics Database (CTD),Trimethylarsine oxide,C052920,trimethylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C052920,5599,MAPK8,https://ctdbase.org/detail.go?type=gene&acc=5599,,,5599.0,MAPK8,10116,Rattus norvegicus (Norway rat),Trimethylarsine oxide results in decreased expression of MAPK8 mRNA,,,PMID:17481689,https://www.ncbi.nlm.nih.gov/pubmed/17481689,17481689,,
147,1495177,104930,Comparative Toxicogenomics Database (CTD),Trimethylarsine oxide,C052920,trimethylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C052920,4780,NFE2L2,https://ctdbase.org/detail.go?type=gene&acc=4780,,,4780.0,NFE2L2,9606,Homo sapiens (human),Trimethylarsine oxide results in increased expression of and affects the localization of NFE2L2 protein|nfe2l2 mutant form inhibits the reaction [trimethylarsine oxide results in increased expression of NQO1 protein],,,PMID:24161444,https://www.ncbi.nlm.nih.gov/pubmed/24161444,24161444,,
148,1495178,104930,Comparative Toxicogenomics Database (CTD),Trimethylarsine oxide,C052920,trimethylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C052920,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,9606,Homo sapiens (human),Trimethylarsine oxide promotes the reaction [sulforaphane results in increased expression of NQO1 mrna]|trimethylarsine oxide results in increased expression of and results in increased activity of NQO1 protein|trimethylarsine oxide promotes the reaction [tetrachlorodibenzodioxin results in increased expression of NQO1 mrna]|trimethylarsine oxide promotes the reaction [tetrachlorodibenzodioxin results in increased expression of and results in increased activity of NQO1 protein]|trimethylarsine oxide promotes the reaction [sulforaphane results in increased expression of and results in increased activity of NQO1 protein]|trimethylarsine oxide results in increased expression of NQO1 mrna|nfe2l2 mutant form inhibits the reaction [trimethylarsine oxide results in increased expression of NQO1 protein],,,PMID:24161444,https://www.ncbi.nlm.nih.gov/pubmed/24161444,24161444,,
149,1495179,104930,Comparative Toxicogenomics Database (CTD),Trimethylarsine oxide,C052920,trimethylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C052920,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10090,Mus musculus (house mouse),Trimethylarsine oxide results in increased expression of NQO1 protein|trimethylarsine oxide promotes the reaction [tetrachlorodibenzodioxin results in increased expression of NQO1 mrna],,,PMID:26144063,https://www.ncbi.nlm.nih.gov/pubmed/26144063,26144063,,
150,1495180,104930,Comparative Toxicogenomics Database (CTD),Trimethylarsine oxide,C052920,trimethylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C052920,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10090,Mus musculus (house mouse),Trimethylarsine oxide results in increased expression of and results in increased activity of NQO1 protein,,,PMID:26042454,https://www.ncbi.nlm.nih.gov/pubmed/26042454,26042454,,
151,1495181,104930,Comparative Toxicogenomics Database (CTD),Trimethylarsine oxide,C052920,trimethylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C052920,1728,NQO1,https://ctdbase.org/detail.go?type=gene&acc=1728,,,1728.0,NQO1,10090,Mus musculus (house mouse),Trimethylarsine oxide results in increased expression of NQO1 mRNA,,,PMID:26042454|PMID:26144063,https://www.ncbi.nlm.nih.gov/pubmed/26042454|https://www.ncbi.nlm.nih.gov/pubmed/26144063,26042454|26144063,,
152,1495182,104930,Comparative Toxicogenomics Database (CTD),Trimethylarsine oxide,C052920,trimethylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C052920,4968,OGG1,https://ctdbase.org/detail.go?type=gene&acc=4968,,,4968.0,OGG1,10116,Rattus norvegicus (Norway rat),Trimethylarsine oxide results in increased expression of OGG1 mRNA,,,PMID:17481689,https://www.ncbi.nlm.nih.gov/pubmed/17481689,17481689,,
153,1495183,104930,Comparative Toxicogenomics Database (CTD),Trimethylarsine oxide,C052920,trimethylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C052920,5111,PCNA,https://ctdbase.org/detail.go?type=gene&acc=5111,,,5111.0,PCNA,10116,Rattus norvegicus (Norway rat),Trimethylarsine oxide results in increased expression of PCNA mRNA,,,PMID:17481689,https://www.ncbi.nlm.nih.gov/pubmed/17481689,17481689,,
154,1495184,104930,Comparative Toxicogenomics Database (CTD),Trimethylarsine oxide,C052920,trimethylarsine oxide,https://ctdbase.org/detail.go?type=chem&acc=C052920,5578,PRKCA,https://ctdbase.org/detail.go?type=gene&acc=5578,,,5578.0,PRKCA,10116,Rattus norvegicus (Norway rat),Trimethylarsine oxide results in increased expression of PRKCA mRNA,,,PMID:17481689,https://www.ncbi.nlm.nih.gov/pubmed/17481689,17481689,,
155,1496346,104974,Drug Gene Interaction database (DGIdb),Saredutant,,SAREDUTANT,https://www.dgidb.org/drugs/ncit:C152301,,TACR2,https://www.dgidb.org/genes/hgnc:11527,,,6865.0,TACR2,9606,Homo sapiens (human),Inhibitor,,,,,,,
156,1496347,104999,Therapeutic Target Database (TTD),"Methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate",D0GQ1S,DMCM,https://idrblab.net/ttd/data/drug/details/D0GQ1S,T51452,GABA(A) receptor alpha-2 (GABRA2),https://idrblab.net/ttd/data/target/details/T51452,P47869,Gamma-aminobutyric acid receptor subunit alpha-2,2555.0,GABRA2,9606,Homo sapiens (human),Modulator (allosteric modulator),,,,,,,
157,1496348,104999,Therapeutic Target Database (TTD),"Methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate",D0GQ1S,DMCM,https://idrblab.net/ttd/data/drug/details/D0GQ1S,T62292,GABA(A) receptor alpha-3 (GABRA3),https://idrblab.net/ttd/data/target/details/T62292,P34903,Gamma-aminobutyric acid receptor subunit alpha-3,2556.0,GABRA3,9606,Homo sapiens (human),Modulator (allosteric modulator),,,,,,,
158,1496349,104999,Therapeutic Target Database (TTD),"Methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate",D0GQ1S,DMCM,https://idrblab.net/ttd/data/drug/details/D0GQ1S,T26368,GABA(A) receptor alpha-5 (GABRA5),https://idrblab.net/ttd/data/target/details/T26368,P31644,Gamma-aminobutyric acid receptor subunit alpha-5,2558.0,GABRA5,9606,Homo sapiens (human),Modulator (allosteric modulator),,,,,,,
159,1496350,104999,Therapeutic Target Database (TTD),"Methyl 6,7-dimethoxy-4-ethyl-beta-carboline-3-carboxylate",D0GQ1S,DMCM,https://idrblab.net/ttd/data/drug/details/D0GQ1S,T28722,GABA(A) receptor gamma-3 (GABRG3),https://idrblab.net/ttd/data/target/details/T28722,Q99928,Gamma-aminobutyric acid receptor subunit gamma-3,2567.0,GABRG3,9606,Homo sapiens (human),Modulator (allosteric modulator),,,,,,,
160,1496351,105008,Therapeutic Target Database (TTD),Paxilline,D0V4WT,paxilline,https://idrblab.net/ttd/data/drug/details/D0V4WT,T67063,Charybdotoxin receptor beta-4 (BKbeta4),https://idrblab.net/ttd/data/target/details/T67063,Q86W47,Calcium-activated potassium channel subunit beta-4,27345.0,KCNMB4,9606,Homo sapiens (human),Blocker (channel blocker),,,,,,,
161,1496352,105008,Therapeutic Target Database (TTD),Paxilline,D0V4WT,paxilline,https://idrblab.net/ttd/data/drug/details/D0V4WT,T52297,Oxysterols receptor LXR-alpha (NR1H3),https://idrblab.net/ttd/data/target/details/T52297,Q13133,Oxysterols receptor LXR-alpha,10062.0,NR1H3,9606,Homo sapiens (human),Agonist,,,,,,,
162,1496353,105008,Comparative Toxicogenomics Database (CTD),Paxilline,C048220,paxilline,https://ctdbase.org/detail.go?type=chem&acc=C048220,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606,Homo sapiens (human),Paxilline inhibits the reaction [cilostazol inhibits the reaction [TNF results in decreased phosphorylation of AKT1 protein]],,,PMID:12807996,https://www.ncbi.nlm.nih.gov/pubmed/12807996,12807996,,
163,1496354,105008,Comparative Toxicogenomics Database (CTD),Paxilline,C048220,paxilline,https://ctdbase.org/detail.go?type=chem&acc=C048220,1385,CREB1,https://ctdbase.org/detail.go?type=gene&acc=1385,,,1385.0,CREB1,9606,Homo sapiens (human),Paxilline inhibits the reaction [cilostazol inhibits the reaction [TNF results in decreased phosphorylation of CREB1 protein]],,,PMID:12807996,https://www.ncbi.nlm.nih.gov/pubmed/12807996,12807996,,
164,1497979,105104,BindingDB,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide",21130,"N-methyl-2-phenyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21130,9093,Kappa-type opioid receptor [Y313F],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9093,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606,Homo sapiens (human),,Ki (nM),59,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
165,1497980,105104,BindingDB,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide",21130,"N-methyl-2-phenyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21130,9094,Kappa-type opioid receptor [I316A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9094,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606,Homo sapiens (human),,Ki (nM),1.5e+2,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
166,1497981,105104,BindingDB,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide",21130,"N-methyl-2-phenyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21130,9095,Kappa-type opioid receptor [Y320A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9095,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606,Homo sapiens (human),,Ki (nM),2.9e+2,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
167,1497982,105104,BindingDB,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide",21130,"N-methyl-2-phenyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21130,9096,Kappa-type opioid receptor [Y320F],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9096,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606,Homo sapiens (human),,Ki (nM),1.9e+2,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
168,1497983,105104,BindingDB,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide",21130,"N-methyl-2-phenyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21130,9073,Kappa-type opioid receptor [Q115A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9073,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
169,1497984,105104,BindingDB,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide",21130,"N-methyl-2-phenyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21130,9074,Kappa-type opioid receptor [Y119A],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9074,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
170,1497985,105104,BindingDB,"n-Methyl-2-phenyl-n-[(5r,7s,8s)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]dec-8-yl]acetamide",21130,"N-methyl-2-phenyl-N-[(5R,7S,8S)-7-(pyrrolidin-1-yl)-1-oxaspiro[4.5]decan-8-yl]acetamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=21130,9075,Kappa-type opioid receptor [Y119F],https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=9075,P41145,Kappa-type opioid receptor,4986.0,OPRK1,9606,Homo sapiens (human),,,,PMID:24121503|DOI:10.1074/jbc.M113.515668,https://www.ncbi.nlm.nih.gov/pubmed/24121503|https://doi.org/10.1074/jbc.M113.515668,24121503,10.1074/jbc.M113.515668,
171,1499236,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,84443,FRMPD3,https://ctdbase.org/detail.go?type=gene&acc=84443,,,84443.0,FRMPD3,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in decreased expression of FRMPD3 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
172,1499237,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,100861412,FSBP,https://ctdbase.org/detail.go?type=gene&acc=100861412,,,100861412.0,FSBP,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with glyphosate] results in decreased expression of FSBP mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
173,1499238,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,161835,FSIP1,https://ctdbase.org/detail.go?type=gene&acc=161835,,,161835.0,FSIP1,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose co-treated with herbicides] results in increased expression of FSIP1 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
174,1499239,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,2495,FTH1,https://ctdbase.org/detail.go?type=gene&acc=2495,,,2495.0,FTH1,10090,Mus musculus (house mouse),FTH1 protein inhibits the reaction [glucose results in increased abundance of reactive oxygen species],,,PMID:18931039,https://www.ncbi.nlm.nih.gov/pubmed/18931039,18931039,,
175,1499240,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,2495,FTH1,https://ctdbase.org/detail.go?type=gene&acc=2495,,,2495.0,FTH1,10116,Rattus norvegicus (Norway rat),[[oxygen deficiency co-treated with glucose deficiency] results in increased susceptibility to oxygen] results in increased expression of [FTH1 protein binds to FTL protein],,,PMID:16135072,https://www.ncbi.nlm.nih.gov/pubmed/16135072,16135072,,
176,1499241,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,2512,FTL,https://ctdbase.org/detail.go?type=gene&acc=2512,,,2512.0,FTL,10116,Rattus norvegicus (Norway rat),[[oxygen deficiency co-treated with glucose deficiency] results in increased susceptibility to oxygen] results in increased expression of [FTH1 protein binds to FTL protein],,,PMID:16135072,https://www.ncbi.nlm.nih.gov/pubmed/16135072,16135072,,
177,1499242,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,14325,FTL1,https://ctdbase.org/detail.go?type=gene&acc=14325,,,14325.0,Ftl1,10090,Mus musculus (house mouse),[INS protein co-treated with glucose] results in decreased expression of FTL1 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
178,1499243,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,8880,FUBP1,https://ctdbase.org/detail.go?type=gene&acc=8880,,,8880.0,FUBP1,9606,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of FUBP1 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
179,1499417,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,10146,G3BP1,https://ctdbase.org/detail.go?type=gene&acc=10146,,,10146.0,G3BP1,9606,Homo sapiens (human),G3BP1 protein results in increased uptake of glucose|ywhaz protein affects the reaction [G3BP1 protein results in increased uptake of glucose]|deoxyglucose inhibits the reaction [G3BP1 protein results in increased uptake of glucose],,,PMID:35945655,https://www.ncbi.nlm.nih.gov/pubmed/35945655,35945655,,
180,1499418,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,2538,G6PC1,https://ctdbase.org/detail.go?type=gene&acc=2538,,,2538.0,G6PC1,9606,Homo sapiens (human),Glucose promotes the reaction [[ARNT protein binds to G6PC1 promoter] which results in increased expression of G6PC1 mrna],,,PMID:15767253,https://www.ncbi.nlm.nih.gov/pubmed/15767253,15767253|15767253,,
181,1499419,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,2538,G6PC1,https://ctdbase.org/detail.go?type=gene&acc=2538,,,2538.0,G6PC1,9606,Homo sapiens (human),Glucose results in increased expression of G6PC1 mRNA,,,PMID:36156098,https://www.ncbi.nlm.nih.gov/pubmed/36156098,36156098,,
182,1499420,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,2538,G6PC1,https://ctdbase.org/detail.go?type=gene&acc=2538,,,2538.0,G6PC1,9606,Homo sapiens (human),Glucose results in increased stability of and results in increased expression of G6PC1 mRNA,,,PMID:15767253,https://www.ncbi.nlm.nih.gov/pubmed/15767253,15767253,,
183,1499421,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,2538,G6PC1,https://ctdbase.org/detail.go?type=gene&acc=2538,,,2538.0,G6PC1,10090,Mus musculus (house mouse),[glucose co-treated with S 4048] results in increased expression of G6PC1 mRNA,,,PMID:31974165,https://www.ncbi.nlm.nih.gov/pubmed/31974165,31974165,,
184,1499422,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,2538,G6PC1,https://ctdbase.org/detail.go?type=gene&acc=2538,,,2538.0,G6PC1,10116,Rattus norvegicus (Norway rat),Glucose results in decreased expression of G6PC1 mRNA,,,PMID:14988444,https://www.ncbi.nlm.nih.gov/pubmed/14988444,14988444,,
185,1500345,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,151449,GDF7,https://ctdbase.org/detail.go?type=gene&acc=151449,,,151449.0,GDF7,10090,Mus musculus (house mouse),"[lard co-treated with cholesterol, dietary co-treated with dietary sucrose co-treated with fructose co-treated with glucose] results in decreased expression of GDF7 mRNA",,,PMID:37567420,https://www.ncbi.nlm.nih.gov/pubmed/37567420,37567420,,
186,1500346,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,2669,GEM,https://ctdbase.org/detail.go?type=gene&acc=2669,,,2669.0,GEM,10090,Mus musculus (house mouse),Glucose results in increased expression of GEM mRNA,,,PMID:17178593,https://www.ncbi.nlm.nih.gov/pubmed/17178593,17178593,,
187,1500347,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,2673,GFPT1,https://ctdbase.org/detail.go?type=gene&acc=2673,,,2673.0,GFPT1,9913,Bos taurus (cattle),GFPT1 protein affects the reaction [glucose results in increased O-linked glycosylation of NOS3 protein]|gfpt1 protein affects the susceptibility to glucose|gfpt1 protein affects the reaction [glucose results in decreased activity of NOS3 protein]|gfpt1 protein affects the reaction [glucose results in decreased phosphorylation of NOS3 protein],,,PMID:11696579,https://www.ncbi.nlm.nih.gov/pubmed/11696579,11696579,,
188,1500348,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,2673,GFPT1,https://ctdbase.org/detail.go?type=gene&acc=2673,,,2673.0,GFPT1,9606,Homo sapiens (human),[INS protein co-treated with glucose] results in increased expression of GFPT1 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
189,1500349,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,2681,GGTA1,https://ctdbase.org/detail.go?type=gene&acc=2681,,,2681.0,GGTA1,9606,Homo sapiens (human),[INS protein co-treated with glucose] results in decreased expression of GGTA1 mRNA,,,PMID:22634610,https://www.ncbi.nlm.nih.gov/pubmed/22634610,22634610,,
190,1500350,107526,Comparative Toxicogenomics Database (CTD),D(+)-Glucose,D005947,Glucose,https://ctdbase.org/detail.go?type=chem&acc=D005947,2688,GH1,https://ctdbase.org/detail.go?type=gene&acc=2688,,,2688.0,GH1,9606,Homo sapiens (human),GH1 protein promotes the reaction [glucose results in increased phosphorylation of TBC1D4 protein],,,PMID:21559284,https://www.ncbi.nlm.nih.gov/pubmed/21559284,21559284,,
191,1487818,107901,Comparative Toxicogenomics Database (CTD),Epoxiconazole,C109476,epoxiconazole,https://ctdbase.org/detail.go?type=chem&acc=C109476,25,ABL1,https://ctdbase.org/detail.go?type=gene&acc=25,,,25.0,ABL1,10116,Rattus norvegicus (Norway rat),[cyproconazole co-treated with epoxiconazole] results in increased expression of ABL1 mRNA,,,PMID:29038839,https://www.ncbi.nlm.nih.gov/pubmed/29038839,29038839,,
192,1491065,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,9820,CUL7,https://ctdbase.org/detail.go?type=gene&acc=9820,,,9820.0,CUL7,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of CUL7 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
193,1491066,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,23316,CUX2,https://ctdbase.org/detail.go?type=gene&acc=23316,,,23316.0,CUX2,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of CUX2 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
194,1491067,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,2919,CXCL1,https://ctdbase.org/detail.go?type=gene&acc=2919,,,2919.0,CXCL1,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of CXCL1 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
195,1491068,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,10663,CXCR6,https://ctdbase.org/detail.go?type=gene&acc=10663,,,10663.0,CXCR6,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of CXCR6 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
196,1491069,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,26999,CYFIP2,https://ctdbase.org/detail.go?type=gene&acc=26999,,,26999.0,CYFIP2,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of CYFIP2 mRNA",,,PMID:27553808,https://www.ncbi.nlm.nih.gov/pubmed/27553808,27553808,,
197,1494170,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,376940,ZC3H6,https://ctdbase.org/detail.go?type=gene&acc=376940,,,376940.0,ZC3H6,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of ZC3H6 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
198,1494171,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,51304,ZDHHC3,https://ctdbase.org/detail.go?type=gene&acc=51304,,,51304.0,ZDHHC3,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of ZDHHC3 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
199,1494172,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,93550,ZFAND4,https://ctdbase.org/detail.go?type=gene&acc=93550,,,93550.0,ZFAND4,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of ZFAND4 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
200,1494173,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,54678,ZFP108,https://ctdbase.org/detail.go?type=gene&acc=54678,,,54678.0,Zfp108,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of ZFP108 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
201,1494174,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,434178,ZFP141,https://ctdbase.org/detail.go?type=gene&acc=434178,,,434178.0,Zfp141,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of ZFP141 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
202,1494175,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,72154,ZFP157,https://ctdbase.org/detail.go?type=gene&acc=72154,,,72154.0,Zfp157,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of ZFP157 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
203,1494176,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,67911,ZFP169,https://ctdbase.org/detail.go?type=gene&acc=67911,,,67911.0,Zfp169,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of ZFP169 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
204,1494177,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,232784,ZFP212,https://ctdbase.org/detail.go?type=gene&acc=232784,,,232784.0,Zfp212,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of ZFP212 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
205,1495491,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,9514,GAL3ST1,https://ctdbase.org/detail.go?type=gene&acc=9514,,,9514.0,GAL3ST1,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of GAL3ST1 mRNA",,,PMID:27553808,https://www.ncbi.nlm.nih.gov/pubmed/27553808,27553808,,
206,1495492,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,2582,GALE,https://ctdbase.org/detail.go?type=gene&acc=2582,,,2582.0,GALE,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of GALE mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
207,1495493,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,130589,GALM,https://ctdbase.org/detail.go?type=gene&acc=130589,,,130589.0,GALM,10116,Rattus norvegicus (Norway rat),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of GALM mRNA",,,PMID:33126064,https://www.ncbi.nlm.nih.gov/pubmed/33126064,33126064,,
208,1497863,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,93185,IGSF8,https://ctdbase.org/detail.go?type=gene&acc=93185,,,93185.0,IGSF8,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of IGSF8 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
209,1497864,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,121457,IKBIP,https://ctdbase.org/detail.go?type=gene&acc=121457,,,121457.0,IKBIP,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of IKBIP mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
210,1497865,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,22807,IKZF2,https://ctdbase.org/detail.go?type=gene&acc=22807,,,22807.0,IKZF2,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of IKZF2 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
211,1497866,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,3603,IL16,https://ctdbase.org/detail.go?type=gene&acc=3603,,,3603.0,IL16,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of IL16 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
212,1497867,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,3552,IL1A,https://ctdbase.org/detail.go?type=gene&acc=3552,,,3552.0,IL1A,9606,Homo sapiens (human),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of IL1A mRNA",,,PMID:32790152,https://www.ncbi.nlm.nih.gov/pubmed/32790152,32790152,,
213,1497868,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,3553,IL1B,https://ctdbase.org/detail.go?type=gene&acc=3553,,,3553.0,IL1B,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of IL1B mrna|ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of IL1B protein",,,PMID:35066053,https://www.ncbi.nlm.nih.gov/pubmed/35066053,35066053,,
214,1497869,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,3554,IL1R1,https://ctdbase.org/detail.go?type=gene&acc=3554,,,3554.0,IL1R1,9606,Homo sapiens (human),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of IL1R1 mRNA",,,PMID:32790152,https://www.ncbi.nlm.nih.gov/pubmed/32790152,32790152,,
215,1499071,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,22914,KLRK1,https://ctdbase.org/detail.go?type=gene&acc=22914,,,22914.0,KLRK1,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of KLRK1 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
216,1499072,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,4297,KMT2A,https://ctdbase.org/detail.go?type=gene&acc=4297,,,4297.0,KMT2A,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of KMT2A mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
217,1499073,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,25984,KRT23,https://ctdbase.org/detail.go?type=gene&acc=25984,,,25984.0,KRT23,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of KRT23 mRNA",,,PMID:27553808|PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/27553808|https://www.ncbi.nlm.nih.gov/pubmed/35832492,27553808|35832492,,
218,1499074,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,8844,KSR1,https://ctdbase.org/detail.go?type=gene&acc=8844,,,8844.0,KSR1,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of KSR1 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
219,1499075,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,3909,LAMA3,https://ctdbase.org/detail.go?type=gene&acc=3909,,,3909.0,LAMA3,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of LAMA3 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
220,1499076,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,55353,LAPTM4B,https://ctdbase.org/detail.go?type=gene&acc=55353,,,55353.0,LAPTM4B,7955,Danio rerio (zebrafish),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of LAPTM4B mrna|[ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate co-treated with perfluorooctanoic acid] results in decreased expression of LAPTM4B mRNA",,,PMID:36356740,https://www.ncbi.nlm.nih.gov/pubmed/36356740,36356740,,
221,1499077,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,23395,LARS2,https://ctdbase.org/detail.go?type=gene&acc=23395,,,23395.0,LARS2,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of LARS2 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
222,1499078,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,81606,LBH,https://ctdbase.org/detail.go?type=gene&acc=81606,,,81606.0,LBH,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of LBH mRNA",,,PMID:27553808,https://www.ncbi.nlm.nih.gov/pubmed/27553808,27553808,,
223,1499706,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,115399,LRRC56,https://ctdbase.org/detail.go?type=gene&acc=115399,,,115399.0,LRRC56,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of LRRC56 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
224,1499707,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,4045,LSAMP,https://ctdbase.org/detail.go?type=gene&acc=4045,,,4045.0,LSAMP,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of LSAMP mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
225,1499708,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,110454,LY6A,https://ctdbase.org/detail.go?type=gene&acc=110454,,,110454.0,Ly6a,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of LY6A mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
226,1499709,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,8581,LY6D,https://ctdbase.org/detail.go?type=gene&acc=8581,,,8581.0,LY6D,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of LY6D mRNA",,,PMID:27553808|PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/27553808|https://www.ncbi.nlm.nih.gov/pubmed/35832492,27553808|35832492,,
227,1499710,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,256586,LYSMD2,https://ctdbase.org/detail.go?type=gene&acc=256586,,,256586.0,LYSMD2,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of LYSMD2 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
228,1500351,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,4212,MEIS2,https://ctdbase.org/detail.go?type=gene&acc=4212,,,4212.0,MEIS2,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of MEIS2 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
229,1500352,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,155368,METTL27,https://ctdbase.org/detail.go?type=gene&acc=155368,,,155368.0,METTL27,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of METTL27 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
230,1500353,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,4240,MFGE8,https://ctdbase.org/detail.go?type=gene&acc=4240,,,4240.0,MFGE8,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in increased expression of MFGE8 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
231,1500354,114481,Comparative Toxicogenomics Database (CTD),"2,3,3,3-Tetrafluoro-2-(heptafluoropropoxy)propanoic acid",C000611729,"ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate",https://ctdbase.org/detail.go?type=chem&acc=C000611729,9258,MFHAS1,https://ctdbase.org/detail.go?type=gene&acc=9258,,,9258.0,MFHAS1,10090,Mus musculus (house mouse),"Ammonium 2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)-propanoate results in decreased expression of MFHAS1 mRNA",,,PMID:35832492,https://www.ncbi.nlm.nih.gov/pubmed/35832492,35832492,,
232,1487966,119607,Comparative Toxicogenomics Database (CTD),Valdecoxib,C406224,valdecoxib,https://ctdbase.org/detail.go?type=chem&acc=C406224,6709,SPTAN1,https://ctdbase.org/detail.go?type=gene&acc=6709,,,6709.0,SPTAN1,10116,Rattus norvegicus (Norway rat),Valdecoxib results in increased expression of SPTAN1 mRNA,,,PMID:24136188,https://www.ncbi.nlm.nih.gov/pubmed/24136188,24136188,,
233,1491720,122165,Comparative Toxicogenomics Database (CTD),"L-Proline, 1-(N-((3-((propylamino)carbonyl)oxiranyl)carbonyl)-L-isoleucyl)-, (2S-trans)-",C068250,N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline,https://ctdbase.org/detail.go?type=chem&acc=C068250,7124,TNF,https://ctdbase.org/detail.go?type=gene&acc=7124,,,7124.0,TNF,10090,Mus musculus (house mouse),N-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline inhibits the reaction [mercury results in increased expression of TNF mrna]|n-(3-propylcarbamoyloxirane-2-carbonyl)-isoleucyl-proline inhibits the reaction [mercuric chloride results in increased expression of TNF mrna],,,PMID:25237059,https://www.ncbi.nlm.nih.gov/pubmed/25237059,25237059,,
234,1491721,122187,Drug Gene Interaction database (DGIdb),5-Fluoro-8-hydroxy-2-(dipropylamino)tetralin,,BW723C86,https://www.dgidb.org/drugs/iuphar.ligand:161,,ATXN2,https://www.dgidb.org/genes/hgnc:10555,,,6311.0,ATXN2,9606,Homo sapiens (human),,,,,,,,
235,1491722,122215,BindingDB,Sandoz 58-035,50034738,3-(Decyl-dimethyl-silanyl)-N-(1-phenyl-2-p-tolyl-ethyl)-propionamide,https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50034738,7016,Liver carboxylesterase 1,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=7016,P23141,Liver carboxylesterase 1,1066.0,CES1,9606,Homo sapiens (human),,IC50 (nM),1.987e+4,PMID:25146964|DOI:10.1111/cbdd.12419,https://www.ncbi.nlm.nih.gov/pubmed/25146964|https://doi.org/10.1111/cbdd.12419,25146964,10.1111/cbdd.12419,
236,1491723,122272,Drug Gene Interaction database (DGIdb),"5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide",,BMS-182874,https://www.dgidb.org/drugs/chembl:CHEMBL267458,,HSD17B10,https://www.dgidb.org/genes/hgnc:4800,,,3028.0,HSD17B10,9606,Homo sapiens (human),,,,,,,,
237,1491724,122272,Drug Gene Interaction database (DGIdb),"5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulfonamide",,BMS-182874,https://www.dgidb.org/drugs/chembl:CHEMBL267458,,CYP2C9,https://www.dgidb.org/genes/hgnc:2623,,,1559.0,CYP2C9,9606,Homo sapiens (human),,,,,,,,
238,1491725,122623,Drug Gene Interaction database (DGIdb),Z-Pro-prolinal,,Z-PRO-PROLINAL,https://www.dgidb.org/drugs/drugbank:DB03535,,MAPT,https://www.dgidb.org/genes/hgnc:6893,,,4137.0,MAPT,9606,Homo sapiens (human),,,,,,,,
239,1491726,122765,Drug Gene Interaction database (DGIdb),4-Aminobenzamidine hydrochloride,,CHEMBL:CHEMBL545184,https://www.dgidb.org/drugs/chembl:CHEMBL545184,,EHMT2,https://www.dgidb.org/genes/hgnc:14129,,,10919.0,EHMT2,9606,Homo sapiens (human),,,,,,,,
240,1491727,122797,Drug Gene Interaction database (DGIdb),4'-Demethylepipodophyllotoxin,,4'-DEMETHYLEPIPODOPHYLLOTOXIN,https://www.dgidb.org/drugs/chembl:CHEMBL31929,,AR,https://www.dgidb.org/genes/hgnc:644,,,367.0,AR,9606,Homo sapiens (human),,,,,,,,
241,1493198,123976,IUPHAR/BPS Guide to PHARMACOLOGY,27-Hydroxycholesterol,2752,27-hydroxycholesterol,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2752,602,Liver X receptor-α,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=602,Q13133,Oxysterols receptor LXR-alpha,10062.0,NR1H3,9606,Homo sapiens (human),Agonist,pEC50,7.1,PMID:11504730,https://www.ncbi.nlm.nih.gov/pubmed/11504730,11504730,,
242,1493199,123976,IUPHAR/BPS Guide to PHARMACOLOGY,27-Hydroxycholesterol,2752,27-hydroxycholesterol,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=2752,601,Liver X receptor-β,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=601,P55055,Oxysterols receptor LXR-beta,7376.0,NR1H2,9606,Homo sapiens (human),Agonist,pEC50,7.15,PMID:11504730,https://www.ncbi.nlm.nih.gov/pubmed/11504730,11504730,,
243,1493200,123976,BindingDB,27-Hydroxycholesterol,20183,"(1S,2R,5S,10S,11S,14R,15R)-14-[(2R,6R)-7-hydroxy-6-methylheptan-2-yl]-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-5-ol",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=20183,877,Oxysterols receptor LXR-alpha,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=877,Q13133,Oxysterols receptor LXR-alpha,10062.0,NR1H3,9606,Homo sapiens (human),,,,PMID:11300870|DOI:10.1021/jm0004749,https://www.ncbi.nlm.nih.gov/pubmed/11300870|https://doi.org/10.1021/jm0004749,11300870,10.1021/jm0004749,
244,1493201,124007,Drug Gene Interaction database (DGIdb),"3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one",,LITHOCHOLIC ACID,https://www.dgidb.org/drugs/iuphar.ligand:611,,NFE2L2,https://www.dgidb.org/genes/hgnc:7782,,,4780.0,NFE2L2,9606,Homo sapiens (human),,,,,,,,
245,1493202,124007,Drug Gene Interaction database (DGIdb),"3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one",,LITHOCHOLIC ACID,https://www.dgidb.org/drugs/iuphar.ligand:611,,PLK1,https://www.dgidb.org/genes/hgnc:9077,,,5347.0,PLK1,9606,Homo sapiens (human),,,,,,,,
246,1493203,124007,Drug Gene Interaction database (DGIdb),"3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo(3,2-b)pyrid-5-one",,LITHOCHOLIC ACID,https://www.dgidb.org/drugs/iuphar.ligand:611,,SNCA,https://www.dgidb.org/genes/hgnc:11138,,,6622.0,SNCA,9606,Homo sapiens (human),,,,,,,,
247,1493204,124039,Comparative Toxicogenomics Database (CTD),Fraxinellone,C075391,fraxinellone,https://ctdbase.org/detail.go?type=chem&acc=C075391,834,CASP1,https://ctdbase.org/detail.go?type=gene&acc=834,,,834.0,CASP1,9606,Homo sapiens (human),Fraxinellone inhibits the reaction [[lipopolysaccharides co-treated with adenosine triphosphate] results in increased activity of CASP1 protein],,,PMID:25448682,https://www.ncbi.nlm.nih.gov/pubmed/25448682,25448682,,
248,1493205,124039,Comparative Toxicogenomics Database (CTD),Fraxinellone,C075391,fraxinellone,https://ctdbase.org/detail.go?type=chem&acc=C075391,1576,CYP3A4,https://ctdbase.org/detail.go?type=gene&acc=1576,,,1576.0,CYP3A4,9606,Homo sapiens (human),CYP3A4 protein results in increased glutathionylation of fraxinellone,,,PMID:32484342,https://www.ncbi.nlm.nih.gov/pubmed/32484342,32484342,,
249,1493206,124039,Comparative Toxicogenomics Database (CTD),Fraxinellone,C075391,fraxinellone,https://ctdbase.org/detail.go?type=chem&acc=C075391,3383,ICAM1,https://ctdbase.org/detail.go?type=gene&acc=3383,,,3383.0,ICAM1,10090,Mus musculus (house mouse),Fraxinellone inhibits the reaction [dextran sulfate results in increased expression of ICAM1 mrna],,,PMID:25448682,https://www.ncbi.nlm.nih.gov/pubmed/25448682,25448682,,
250,1488764,128919,Comparative Toxicogenomics Database (CTD),Xaliproden,C462299,xaliproden,https://ctdbase.org/detail.go?type=chem&acc=C462299,3757,KCNH2,https://ctdbase.org/detail.go?type=gene&acc=3757,,,3757.0,KCNH2,9606,Homo sapiens (human),Xaliproden results in decreased activity of KCNH2 protein,,,PMID:28551711,https://www.ncbi.nlm.nih.gov/pubmed/28551711,28551711,,
251,1497262,132519,Comparative Toxicogenomics Database (CTD),Ilomastat,C078131,N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide,https://ctdbase.org/detail.go?type=chem&acc=C078131,4318,MMP9,https://ctdbase.org/detail.go?type=gene&acc=4318,,,4318.0,MMP9,10116,Rattus norvegicus (Norway rat),N-(2(R)-2-(hydroxamidocarbonylmethyl)-4-methylpentanoyl)-L-tryptophan methylamide inhibits the reaction [adenosine triphosphate results in increased activity of MMP9 protein],,,PMID:20195827,https://www.ncbi.nlm.nih.gov/pubmed/20195827,20195827,,
252,1489735,132663,Therapeutic Target Database (TTD),Adenosine kinase inhibitor GP515,D07OAC,GP515,https://idrblab.net/ttd/data/drug/details/D07OAC,T71390,Steroid 5-alpha-reductase 2 (SRD5A2),https://idrblab.net/ttd/data/target/details/T71390,P31213,3-oxo-5-alpha-steroid 4-dehydrogenase 2,6716.0,SRD5A2,9606,Homo sapiens (human),Inhibitor,,,,,,,
253,1489736,132663,Therapeutic Target Database (TTD),Adenosine kinase inhibitor GP515,D07OAC,GP515,https://idrblab.net/ttd/data/drug/details/D07OAC,T70309,Steroid 5-alpha-reductase 1 (SRD5A1),https://idrblab.net/ttd/data/target/details/T70309,P18405,3-oxo-5-alpha-steroid 4-dehydrogenase 1,6715.0,SRD5A1,9606,Homo sapiens (human),Inhibitor,,,,,,,
254,1489737,132916,IUPHAR/BPS Guide to PHARMACOLOGY,Pranazepide,874,pranazepide,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=874,76,CCK1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=76,P30551,Cholecystokinin receptor type A,24889.0,Cckar,10116,Rattus norvegicus (Norway rat),Antagonist,pIC50,9.4,PMID:7509389,https://www.ncbi.nlm.nih.gov/pubmed/7509389,7509389,,
255,1489738,132932,Comparative Toxicogenomics Database (CTD),3-(Difluoromethyl)-1-(4-methoxyphenyl)-5-(4-(methylsulfinyl)phenyl)pyrazole,C108904,3-(difluoromethyl)-1-(4-methoxyphenyl)-5-(4-(methylsulfinyl)phenyl)pyrazole,https://ctdbase.org/detail.go?type=chem&acc=C108904,4985,OPRD1,https://ctdbase.org/detail.go?type=gene&acc=4985,,,4985.0,OPRD1,10116,Rattus norvegicus (Norway rat),[naltrindole binds to and results in decreased activity of OPRD1 protein] which results in decreased susceptibility to 3-(difluoromethyl)-1-(4-methoxyphenyl)-5-(4-(methylsulfinyl)phenyl)pyrazole,,,PMID:12962910,https://www.ncbi.nlm.nih.gov/pubmed/12962910,12962910,,
256,1489739,132971,DrugBank,Abiraterone,DB05812,Abiraterone,https://www.drugbank.ca/drugs/DB05812,BE0000344,"Steroid 17-alpha-hydroxylase/17,20 lyase",https://www.drugbank.ca/bio_entities/BE0000344,P05093,"Steroid 17-alpha-hydroxylase/17,20 lyase",1586.0,CYP17A1,9606,Homo sapiens (human),Inhibitor,,,PMID:20645691|PMID:15150570,https://www.ncbi.nlm.nih.gov/pubmed/20645691|https://www.ncbi.nlm.nih.gov/pubmed/15150570,20645691|15150570,,
257,1489740,132971,DrugBank,Abiraterone,DB05812,Abiraterone,https://www.drugbank.ca/drugs/DB05812,BE0002638,Cytochrome P450 3A4,https://www.drugbank.ca/bio_entities/BE0002638,P08684,Cytochrome P450 3A4,1576.0,CYP3A4,9606,Homo sapiens (human),Substrate|Inhibitor,,,PMID:22714819,https://www.ncbi.nlm.nih.gov/pubmed/22714819,22714819,,
258,1489741,132971,DrugBank,Abiraterone,DB05812,Abiraterone,https://www.drugbank.ca/drugs/DB05812,BE0002433,Cytochrome P450 1A2,https://www.drugbank.ca/bio_entities/BE0002433,P05177,Cytochrome P450 1A2,1544.0,CYP1A2,9606,Homo sapiens (human),Inhibitor,,,PMID:28893623|PMID:27106175|PMID:22714819,https://www.ncbi.nlm.nih.gov/pubmed/28893623|https://www.ncbi.nlm.nih.gov/pubmed/27106175|https://www.ncbi.nlm.nih.gov/pubmed/22714819,28893623|27106175|22714819,,
259,1498629,134560,BindingDB,"1,3,4-Thiadiazole-2-sulfonamide, 5-(((4-aminophenyl)sulfonyl)amino)-",10870,"2-N-(4-aminobenzene)-1,3,4-thiadiazole-2,5-disulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10870,1229,"Carbonic anhydrase 5B, mitochondrial",https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1229,Q9Y2D0,"Carbonic anhydrase 5B, mitochondrial",11238.0,CA5B,9606,Homo sapiens (human),,Ki (nM),30,PMID:16302824|DOI:10.1021/jm050483n,https://www.ncbi.nlm.nih.gov/pubmed/16302824|https://doi.org/10.1021/jm050483n,16302824,10.1021/jm050483n,
260,1498630,134560,BindingDB,"1,3,4-Thiadiazole-2-sulfonamide, 5-(((4-aminophenyl)sulfonyl)amino)-",10870,"2-N-(4-aminobenzene)-1,3,4-thiadiazole-2,5-disulfonamide",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=10870,1193,Carbonic anhydrase 2,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1193,P00918,Carbonic anhydrase 2,760.0,CA2,9606,Homo sapiens (human),,Ki (nM),2,PMID:16302824|DOI:10.1021/jm050483n,https://www.ncbi.nlm.nih.gov/pubmed/16302824|https://doi.org/10.1021/jm050483n,16302824,10.1021/jm050483n,
261,1490519,134799,Comparative Toxicogenomics Database (CTD),3alpha-Hydroxynorethynodrel,C002029,"17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol",https://ctdbase.org/detail.go?type=chem&acc=C002029,1017,CDK2,https://ctdbase.org/detail.go?type=gene&acc=1017,,,1017.0,CDK2,10116,Rattus norvegicus (Norway rat),"17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol results in decreased expression of and results in decreased activity of CDK2 protein",,,PMID:16019103,https://www.ncbi.nlm.nih.gov/pubmed/16019103,16019103,,
262,1490520,134799,Comparative Toxicogenomics Database (CTD),3alpha-Hydroxynorethynodrel,C002029,"17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol",https://ctdbase.org/detail.go?type=chem&acc=C002029,1019,CDK4,https://ctdbase.org/detail.go?type=gene&acc=1019,,,1019.0,CDK4,10116,Rattus norvegicus (Norway rat),"17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol results in decreased expression of CDK4 protein",,,PMID:16019103,https://www.ncbi.nlm.nih.gov/pubmed/16019103,16019103,,
263,1490521,134799,Comparative Toxicogenomics Database (CTD),3alpha-Hydroxynorethynodrel,C002029,"17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol",https://ctdbase.org/detail.go?type=chem&acc=C002029,1026,CDKN1A,https://ctdbase.org/detail.go?type=gene&acc=1026,,,1026.0,CDKN1A,10116,Rattus norvegicus (Norway rat),"17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol results in increased expression of CDKN1A protein",,,PMID:16019103,https://www.ncbi.nlm.nih.gov/pubmed/16019103,16019103,,
264,1490522,134799,Comparative Toxicogenomics Database (CTD),3alpha-Hydroxynorethynodrel,C002029,"17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol",https://ctdbase.org/detail.go?type=chem&acc=C002029,22818,COPZ1,https://ctdbase.org/detail.go?type=gene&acc=22818,,,22818.0,COPZ1,8022,Oncorhynchus mykiss (rainbow trout),"17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol results in increased expression of COPZ1 mRNA",,,PMID:17275934,https://www.ncbi.nlm.nih.gov/pubmed/17275934,17275934,,
265,1490523,134799,Comparative Toxicogenomics Database (CTD),3alpha-Hydroxynorethynodrel,C002029,"17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol",https://ctdbase.org/detail.go?type=chem&acc=C002029,1588,CYP19A1,https://ctdbase.org/detail.go?type=gene&acc=1588,,,1588.0,CYP19A1,7955,Danio rerio (zebrafish),"17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol results in decreased expression of CYP19A1 mRNA",,,PMID:15210295,https://www.ncbi.nlm.nih.gov/pubmed/15210295,15210295,,
266,1490524,134799,Comparative Toxicogenomics Database (CTD),3alpha-Hydroxynorethynodrel,C002029,"17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol",https://ctdbase.org/detail.go?type=chem&acc=C002029,403332,CYP19A2,https://ctdbase.org/detail.go?type=gene&acc=403332,,,403332.0,CYP19A2,7955,Danio rerio (zebrafish),"17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol results in increased expression of CYP19A2 mrna|benzo(a)pyrene inhibits the reaction [17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol results in increased expression of CYP19A2 mrna]",,,PMID:15210295,https://www.ncbi.nlm.nih.gov/pubmed/15210295,15210295,,
267,1490525,134799,Comparative Toxicogenomics Database (CTD),3alpha-Hydroxynorethynodrel,C002029,"17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol",https://ctdbase.org/detail.go?type=chem&acc=C002029,1543,CYP1A1,https://ctdbase.org/detail.go?type=gene&acc=1543,,,1543.0,CYP1A1,8022,Oncorhynchus mykiss (rainbow trout),"17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol results in decreased expression of CYP1A1 mrna|[17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol co-treated with paraquat co-treated with tetrachlorodibenzodioxin] results in increased expression of CYP1A1 mRNA",,,PMID:17275934,https://www.ncbi.nlm.nih.gov/pubmed/17275934,17275934,,
268,1490526,134799,Comparative Toxicogenomics Database (CTD),3alpha-Hydroxynorethynodrel,C002029,"17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol",https://ctdbase.org/detail.go?type=chem&acc=C002029,1545,CYP1B1,https://ctdbase.org/detail.go?type=gene&acc=1545,,,1545.0,CYP1B1,8022,Oncorhynchus mykiss (rainbow trout),"[17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol co-treated with paraquat co-treated with tetrachlorodibenzodioxin] results in increased expression of CYP1B1 mrna|17alpha-ethynylestr-5(10)-ene-3alpha,17beta-diol results in decreased expression of CYP1B1 mRNA",,,PMID:17275934,https://www.ncbi.nlm.nih.gov/pubmed/17275934,17275934,,
269,1498631,135269,Comparative Toxicogenomics Database (CTD),"Salicylic acid, valerate",C401835,valerylsalicylate,https://ctdbase.org/detail.go?type=chem&acc=C401835,5742,PTGS1,https://ctdbase.org/detail.go?type=gene&acc=5742,,,5742.0,PTGS1,9606,Homo sapiens (human),Valerylsalicylate inhibits the reaction [arachidonic acid results in increased activity of PTGS1 protein],,,PMID:19751497,https://www.ncbi.nlm.nih.gov/pubmed/19751497,19751497,,
270,1498632,135269,Comparative Toxicogenomics Database (CTD),"Salicylic acid, valerate",C401835,valerylsalicylate,https://ctdbase.org/detail.go?type=chem&acc=C401835,5742,PTGS1,https://ctdbase.org/detail.go?type=gene&acc=5742,,,5742.0,PTGS1,9606,Homo sapiens (human),Valerylsalicylate results in decreased activity of PTGS1 protein,,,PMID:15700047|PMID:20304815,https://www.ncbi.nlm.nih.gov/pubmed/15700047|https://www.ncbi.nlm.nih.gov/pubmed/20304815,15700047|20304815,,
271,1498633,135269,Comparative Toxicogenomics Database (CTD),"Salicylic acid, valerate",C401835,valerylsalicylate,https://ctdbase.org/detail.go?type=chem&acc=C401835,6648,SOD2,https://ctdbase.org/detail.go?type=gene&acc=6648,,,6648.0,SOD2,10090,Mus musculus (house mouse),Valerylsalicylate affects the reaction [SOD2 protein affects the susceptibility to acetylcholine],,,PMID:20304815,https://www.ncbi.nlm.nih.gov/pubmed/20304815,20304815,,
272,1498634,135326,Drug Gene Interaction database (DGIdb),Iobenguane I-123,,IOBENGUANE I-123,https://www.dgidb.org/drugs/rxcui:1426748,,SLC6A2,https://www.dgidb.org/genes/hgnc:11048,,,6530.0,SLC6A2,9606,Homo sapiens (human),,,,,,,,
273,1498635,135411,IUPHAR/BPS Guide to PHARMACOLOGY,6-[3-(1-Adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic Acid,3431,AHPN,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3431,592,Retinoic acid receptor-γ,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=592,P13631,Retinoic acid receptor gamma ,5916.0,RARG,9606,Homo sapiens (human),Agonist,pKi,7.11,PMID:8544175,https://www.ncbi.nlm.nih.gov/pubmed/8544175,8544175,,
274,1498636,135411,Therapeutic Target Database (TTD),6-[3-(1-Adamantyl)-4-hydroxyphenyl]-2-naphthalenecarboxylic Acid,D09YFJ,PMID27336223-Compound-12,https://idrblab.net/ttd/data/drug/details/D09YFJ,T82146,Retinoic acid receptor gamma (RARG),https://idrblab.net/ttd/data/target/details/T82146,P13631,Retinoic acid receptor gamma ,5916.0,RARG,9606,Homo sapiens (human),Agonist,,,,,,,
275,1492341,148195,DrugBank,Lonafarnib,DB06448,Lonafarnib,https://www.drugbank.ca/drugs/DB06448,BE0004866,Cytochrome P450 3A5,https://www.drugbank.ca/bio_entities/BE0004866,P20815,Cytochrome P450 3A5,1577.0,CYP3A5,9606,Homo sapiens (human),Substrate|Inhibitor,,,,,,,
276,1492342,148195,DrugBank,Lonafarnib,DB06448,Lonafarnib,https://www.drugbank.ca/drugs/DB06448,BE0004866,Cytochrome P450 3A7,https://www.drugbank.ca/bio_entities/BE0004866,P24462,Cytochrome P450 3A7,100861540.0,CYP3A7-CYP3A51P,9606,Homo sapiens (human),Substrate|Inhibitor,,,,,,,
277,1492343,148195,DrugBank,Lonafarnib,DB06448,Lonafarnib,https://www.drugbank.ca/drugs/DB06448,BE0002887,Cytochrome P450 2C8,https://www.drugbank.ca/bio_entities/BE0002887,P10632,Cytochrome P450 2C8,1558.0,CYP2C8,9606,Homo sapiens (human),Substrate|Inhibitor,,,PMID:16443667,https://www.ncbi.nlm.nih.gov/pubmed/16443667,16443667,,
278,1492344,148195,DrugBank,Lonafarnib,DB06448,Lonafarnib,https://www.drugbank.ca/drugs/DB06448,BE0002793,Cytochrome P450 2C9,https://www.drugbank.ca/bio_entities/BE0002793,P11712,Cytochrome P450 2C9 ,1559.0,CYP2C9,9606,Homo sapiens (human),Substrate,,,,,,,
279,1492345,148195,DrugBank,Lonafarnib,DB06448,Lonafarnib,https://www.drugbank.ca/drugs/DB06448,BE0003536,Cytochrome P450 2C19,https://www.drugbank.ca/bio_entities/BE0003536,P33261,Cytochrome P450 2C19,1557.0,CYP2C19,9606,Homo sapiens (human),Substrate|Inhibitor,,,,,,,
280,1492346,148195,DrugBank,Lonafarnib,DB06448,Lonafarnib,https://www.drugbank.ca/drugs/DB06448,BE0002433,Cytochrome P450 1A2,https://www.drugbank.ca/bio_entities/BE0002433,P05177,Cytochrome P450 1A2,1544.0,CYP1A2,9606,Homo sapiens (human),Substrate,,,,,,,
281,1492347,148195,DrugBank,Lonafarnib,DB06448,Lonafarnib,https://www.drugbank.ca/drugs/DB06448,BE0003336,Cytochrome P450 2A6,https://www.drugbank.ca/bio_entities/BE0003336,P11509,Cytochrome P450 2A6,1548.0,CYP2A6,9606,Homo sapiens (human),Substrate,,,,,,,
282,1492348,148195,DrugBank,Lonafarnib,DB06448,Lonafarnib,https://www.drugbank.ca/drugs/DB06448,BE0003533,Cytochrome P450 2E1,https://www.drugbank.ca/bio_entities/BE0003533,P05181,Cytochrome P450 2E1,1571.0,CYP2E1,9606,Homo sapiens (human),Substrate,,,,,,,
283,1492349,148195,DrugBank,Lonafarnib,DB06448,Lonafarnib,https://www.drugbank.ca/drugs/DB06448,BE0001032,Multidrug resistance protein 1,https://www.drugbank.ca/bio_entities/BE0001032,P08183,ATP-dependent translocase ABCB1,5243.0,ABCB1,9606,Homo sapiens (human),Substrate|Inhibitor,,,PMID:11606389|PMID:14671431,https://www.ncbi.nlm.nih.gov/pubmed/11606389|https://www.ncbi.nlm.nih.gov/pubmed/14671431,11606389|14671431,,
284,1492350,148195,DrugBank,Lonafarnib,DB06448,Lonafarnib,https://www.drugbank.ca/drugs/DB06448,BE0001004,Solute carrier organic anion transporter family member 1B1,https://www.drugbank.ca/bio_entities/BE0001004,Q9Y6L6,Solute carrier organic anion transporter family member 1B1,10599.0,SLCO1B1,9606,Homo sapiens (human),Inhibitor,,,,,,,
285,1492351,148195,DrugBank,Lonafarnib,DB06448,Lonafarnib,https://www.drugbank.ca/drugs/DB06448,BE0003659,Solute carrier organic anion transporter family member 1B3,https://www.drugbank.ca/bio_entities/BE0003659,Q9NPD5,Solute carrier organic anion transporter family member 1B3,28234.0,SLCO1B3,9606,Homo sapiens (human),Inhibitor,,,,,,,
286,1492863,151194,Drug Gene Interaction database (DGIdb),Vatalanib,,VATALANIB,https://www.dgidb.org/drugs/ncit:C1868,,AR,https://www.dgidb.org/genes/hgnc:644,,,367.0,AR,9606,Homo sapiens (human),,,,,,,,
287,1492864,151194,Drug Gene Interaction database (DGIdb),Vatalanib,,VATALANIB,https://www.dgidb.org/drugs/ncit:C1868,,PDGFRB,https://www.dgidb.org/genes/hgnc:8804,,,5159.0,PDGFRB,9606,Homo sapiens (human),,,,,,,,
288,1492865,151194,Drug Gene Interaction database (DGIdb),Vatalanib,,VATALANIB,https://www.dgidb.org/drugs/ncit:C1868,,PDGFRB,https://www.dgidb.org/genes/hgnc:8804,,,5159.0,PDGFRB,9606,Homo sapiens (human),,,,,,,,
289,1492866,151194,Drug Gene Interaction database (DGIdb),Vatalanib,,VATALANIB,https://www.dgidb.org/drugs/ncit:C1868,,RPS6KB1,https://www.dgidb.org/genes/hgnc:10436,,,6198.0,RPS6KB1,9606,Homo sapiens (human),,,,,,,,
290,1492867,151194,Drug Gene Interaction database (DGIdb),Vatalanib,,VATALANIB,https://www.dgidb.org/drugs/ncit:C1868,,KDR,https://www.dgidb.org/genes/hgnc:6307,,,3791.0,KDR,9606,Homo sapiens (human),,,,,,,,
291,1492868,151501,IUPHAR/BPS Guide to PHARMACOLOGY,2-(4-Chlorophenoxy)butanoic acid,4097,S-(-)CPB,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=4097,698,ClC-1,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=698,P35523,Chloride channel protein 1,1180.0,CLCN1,9606,Homo sapiens (human),,,7.52,,,,,
292,1492869,151501,Therapeutic Target Database (TTD),2-(4-Chlorophenoxy)butanoic acid,D0YK1E,S-(-)CPB,https://idrblab.net/ttd/data/drug/details/D0YK1E,T72467,Chloride channel protein 1 (ClC-1),https://idrblab.net/ttd/data/target/details/T72467,P35523,Chloride channel protein 1,1180.0,CLCN1,9606,Homo sapiens (human),Blocker (channel blocker),,,,,,,
293,1492870,151722,Comparative Toxicogenomics Database (CTD),Copper Histidine,C098468,copper histidine,https://ctdbase.org/detail.go?type=chem&acc=C098468,351,APP,https://ctdbase.org/detail.go?type=gene&acc=351,,,351.0,APP,10090,Mus musculus (house mouse),Copper histidine results in increased expression of APP mRNA,,,PMID:15467011,https://www.ncbi.nlm.nih.gov/pubmed/15467011,15467011,,
294,1496505,158333,Comparative Toxicogenomics Database (CTD),tert-Butylphenyl diphenyl phosphate,C046393,tert-butylphenyl diphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C046393,2116,ETV2,https://ctdbase.org/detail.go?type=gene&acc=2116,,,2116.0,ETV2,9606,Homo sapiens (human),Tert-butylphenyl diphenyl phosphate inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in increased expression of SPN protein]|tert-butylphenyl diphenyl phosphate inhibits the reaction [[ETV2 protein co-treated with GATA2 protein] results in decreased expression of CDH5 protein],,,PMID:31404653,https://www.ncbi.nlm.nih.gov/pubmed/31404653,31404653,,
295,1496506,158333,Comparative Toxicogenomics Database (CTD),tert-Butylphenyl diphenyl phosphate,C046393,tert-butylphenyl diphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C046393,2243,FGA,https://ctdbase.org/detail.go?type=gene&acc=2243,,,2243.0,FGA,9031,Gallus gallus (chicken),Tert-butylphenyl diphenyl phosphate results in decreased expression of FGA mRNA,,,PMID:30133003,https://www.ncbi.nlm.nih.gov/pubmed/30133003,30133003,,
296,1496507,158333,Comparative Toxicogenomics Database (CTD),tert-Butylphenyl diphenyl phosphate,C046393,tert-butylphenyl diphenyl phosphate,https://ctdbase.org/detail.go?type=chem&acc=C046393,2303,FOXC2,https://ctdbase.org/detail.go?type=gene&acc=2303,,,2303.0,FOXC2,10090,Mus musculus (house mouse),Tert-butylphenyl diphenyl phosphate results in decreased expression of FOXC2 mRNA,,,PMID:32976586,https://www.ncbi.nlm.nih.gov/pubmed/32976586,32976586,,
297,1497108,158397,Drug Gene Interaction database (DGIdb),(S)-Ampa,,(S)-AMPA,https://www.dgidb.org/drugs/drugbank:DB02057,,CYP2C19,https://www.dgidb.org/genes/hgnc:2621,,,1557.0,CYP2C19,9606,Homo sapiens (human),,,,,,,,
298,1497109,158758,Therapeutic Target Database (TTD),(S)-(+)-rolipram,D02FZD,(S)-Rolipram,https://idrblab.net/ttd/data/drug/details/D02FZD,T61744,Phosphodiesterase 4A (PDE4A),https://idrblab.net/ttd/data/target/details/T61744,P27815,"cAMP-specific 3',5'-cyclic phosphodiesterase 4A",5141.0,PDE4A,9606,Homo sapiens (human),Inhibitor,,,,,,,
299,1497110,158758,Therapeutic Target Database (TTD),(S)-(+)-rolipram,D02FZD,(S)-Rolipram,https://idrblab.net/ttd/data/drug/details/D02FZD,T10265,Phosphodiesterase 4B (PDE4B),https://idrblab.net/ttd/data/target/details/T10265,Q07343,"cAMP-specific 3',5'-cyclic phosphodiesterase 4B",5142.0,PDE4B,9606,Homo sapiens (human),Inhibitor,,,,,,,
300,1497111,158798,ChEMBL,Antazoline phosphate,CHEMBL1200550,ANTAZOLINE PHOSPHATE,https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1200550/,CHEMBL231,Histamine H1 receptor,https://www.ebi.ac.uk/chembl/target_report_card/CHEMBL231/,P35367,Histamine H1 receptor,3269.0,HRH1,9606,Homo sapiens (human),Histamine H1 receptor antagonist,,,PMID:6113566,https://www.ncbi.nlm.nih.gov/pubmed/6113566,6113566,,
301,1497112,159325,DrugBank,Torcetrapib,DB06281,Torcetrapib,https://www.drugbank.ca/drugs/DB06281,BE0003516,Cholesteryl ester transfer protein,https://www.drugbank.ca/bio_entities/BE0003516,P11597,Cholesteryl ester transfer protein,1071.0,CETP,9606,Homo sapiens (human),Antagonist,,,PMID:18422466|PMID:18221079,https://www.ncbi.nlm.nih.gov/pubmed/18422466|https://www.ncbi.nlm.nih.gov/pubmed/18221079,18422466|18221079,,
302,1497113,159325,DrugBank,Torcetrapib,DB06281,Torcetrapib,https://www.drugbank.ca/drugs/DB06281,BE0003542,"Cytochrome P450 11B2, mitochondrial",https://www.drugbank.ca/bio_entities/BE0003542,P19099,"Cytochrome P450 11B2, mitochondrial",1585.0,CYP11B2,9606,Homo sapiens (human),Inducer,,,PMID:19164467,https://www.ncbi.nlm.nih.gov/pubmed/19164467,19164467,,
303,1497114,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,60496,AASDHPPT,https://ctdbase.org/detail.go?type=gene&acc=60496,,,60496.0,AASDHPPT,9606,Homo sapiens (human),Torcetrapib results in increased expression of AASDHPPT mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
304,1497115,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,2334,AFF2,https://ctdbase.org/detail.go?type=gene&acc=2334,,,2334.0,AFF2,9606,Homo sapiens (human),Torcetrapib results in increased expression of AFF2 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
305,1497978,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,730112,CIMIP2B,https://ctdbase.org/detail.go?type=gene&acc=730112,,,730112.0,CIMIP2B,9606,Homo sapiens (human),Torcetrapib results in increased expression of CIMIP2B mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
306,1499858,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,4286,MITF,https://ctdbase.org/detail.go?type=gene&acc=4286,,,4286.0,MITF,9606,Homo sapiens (human),Torcetrapib results in increased expression of MITF mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
307,1499859,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,4289,MKLN1,https://ctdbase.org/detail.go?type=gene&acc=4289,,,4289.0,MKLN1,9606,Homo sapiens (human),Torcetrapib results in increased expression of MKLN1 mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
308,1499860,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,22808,MRAS,https://ctdbase.org/detail.go?type=gene&acc=22808,,,22808.0,MRAS,9606,Homo sapiens (human),Torcetrapib results in increased expression of MRAS mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
309,1499861,159325,Comparative Toxicogenomics Database (CTD),Torcetrapib,C483909,torcetrapib,https://ctdbase.org/detail.go?type=chem&acc=C483909,10627,MYL12A,https://ctdbase.org/detail.go?type=gene&acc=10627,,,10627.0,MYL12A,9606,Homo sapiens (human),Torcetrapib results in increased expression of MYL12A mRNA,,,PMID:23228038,https://www.ncbi.nlm.nih.gov/pubmed/23228038,23228038,,
310,1488608,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,27235,COQ2,https://ctdbase.org/detail.go?type=gene&acc=27235,,,27235.0,COQ2,9606,Homo sapiens (human),Abrine results in increased expression of COQ2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
311,1488609,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,84274,COQ5,https://ctdbase.org/detail.go?type=gene&acc=84274,,,84274.0,COQ5,9606,Homo sapiens (human),Abrine results in increased expression of COQ5 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
312,1488610,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,51004,COQ6,https://ctdbase.org/detail.go?type=gene&acc=51004,,,51004.0,COQ6,9606,Homo sapiens (human),Abrine results in increased expression of COQ6 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
313,1488611,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,79934,COQ8B,https://ctdbase.org/detail.go?type=gene&acc=79934,,,79934.0,COQ8B,9606,Homo sapiens (human),Abrine results in increased expression of COQ8B mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
314,1488612,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,57017,COQ9,https://ctdbase.org/detail.go?type=gene&acc=57017,,,57017.0,COQ9,9606,Homo sapiens (human),Abrine results in increased expression of COQ9 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
315,1489742,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1396,CRIP1,https://ctdbase.org/detail.go?type=gene&acc=1396,,,1396.0,CRIP1,9606,Homo sapiens (human),Abrine results in decreased expression of CRIP1 protein,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
316,1489743,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,401262,CRIP3,https://ctdbase.org/detail.go?type=gene&acc=401262,,,401262.0,CRIP3,9606,Homo sapiens (human),Abrine results in decreased expression of CRIP3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
317,1489744,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,103691737,CRIPAK,https://ctdbase.org/detail.go?type=gene&acc=103691737,,,103691737.0,Cripak,9606,Homo sapiens (human),Abrine results in decreased expression of CRIPAK mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
318,1489745,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,83690,CRISPLD1,https://ctdbase.org/detail.go?type=gene&acc=83690,,,83690.0,CRISPLD1,9606,Homo sapiens (human),Abrine results in decreased expression of CRISPLD1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
319,1490516,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5621,PRNP,https://ctdbase.org/detail.go?type=gene&acc=5621,,,5621.0,PRNP,9606,Homo sapiens (human),Abrine results in decreased expression of PRNP protein,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
320,1490517,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5624,PROC,https://ctdbase.org/detail.go?type=gene&acc=5624,,,5624.0,PROC,9606,Homo sapiens (human),Abrine results in decreased expression of PROC mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
321,1490518,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,147011,PROCA1,https://ctdbase.org/detail.go?type=gene&acc=147011,,,147011.0,PROCA1,9606,Homo sapiens (human),Abrine results in decreased expression of PROCA1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
322,1490800,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,4283,CXCL9,https://ctdbase.org/detail.go?type=gene&acc=4283,,,4283.0,CXCL9,10090,Mus musculus (house mouse),Abrine results in increased expression of CXCL9 mRNA,,,PMID:22595364,https://www.ncbi.nlm.nih.gov/pubmed/22595364,22595364,,
323,1490801,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,3579,CXCR2,https://ctdbase.org/detail.go?type=gene&acc=3579,,,3579.0,CXCR2,9606,Homo sapiens (human),Abrine results in increased expression of CXCR2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
324,1491879,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,79877,DCAKD,https://ctdbase.org/detail.go?type=gene&acc=79877,,,79877.0,DCAKD,9606,Homo sapiens (human),Abrine results in decreased expression of DCAKD mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
325,1491880,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,195208,DCDC2A,https://ctdbase.org/detail.go?type=gene&acc=195208,,,195208.0,Dcdc2a,10090,Mus musculus (house mouse),Abrine results in increased expression of DCDC2A mRNA,,,PMID:22595364,https://www.ncbi.nlm.nih.gov/pubmed/22595364,22595364,,
326,1491881,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,728597,DCDC2C,https://ctdbase.org/detail.go?type=gene&acc=728597,,,728597.0,DCDC2C,9606,Homo sapiens (human),Abrine results in increased expression of DCDC2C mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
327,1491882,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,8642,DCHS1,https://ctdbase.org/detail.go?type=gene&acc=8642,,,8642.0,DCHS1,9606,Homo sapiens (human),Abrine results in decreased expression of DCHS1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
328,1491883,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1633,DCK,https://ctdbase.org/detail.go?type=gene&acc=1633,,,1633.0,DCK,9606,Homo sapiens (human),Abrine results in decreased expression of DCK mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
329,1492044,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,64858,DCLRE1B,https://ctdbase.org/detail.go?type=gene&acc=64858,,,64858.0,DCLRE1B,9606,Homo sapiens (human),Abrine results in decreased expression of DCLRE1B mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
330,1492045,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,64421,DCLRE1C,https://ctdbase.org/detail.go?type=gene&acc=64421,,,64421.0,DCLRE1C,10090,Mus musculus (house mouse),Abrine results in decreased expression of DCLRE1C mRNA,,,PMID:22595364,https://www.ncbi.nlm.nih.gov/pubmed/22595364,22595364,,
331,1492046,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,55802,DCP1A,https://ctdbase.org/detail.go?type=gene&acc=55802,,,55802.0,DCP1A,9606,Homo sapiens (human),Abrine results in increased expression of DCP1A mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
332,1492047,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,149095,DCST1,https://ctdbase.org/detail.go?type=gene&acc=149095,,,149095.0,DCST1,10090,Mus musculus (house mouse),Abrine results in decreased expression of DCST1 mRNA,,,PMID:22595364,https://www.ncbi.nlm.nih.gov/pubmed/22595364,22595364,,
333,1492048,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,123879,DCUN1D3,https://ctdbase.org/detail.go?type=gene&acc=123879,,,123879.0,DCUN1D3,9606,Homo sapiens (human),Abrine results in increased expression of DCUN1D3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
334,1492049,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,79016,DDA1,https://ctdbase.org/detail.go?type=gene&acc=79016,,,79016.0,DDA1,9606,Homo sapiens (human),Abrine results in increased expression of DDA1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
335,1492050,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1643,DDB2,https://ctdbase.org/detail.go?type=gene&acc=1643,,,1643.0,DDB2,9606,Homo sapiens (human),Abrine results in increased expression of DDB2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
336,1492051,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1644,DDC,https://ctdbase.org/detail.go?type=gene&acc=1644,,,1644.0,DDC,9606,Homo sapiens (human),Abrine results in decreased expression of DDC mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
337,1492052,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,23259,DDHD2,https://ctdbase.org/detail.go?type=gene&acc=23259,,,23259.0,DDHD2,9606,Homo sapiens (human),Abrine results in decreased expression of DDHD2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
338,1492499,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,2185,PTK2B,https://ctdbase.org/detail.go?type=gene&acc=2185,,,2185.0,PTK2B,9606,Homo sapiens (human),Abrine results in decreased expression of PTK2B mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
339,1492500,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5753,PTK6,https://ctdbase.org/detail.go?type=gene&acc=5753,,,5753.0,PTK6,9606,Homo sapiens (human),Abrine results in increased expression of PTK6 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
340,1492501,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5754,PTK7,https://ctdbase.org/detail.go?type=gene&acc=5754,,,5754.0,PTK7,9606,Homo sapiens (human),Abrine results in decreased expression of PTK7 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
341,1493014,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5806,PTX3,https://ctdbase.org/detail.go?type=gene&acc=5806,,,5806.0,PTX3,9606,Homo sapiens (human),Abrine results in increased expression of PTX3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
342,1493015,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,8226,PUDP,https://ctdbase.org/detail.go?type=gene&acc=8226,,,8226.0,PUDP,9606,Homo sapiens (human),Abrine results in decreased expression of PUDP mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
343,1493016,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,22827,PUF60,https://ctdbase.org/detail.go?type=gene&acc=22827,,,22827.0,PUF60,9606,Homo sapiens (human),Abrine results in increased expression of PUF60 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
344,1493017,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5814,PURB,https://ctdbase.org/detail.go?type=gene&acc=5814,,,5814.0,PURB,9606,Homo sapiens (human),Abrine results in increased expression of PURB protein,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
345,1493018,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,80324,PUS1,https://ctdbase.org/detail.go?type=gene&acc=80324,,,80324.0,PUS1,9606,Homo sapiens (human),Abrine results in increased expression of PUS1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
346,1493867,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,8632,DNAH17,https://ctdbase.org/detail.go?type=gene&acc=8632,,,8632.0,DNAH17,9606,Homo sapiens (human),Abrine results in increased expression of DNAH17 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
347,1494021,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1768,DNAH6,https://ctdbase.org/detail.go?type=gene&acc=1768,,,1768.0,DNAH6,9606,Homo sapiens (human),Abrine results in increased expression of DNAH6 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
348,1494022,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1769,DNAH8,https://ctdbase.org/detail.go?type=gene&acc=1769,,,1769.0,DNAH8,10090,Mus musculus (house mouse),Abrine results in decreased expression of DNAH8 mRNA,,,PMID:22595364,https://www.ncbi.nlm.nih.gov/pubmed/22595364,22595364,,
349,1494023,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,27019,DNAI1,https://ctdbase.org/detail.go?type=gene&acc=27019,,,27019.0,DNAI1,9606,Homo sapiens (human),Abrine results in increased expression of DNAI1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
350,1494024,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,64446,DNAI2,https://ctdbase.org/detail.go?type=gene&acc=64446,,,64446.0,DNAI2,9606,Homo sapiens (human),Abrine results in increased expression of DNAI2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
351,1494025,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,79819,DNAI4,https://ctdbase.org/detail.go?type=gene&acc=79819,,,79819.0,DNAI4,9606,Homo sapiens (human),Abrine results in increased expression of DNAI4 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
352,1494026,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,3301,DNAJA1,https://ctdbase.org/detail.go?type=gene&acc=3301,,,3301.0,DNAJA1,9606,Homo sapiens (human),Abrine results in decreased expression of DNAJA1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
353,1494027,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,3337,DNAJB1,https://ctdbase.org/detail.go?type=gene&acc=3337,,,3337.0,DNAJB1,9606,Homo sapiens (human),Abrine results in decreased expression of DNAJB1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
354,1494028,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,3300,DNAJB2,https://ctdbase.org/detail.go?type=gene&acc=3300,,,3300.0,DNAJB2,9606,Homo sapiens (human),Abrine results in increased expression of DNAJB2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
355,1494029,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,11080,DNAJB4,https://ctdbase.org/detail.go?type=gene&acc=11080,,,11080.0,DNAJB4,9606,Homo sapiens (human),Abrine results in increased expression of DNAJB4 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
356,1494030,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,25822,DNAJB5,https://ctdbase.org/detail.go?type=gene&acc=25822,,,25822.0,DNAJB5,9606,Homo sapiens (human),Abrine results in increased expression of DNAJB5 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
357,1495645,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1827,RCAN1,https://ctdbase.org/detail.go?type=gene&acc=1827,,,1827.0,RCAN1,9606,Homo sapiens (human),Abrine results in increased expression of RCAN1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
358,1495646,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,11123,RCAN3,https://ctdbase.org/detail.go?type=gene&acc=11123,,,11123.0,RCAN3,9606,Homo sapiens (human),Abrine results in decreased expression of RCAN3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
359,1495851,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,55213,RCBTB1,https://ctdbase.org/detail.go?type=gene&acc=55213,,,55213.0,RCBTB1,9606,Homo sapiens (human),Abrine results in decreased expression of RCBTB1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
360,1495852,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1102,RCBTB2,https://ctdbase.org/detail.go?type=gene&acc=1102,,,1102.0,RCBTB2,9606,Homo sapiens (human),Abrine results in increased expression of RCBTB2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
361,1495853,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,1104,RCC1,https://ctdbase.org/detail.go?type=gene&acc=1104,,,1104.0,RCC1,9606,Homo sapiens (human),Abrine results in decreased expression of RCC1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
362,1495854,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,91433,RCCD1,https://ctdbase.org/detail.go?type=gene&acc=91433,,,91433.0,RCCD1,9606,Homo sapiens (human),Abrine results in decreased expression of RCCD1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
363,1495855,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,9986,RCE1,https://ctdbase.org/detail.go?type=gene&acc=9986,,,9986.0,RCE1,9606,Homo sapiens (human),Abrine results in increased expression of RCE1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
364,1495856,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,25898,RCHY1,https://ctdbase.org/detail.go?type=gene&acc=25898,,,25898.0,RCHY1,9606,Homo sapiens (human),Abrine results in increased expression of RCHY1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
365,1495857,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,5955,RCN2,https://ctdbase.org/detail.go?type=gene&acc=5955,,,5955.0,RCN2,9606,Homo sapiens (human),Abrine results in decreased expression of RCN2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
366,1495858,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,57333,RCN3,https://ctdbase.org/detail.go?type=gene&acc=57333,,,57333.0,RCN3,9606,Homo sapiens (human),Abrine results in decreased expression of RCN3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
367,1495859,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,23186,RCOR1,https://ctdbase.org/detail.go?type=gene&acc=23186,,,23186.0,RCOR1,10090,Mus musculus (house mouse),Abrine results in increased expression of RCOR1 mRNA,,,PMID:22595364,https://www.ncbi.nlm.nih.gov/pubmed/22595364,22595364,,
368,1495860,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,55758,RCOR3,https://ctdbase.org/detail.go?type=gene&acc=55758,,,55758.0,RCOR3,9606,Homo sapiens (human),Abrine results in increased expression of RCOR3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
369,1495861,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,92241,RCSD1,https://ctdbase.org/detail.go?type=gene&acc=92241,,,92241.0,RCSD1,9606,Homo sapiens (human),Abrine results in increased expression of RCSD1 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
370,1498784,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,64320,RNF25,https://ctdbase.org/detail.go?type=gene&acc=64320,,,64320.0,RNF25,9606,Homo sapiens (human),Abrine results in increased expression of RNF25 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
371,1498785,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,80196,RNF34,https://ctdbase.org/detail.go?type=gene&acc=80196,,,80196.0,RNF34,9606,Homo sapiens (human),Abrine results in increased expression of RNF34 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
372,1498786,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,152006,RNF38,https://ctdbase.org/detail.go?type=gene&acc=152006,,,152006.0,RNF38,9606,Homo sapiens (human),Abrine results in decreased expression of RNF38 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
373,1498787,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,80352,RNF39,https://ctdbase.org/detail.go?type=gene&acc=80352,,,80352.0,RNF39,9606,Homo sapiens (human),Abrine results in increased expression of RNF39 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
374,1498788,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,6047,RNF4,https://ctdbase.org/detail.go?type=gene&acc=6047,,,6047.0,RNF4,9606,Homo sapiens (human),Abrine results in decreased expression of RNF4 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
375,1498789,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,9810,RNF40,https://ctdbase.org/detail.go?type=gene&acc=9810,,,9810.0,RNF40,9606,Homo sapiens (human),Abrine results in increased expression of RNF40 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
376,1498790,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,6049,RNF6,https://ctdbase.org/detail.go?type=gene&acc=6049,,,6049.0,RNF6,9606,Homo sapiens (human),Abrine results in increased expression of RNF6 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
377,1498791,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,9616,RNF7,https://ctdbase.org/detail.go?type=gene&acc=9616,,,9616.0,RNF7,9606,Homo sapiens (human),Abrine results in increased expression of RNF7 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
378,1498792,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,84900,RNFT2,https://ctdbase.org/detail.go?type=gene&acc=84900,,,84900.0,RNFT2,9606,Homo sapiens (human),Abrine results in decreased expression of RNFT2 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
379,1498793,160511,Comparative Toxicogenomics Database (CTD),Abrine,C496492,abrine,https://ctdbase.org/detail.go?type=chem&acc=C496492,55599,RNPC3,https://ctdbase.org/detail.go?type=gene&acc=55599,,,55599.0,RNPC3,9606,Homo sapiens (human),Abrine results in increased expression of RNPC3 mRNA,,,PMID:31054353,https://www.ncbi.nlm.nih.gov/pubmed/31054353,31054353,,
380,1497679,182662,Toxin and Toxin Target Database (T3DB),"2,3,4-Tribromobiphenyl",T3D1956,Tribromobiphenyl,http://www.t3db.ca/toxins/T3D1956,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606,Homo sapiens (human),"Pbbs bind to and activate the aryl hydrocarbon receptor (ahr), which in turn initiates the transcriptional upregulation of a number of genes, affecting biochemical and endocrine pathways, cell cycle regulation, morphogenesis, oxidative stress response, and various other processes. this results in the numerous toxic responses characteristic of pbbs. some of the known induced genes include the cytochrome P-450-dependent monooxygenases CYP1A1 and CYP1A2. (L628)",,,,,,,
381,1497680,183134,IUPHAR/BPS Guide to PHARMACOLOGY,"2-Ethyl-5,7-dimethyl-3-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)imidazo(4,5-b)pyridine",3939,[3H]L158809,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3939,34,AT1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=34,P29089,Type-1B angiotensin II receptor,81638.0,Agtr1b,10116,Rattus norvegicus (Norway rat),Antagonist,pKd,9.18,PMID:1480133,https://www.ncbi.nlm.nih.gov/pubmed/1480133,1480133,,
382,1497681,183134,IUPHAR/BPS Guide to PHARMACOLOGY,"2-Ethyl-5,7-dimethyl-3-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)imidazo(4,5-b)pyridine",3939,[3H]L158809,https://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=3939,34,AT1 receptor,https://guidetopharmacology.org/GRAC/ObjectDisplayForward?objectId=34,P25095,Type-1A angiotensin II receptor ,24180.0,Agtr1a,10116,Rattus norvegicus (Norway rat),Antagonist,pKd,9.18,PMID:1480133,https://www.ncbi.nlm.nih.gov/pubmed/1480133,1480133,,
383,1497682,183797,Drug Gene Interaction database (DGIdb),Melagatran,,MELAGATRAN,https://www.dgidb.org/drugs/ncit:C66077,,LRRC59,https://www.dgidb.org/genes/hgnc:28817,,,55379.0,LRRC59,9606,Homo sapiens (human),,,,,,,,
384,1497683,185748,Toxin and Toxin Target Database (T3DB),"2,4-Dibromobiphenyl",T3D1957,"2,4-Dibromobiphenyl",http://www.t3db.ca/toxins/T3D1957,BE0003721,Aryl hydrocarbon receptor,http://www.t3db.ca/biodb/bio_entities/BE0003721,P35869,Aryl hydrocarbon receptor,196.0,AHR,9606,Homo sapiens (human),"Pbbs bind to and activate the aryl hydrocarbon receptor (ahr), which in turn initiates the transcriptional upregulation of a number of genes, affecting biochemical and endocrine pathways, cell cycle regulation, morphogenesis, oxidative stress response, and various other processes. this results in the numerous toxic responses characteristic of pbbs. some of the known induced genes include the cytochrome P-450-dependent monooxygenases CYP1A1 and CYP1A2. (L628)",,,,,,,
385,1489075,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4234,METTL1,https://ctdbase.org/detail.go?type=gene&acc=4234,,,4234.0,METTL1,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of METTL1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
386,1489076,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51603,METTL13,https://ctdbase.org/detail.go?type=gene&acc=51603,,,51603.0,METTL13,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of METTL13 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
387,1489077,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,196074,METTL15,https://ctdbase.org/detail.go?type=gene&acc=196074,,,196074.0,METTL15,9606,Homo sapiens (human),Aflatoxin B1 results in decreased expression of METTL15 mrna|aflatoxin B1 results in increased methylation of METTL15 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
388,1489078,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,196074,METTL15,https://ctdbase.org/detail.go?type=gene&acc=196074,,,196074.0,METTL15,10090,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of METTL15 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
389,1489079,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,79066,METTL16,https://ctdbase.org/detail.go?type=gene&acc=79066,,,79066.0,METTL16,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of METTL16 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
390,1489080,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,79066,METTL16,https://ctdbase.org/detail.go?type=gene&acc=79066,,,79066.0,METTL16,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of METTL16 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
391,1489081,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,64745,METTL17,https://ctdbase.org/detail.go?type=gene&acc=64745,,,64745.0,METTL17,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of METTL17 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
392,1490204,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,763,CA5A,https://ctdbase.org/detail.go?type=gene&acc=763,,,763.0,CA5A,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CA5A intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
393,1490205,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,11238,CA5B,https://ctdbase.org/detail.go?type=gene&acc=11238,,,11238.0,CA5B,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of CA5B mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
394,1490206,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,340591,CA5BP1,https://ctdbase.org/detail.go?type=gene&acc=340591,,,340591.0,CA5BP1,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CA5BP1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
395,1490207,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,340591,CA5BP1,https://ctdbase.org/detail.go?type=gene&acc=340591,,,340591.0,CA5BP1,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CA5BP1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
396,1490208,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,765,CA6,https://ctdbase.org/detail.go?type=gene&acc=765,,,765.0,CA6,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CA6 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
397,1490209,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,767,CA8,https://ctdbase.org/detail.go?type=gene&acc=767,,,767.0,CA8,9606,Homo sapiens (human),Aflatoxin B1 results in decreased expression of CA8 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
398,1490210,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,767,CA8,https://ctdbase.org/detail.go?type=gene&acc=767,,,767.0,CA8,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CA8 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
399,1490211,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,767,CA8,https://ctdbase.org/detail.go?type=gene&acc=767,,,767.0,CA8,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of CA8 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
400,1490212,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51719,CAB39,https://ctdbase.org/detail.go?type=gene&acc=51719,,,51719.0,CAB39,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CAB39 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
401,1490213,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,81617,CAB39L,https://ctdbase.org/detail.go?type=gene&acc=81617,,,81617.0,CAB39L,10090,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of CAB39L mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
402,1490214,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23523,CABIN1,https://ctdbase.org/detail.go?type=gene&acc=23523,,,23523.0,CABIN1,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CABIN1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
403,1490648,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4258,MGST2,https://ctdbase.org/detail.go?type=gene&acc=4258,,,4258.0,MGST2,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MGST2 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
404,1490649,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4259,MGST3,https://ctdbase.org/detail.go?type=gene&acc=4259,,,4259.0,MGST3,9031,Gallus gallus (chicken),Aflatoxin B1 results in increased expression of MGST3 protein,,,PMID:33348051,https://www.ncbi.nlm.nih.gov/pubmed/33348051,33348051,,
405,1490650,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4259,MGST3,https://ctdbase.org/detail.go?type=gene&acc=4259,,,4259.0,MGST3,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MGST3 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
406,1490651,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4259,MGST3,https://ctdbase.org/detail.go?type=gene&acc=4259,,,4259.0,MGST3,10090,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of MGST3 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
407,1491070,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,79778,MICALL2,https://ctdbase.org/detail.go?type=gene&acc=79778,,,79778.0,MICALL2,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of MICALL2 mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
408,1491071,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,79778,MICALL2,https://ctdbase.org/detail.go?type=gene&acc=79778,,,79778.0,MICALL2,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of MICALL2 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
409,1491072,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4277,MICB,https://ctdbase.org/detail.go?type=gene&acc=4277,,,4277.0,MICB,9606,Homo sapiens (human),Aflatoxin B1 affects the expression of MICB protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
410,1491073,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4277,MICB,https://ctdbase.org/detail.go?type=gene&acc=4277,,,4277.0,MICB,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of MICB mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
411,1491074,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10367,MICU1,https://ctdbase.org/detail.go?type=gene&acc=10367,,,10367.0,MICU1,9606,Homo sapiens (human),Aflatoxin B1 results in decreased expression of MICU1 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
412,1491075,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10367,MICU1,https://ctdbase.org/detail.go?type=gene&acc=10367,,,10367.0,MICU1,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of MICU1 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
413,1492673,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100314290,MIR26A,https://ctdbase.org/detail.go?type=gene&acc=100314290,,,100314290.0,Mir26a,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of MIR26A mRNA,,,PMID:24472605,https://www.ncbi.nlm.nih.gov/pubmed/24472605,24472605,,
414,1492674,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,407017,MIR26B,https://ctdbase.org/detail.go?type=gene&acc=407017,,,407017.0,MIR26B,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of MIR26B mRNA,,,PMID:24472605,https://www.ncbi.nlm.nih.gov/pubmed/24472605,24472605,,
415,1492675,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,407018,MIR27A,https://ctdbase.org/detail.go?type=gene&acc=407018,,,407018.0,MIR27A,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of MIR27A mRNA,,,PMID:24472605,https://www.ncbi.nlm.nih.gov/pubmed/24472605,24472605,,
416,1492860,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,29775,CARD10,https://ctdbase.org/detail.go?type=gene&acc=29775,,,29775.0,CARD10,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CARD10 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
417,1492861,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,29775,CARD10,https://ctdbase.org/detail.go?type=gene&acc=29775,,,29775.0,CARD10,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of CARD10 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
418,1492862,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84433,CARD11,https://ctdbase.org/detail.go?type=gene&acc=84433,,,84433.0,CARD11,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CARD11 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
419,1493342,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100500813,MIR3646,https://ctdbase.org/detail.go?type=gene&acc=100500813,,,100500813.0,MIR3646,9606,Homo sapiens (human),Aflatoxin B1 results in decreased expression of MIR3646 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
420,1493343,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100126356,MIR365B,https://ctdbase.org/detail.go?type=gene&acc=100126356,,,100126356.0,MIR365B,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of MIR365B mRNA,,,PMID:24472605,https://www.ncbi.nlm.nih.gov/pubmed/24472605,24472605,,
421,1493344,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,101927704,MIR3663HG,https://ctdbase.org/detail.go?type=gene&acc=101927704,,,101927704.0,MIR3663HG,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of MIR3663HG intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
422,1493345,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,348645,MIR3667HG,https://ctdbase.org/detail.go?type=gene&acc=348645,,,348645.0,MIR3667HG,9606,Homo sapiens (human),Aflatoxin B1 affects the methylation of MIR3667HG intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
423,1493346,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100506457,MIR3681HG,https://ctdbase.org/detail.go?type=gene&acc=100506457,,,100506457.0,MIR3681HG,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MIR3681HG intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
424,1493347,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,442915,MIR370,https://ctdbase.org/detail.go?type=gene&acc=442915,,,442915.0,MIR370,9606,Homo sapiens (human),[CYP2A13 protein co-treated with aflatoxin B1] results in increased expression of MIR370 mRNA,,,PMID:26084420,https://www.ncbi.nlm.nih.gov/pubmed/26084420,26084420,,
425,1493348,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,494324,MIR375,https://ctdbase.org/detail.go?type=gene&acc=494324,,,494324.0,MIR375,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of MIR375 mRNA,,,PMID:24472605,https://www.ncbi.nlm.nih.gov/pubmed/24472605,24472605,,
426,1493349,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,494327,MIR378A,https://ctdbase.org/detail.go?type=gene&acc=494327,,,494327.0,MIR378A,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of MIR378A mRNA,,,PMID:24472605,https://www.ncbi.nlm.nih.gov/pubmed/24472605,24472605,,
427,1493350,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,494331,MIR382,https://ctdbase.org/detail.go?type=gene&acc=494331,,,494331.0,MIR382,9606,Homo sapiens (human),[CYP2A13 protein co-treated with aflatoxin B1] results in increased expression of MIR382 mRNA,,,PMID:26084420,https://www.ncbi.nlm.nih.gov/pubmed/26084420,26084420,,
428,1493527,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,101805492,CASC9,https://ctdbase.org/detail.go?type=gene&acc=101805492,,,101805492.0,CASC9,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CASC9 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
429,1494357,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9031,Gallus gallus (chicken),Aflatoxin B1 results in decreased expression of CAT protein,,,PMID:33348051,https://www.ncbi.nlm.nih.gov/pubmed/33348051,33348051,,
430,1494358,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,847,CAT,https://ctdbase.org/detail.go?type=gene&acc=847,,,847.0,CAT,9606,Homo sapiens (human),Aflatoxin B1 affects the expression of CAT protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
431,1494359,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,407043,MIR7-1,https://ctdbase.org/detail.go?type=gene&acc=407043,,,407043.0,MIR7-1,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of MIR7-1 mRNA,,,PMID:24472605,https://www.ncbi.nlm.nih.gov/pubmed/24472605,24472605,,
432,1494360,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100314117,MIR743A,https://ctdbase.org/detail.go?type=gene&acc=100314117,,,100314117.0,Mir743a,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of MIR743A mRNA,,,PMID:24472605,https://www.ncbi.nlm.nih.gov/pubmed/24472605,24472605,,
433,1494361,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100124496,MIR743B,https://ctdbase.org/detail.go?type=gene&acc=100124496,,,100124496.0,Mir743b,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of MIR743B mRNA,,,PMID:24472605,https://www.ncbi.nlm.nih.gov/pubmed/24472605,24472605,,
434,1494362,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,768219,MIR802,https://ctdbase.org/detail.go?type=gene&acc=768219,,,768219.0,MIR802,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of MIR802 mRNA,,,PMID:24472605,https://www.ncbi.nlm.nih.gov/pubmed/24472605,24472605,,
435,1494363,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100124478,MIR871,https://ctdbase.org/detail.go?type=gene&acc=100124478,,,100124478.0,Mir871,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of MIR871 mRNA,,,PMID:24472605,https://www.ncbi.nlm.nih.gov/pubmed/24472605,24472605,,
436,1494364,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100124456,MIR872,https://ctdbase.org/detail.go?type=gene&acc=100124456,,,100124456.0,Mir872,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of MIR872 mRNA,,,PMID:24472605,https://www.ncbi.nlm.nih.gov/pubmed/24472605,24472605,,
437,1494365,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100124480,MIR880,https://ctdbase.org/detail.go?type=gene&acc=100124480,,,100124480.0,Mir880,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of MIR880 mRNA,,,PMID:24472605,https://www.ncbi.nlm.nih.gov/pubmed/24472605,24472605,,
438,1494366,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,100124460,MIR881,https://ctdbase.org/detail.go?type=gene&acc=100124460,,,100124460.0,Mir881,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of MIR881 mRNA,,,PMID:24472605,https://www.ncbi.nlm.nih.gov/pubmed/24472605,24472605,,
439,1494367,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10485,MIR9-1HG,https://ctdbase.org/detail.go?type=gene&acc=10485,,,10485.0,MIR9-1HG,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of MIR9-1HG intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
440,1495494,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4295,MLN,https://ctdbase.org/detail.go?type=gene&acc=4295,,,4295.0,MLN,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MLN gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
441,1495495,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,79083,MLPH,https://ctdbase.org/detail.go?type=gene&acc=79083,,,79083.0,MLPH,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of MLPH mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
442,1495496,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,64223,MLST8,https://ctdbase.org/detail.go?type=gene&acc=64223,,,64223.0,MLST8,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of MLST8 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
443,1495497,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6945,MLX,https://ctdbase.org/detail.go?type=gene&acc=6945,,,6945.0,MLX,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MLX gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
444,1495498,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,22877,MLXIP,https://ctdbase.org/detail.go?type=gene&acc=22877,,,22877.0,MLXIP,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of MLXIP intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
445,1495499,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,22877,MLXIP,https://ctdbase.org/detail.go?type=gene&acc=22877,,,22877.0,MLXIP,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of MLXIP mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
446,1495500,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51085,MLXIPL,https://ctdbase.org/detail.go?type=gene&acc=51085,,,51085.0,MLXIPL,9606,Homo sapiens (human),Aflatoxin B1 affects the expression of MLXIPL protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
447,1495501,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,51085,MLXIPL,https://ctdbase.org/detail.go?type=gene&acc=51085,,,51085.0,MLXIPL,9606,Homo sapiens (human),Aflatoxin B1 results in decreased expression of MLXIPL mRNA,,,PMID:22100608|PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/27153756,22100608|27153756,,
448,1495986,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,285025,CCDC141,https://ctdbase.org/detail.go?type=gene&acc=285025,,,285025.0,CCDC141,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CCDC141 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
449,1495987,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,285025,CCDC141,https://ctdbase.org/detail.go?type=gene&acc=285025,,,285025.0,CCDC141,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of CCDC141 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
450,1495988,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4319,MMP10,https://ctdbase.org/detail.go?type=gene&acc=4319,,,4319.0,MMP10,9606,Homo sapiens (human),Aflatoxin B1 affects the expression of MMP10 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
451,1495989,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4319,MMP10,https://ctdbase.org/detail.go?type=gene&acc=4319,,,4319.0,MMP10,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of MMP10 mRNA,,,PMID:22100608|PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/27153756,22100608|27153756,,
452,1495990,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4319,MMP10,https://ctdbase.org/detail.go?type=gene&acc=4319,,,4319.0,MMP10,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased mutagenesis of MMP10 gene,,,PMID:36908029,https://www.ncbi.nlm.nih.gov/pubmed/36908029,36908029,,
453,1495991,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4320,MMP11,https://ctdbase.org/detail.go?type=gene&acc=4320,,,4320.0,MMP11,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MMP11 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
454,1495992,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4321,MMP12,https://ctdbase.org/detail.go?type=gene&acc=4321,,,4321.0,MMP12,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of MMP12 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
455,1495993,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4321,MMP12,https://ctdbase.org/detail.go?type=gene&acc=4321,,,4321.0,MMP12,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of MMP12 mRNA,,,PMID:23630614|PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/23630614|https://www.ncbi.nlm.nih.gov/pubmed/25378103,23630614|25378103,,
456,1495994,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4323,MMP14,https://ctdbase.org/detail.go?type=gene&acc=4323,,,4323.0,MMP14,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MMP14 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
457,1495995,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4324,MMP15,https://ctdbase.org/detail.go?type=gene&acc=4324,,,4324.0,MMP15,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MMP15 gene,,,PMID:28458013,https://www.ncbi.nlm.nih.gov/pubmed/28458013,28458013,,
458,1495996,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4324,MMP15,https://ctdbase.org/detail.go?type=gene&acc=4324,,,4324.0,MMP15,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of MMP15 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
459,1497263,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,80323,CCDC68,https://ctdbase.org/detail.go?type=gene&acc=80323,,,80323.0,CCDC68,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of CCDC68 mRNA,,,PMID:23630614|PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/23630614|https://www.ncbi.nlm.nih.gov/pubmed/25378103,23630614|25378103,,
460,1497264,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,26112,CCDC69,https://ctdbase.org/detail.go?type=gene&acc=26112,,,26112.0,CCDC69,9606,Homo sapiens (human),Aflatoxin B1 results in decreased expression of CCDC69 mRNA,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
461,1497265,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,83446,CCDC70,https://ctdbase.org/detail.go?type=gene&acc=83446,,,83446.0,CCDC70,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CCDC70 exon,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
462,1497266,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,64925,CCDC71,https://ctdbase.org/detail.go?type=gene&acc=64925,,,64925.0,CCDC71,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CCDC71 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
463,1497267,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,168455,CCDC71L,https://ctdbase.org/detail.go?type=gene&acc=168455,,,168455.0,CCDC71L,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CCDC71L gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
464,1497268,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,493860,CCDC73,https://ctdbase.org/detail.go?type=gene&acc=493860,,,493860.0,CCDC73,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CCDC73 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
465,1497269,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,91409,CCDC74B,https://ctdbase.org/detail.go?type=gene&acc=91409,,,91409.0,CCDC74B,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of CCDC74B mRNA,,,PMID:21641981,https://www.ncbi.nlm.nih.gov/pubmed/21641981,21641981,,
466,1497270,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,84318,CCDC77,https://ctdbase.org/detail.go?type=gene&acc=84318,,,84318.0,CCDC77,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CCDC77 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
467,1497271,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,124093,CCDC78,https://ctdbase.org/detail.go?type=gene&acc=124093,,,124093.0,CCDC78,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CCDC78 gene,,,PMID:28458013,https://www.ncbi.nlm.nih.gov/pubmed/28458013,28458013,,
468,1497272,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,79780,CCDC82,https://ctdbase.org/detail.go?type=gene&acc=79780,,,79780.0,CCDC82,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CCDC82 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
469,1498305,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,140699,MROH8,https://ctdbase.org/detail.go?type=gene&acc=140699,,,140699.0,MROH8,9606,Homo sapiens (human),Aflatoxin B1 results in decreased expression of MROH8 mRNA,,,PMID:21641981|PMID:22100608|PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/21641981|https://www.ncbi.nlm.nih.gov/pubmed/22100608|https://www.ncbi.nlm.nih.gov/pubmed/32234424,21641981|22100608|32234424,,
470,1498306,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6182,MRPL12,https://ctdbase.org/detail.go?type=gene&acc=6182,,,6182.0,MRPL12,9606,Homo sapiens (human),[plant extracts co-treated with aflatoxin B1 co-treated with aflatoxin B2 co-treated with aflatoxin G1 co-treated with aflatoxin G2] results in decreased expression of MRPL12 mrna|[aflatoxin B1 co-treated with aflatoxin B2 co-treated with aflatoxin G1 co-treated with aflatoxin G2] results in decreased expression of MRPL12 mRNA,,,PMID:31904472,https://www.ncbi.nlm.nih.gov/pubmed/31904472,31904472,,
471,1498476,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,8900,CCNA1,https://ctdbase.org/detail.go?type=gene&acc=8900,,,8900.0,CCNA1,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CCNA1 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
472,1498477,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,890,CCNA2,https://ctdbase.org/detail.go?type=gene&acc=890,,,890.0,CCNA2,9606,Homo sapiens (human),Aflatoxin B1 affects the expression of CCNA2 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
473,1498478,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,890,CCNA2,https://ctdbase.org/detail.go?type=gene&acc=890,,,890.0,CCNA2,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in increased expression of CCNA2 mRNA,,,PMID:23630614|PMID:25378103,https://www.ncbi.nlm.nih.gov/pubmed/23630614|https://www.ncbi.nlm.nih.gov/pubmed/25378103,23630614|25378103,,
474,1498479,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,9606,Homo sapiens (human),Aflatoxin B1 affects the expression of CCNB1 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
475,1498480,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,9606,Homo sapiens (human),Aflatoxin B1 results in decreased expression of CCNB1 mRNA,,,PMID:32234424,https://www.ncbi.nlm.nih.gov/pubmed/32234424,32234424,,
476,1498481,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,891,CCNB1,https://ctdbase.org/detail.go?type=gene&acc=891,,,891.0,CCNB1,10090,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of CCNB1 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
477,1499563,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1234,CCR5,https://ctdbase.org/detail.go?type=gene&acc=1234,,,1234.0,CCR5,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CCR5 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
478,1499564,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1234,CCR5,https://ctdbase.org/detail.go?type=gene&acc=1234,,,1234.0,CCR5,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of CCR5 mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
479,1499565,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1234,CCR5,https://ctdbase.org/detail.go?type=gene&acc=1234,,,1234.0,CCR5,10116,Rattus norvegicus (Norway rat),Aflatoxin B1 results in decreased expression of CCR5 mRNA,,,PMID:33354967,https://www.ncbi.nlm.nih.gov/pubmed/33354967,33354967,,
480,1499566,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1235,CCR6,https://ctdbase.org/detail.go?type=gene&acc=1235,,,1235.0,CCR6,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CCR6 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
481,1499567,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1236,CCR7,https://ctdbase.org/detail.go?type=gene&acc=1236,,,1236.0,CCR7,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of CCR7 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
482,1499568,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1236,CCR7,https://ctdbase.org/detail.go?type=gene&acc=1236,,,1236.0,CCR7,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CCR7 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
483,1499569,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1237,CCR8,https://ctdbase.org/detail.go?type=gene&acc=1237,,,1237.0,CCR8,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of CCR8 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
484,1499570,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,1237,CCR8,https://ctdbase.org/detail.go?type=gene&acc=1237,,,1237.0,CCR8,10090,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of CCR8 mRNA,,,PMID:28789997,https://www.ncbi.nlm.nih.gov/pubmed/28789997,28789997,,
485,1499571,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,10803,CCR9,https://ctdbase.org/detail.go?type=gene&acc=10803,,,10803.0,CCR9,9606,Homo sapiens (human),Aflatoxin B1 results in increased methylation of CCR9 gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
486,1499572,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,9034,CCRL2,https://ctdbase.org/detail.go?type=gene&acc=9034,,,9034.0,CCRL2,9606,Homo sapiens (human),Aflatoxin B1 results in increased expression of CCRL2 mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
487,1499573,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,4436,MSH2,https://ctdbase.org/detail.go?type=gene&acc=4436,,,4436.0,MSH2,9606,Homo sapiens (human),Aflatoxin B1 affects the expression of MSH2 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
488,1499862,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,209588,SECTM1A,https://ctdbase.org/detail.go?type=gene&acc=209588,,,209588.0,Sectm1a,10090,Mus musculus (house mouse),Aflatoxin B1 results in increased expression of SECTM1A mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
489,1499863,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6400,SEL1L,https://ctdbase.org/detail.go?type=gene&acc=6400,,,6400.0,SEL1L,9606,Homo sapiens (human),Aflatoxin B1 results in decreased expression of SEL1L mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
490,1499864,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6400,SEL1L,https://ctdbase.org/detail.go?type=gene&acc=6400,,,6400.0,SEL1L,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of SEL1L gene,,,PMID:27153756,https://www.ncbi.nlm.nih.gov/pubmed/27153756,27153756,,
491,1499865,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6400,SEL1L,https://ctdbase.org/detail.go?type=gene&acc=6400,,,6400.0,SEL1L,10090,Mus musculus (house mouse),Aflatoxin B1 results in decreased expression of SEL1L mRNA,,,PMID:19770486,https://www.ncbi.nlm.nih.gov/pubmed/19770486,19770486,,
492,1499866,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23231,SEL1L3,https://ctdbase.org/detail.go?type=gene&acc=23231,,,23231.0,SEL1L3,9606,Homo sapiens (human),Aflatoxin B1 affects the expression of SEL1L3 protein,,,PMID:20106945,https://www.ncbi.nlm.nih.gov/pubmed/20106945,20106945,,
493,1499867,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,23231,SEL1L3,https://ctdbase.org/detail.go?type=gene&acc=23231,,,23231.0,SEL1L3,9606,Homo sapiens (human),Aflatoxin B1 results in decreased methylation of SEL1L3 intron,,,PMID:30157460,https://www.ncbi.nlm.nih.gov/pubmed/30157460,30157460,,
494,1499868,186907,Comparative Toxicogenomics Database (CTD),Aflatoxin B1,D016604,Aflatoxin B1,https://ctdbase.org/detail.go?type=chem&acc=D016604,6401,SELE,https://ctdbase.org/detail.go?type=gene&acc=6401,,,6401.0,SELE,9606,Homo sapiens (human),Aflatoxin B1 results in decreased expression of SELE mRNA,,,PMID:22100608,https://www.ncbi.nlm.nih.gov/pubmed/22100608,22100608,,
495,1488774,409805,Comparative Toxicogenomics Database (CTD),"N6-[2-[5-(diethylamino)pentan-2-ylamino]-6-methyl-4-pyrimidinyl]-2-methylquinoline-4,6-diamine",C487513,NSC 23766,https://ctdbase.org/detail.go?type=chem&acc=C487513,5879,RAC1,https://ctdbase.org/detail.go?type=gene&acc=5879,,,5879.0,RAC1,10090,Mus musculus (house mouse),NSC 23766 inhibits the reaction [lipopolysaccharides results in increased activity of RAC1 protein],,,PMID:21511011,https://www.ncbi.nlm.nih.gov/pubmed/21511011,21511011,,
496,1490384,439456,Comparative Toxicogenomics Database (CTD),"d-Myo-inositol-1,4,5-triphosphate",D015544,"Inositol 1,4,5-Trisphosphate",https://ctdbase.org/detail.go?type=chem&acc=D015544,5697,PYY,https://ctdbase.org/detail.go?type=gene&acc=5697,,,5697.0,PYY,9606,Homo sapiens (human),"PYY protein results in increased abundance of inositol 1,4,5-trisphosphate|pyx 2 inhibits the reaction [PYY protein results in increased abundance of inositol 1,4,5-trisphosphate]|neuropeptide Y (18-36) inhibits the reaction [PYY protein results in increased abundance of inositol 1,4,5-trisphosphate]",,,PMID:7742479,https://www.ncbi.nlm.nih.gov/pubmed/7742479,7742479,,
497,1490385,439456,Comparative Toxicogenomics Database (CTD),"d-Myo-inositol-1,4,5-triphosphate",D015544,"Inositol 1,4,5-Trisphosphate",https://ctdbase.org/detail.go?type=chem&acc=D015544,6863,TAC1,https://ctdbase.org/detail.go?type=gene&acc=6863,,,6863.0,TAC1,10141,Cavia porcellus (domestic guinea pig),"TAC1 protein results in increased abundance of inositol 1,4,5-trisphosphate",,,PMID:20736509,https://www.ncbi.nlm.nih.gov/pubmed/20736509,20736509,,
498,1490386,439456,Comparative Toxicogenomics Database (CTD),"d-Myo-inositol-1,4,5-triphosphate",D015544,"Inositol 1,4,5-Trisphosphate",https://ctdbase.org/detail.go?type=chem&acc=D015544,7292,TNFSF4,https://ctdbase.org/detail.go?type=gene&acc=7292,,,7292.0,TNFSF4,9606,Homo sapiens (human),"TNFSF4 protein results in increased abundance of inositol 1,4,5-trisphosphate",,,PMID:19416722,https://www.ncbi.nlm.nih.gov/pubmed/19416722,19416722,,
499,1490387,439468,Comparative Toxicogenomics Database (CTD),"Inositol 1,3,4,5,6-pentakisphosphate",C451920,"inositol-1,3,4,5,6-pentakisphosphate",https://ctdbase.org/detail.go?type=chem&acc=C451920,207,AKT1,https://ctdbase.org/detail.go?type=gene&acc=207,,,207.0,AKT1,9606,Homo sapiens (human),"Inositol-1,3,4,5,6-pentakisphosphate results in decreased phosphorylation of AKT1 protein",,,PMID:14755253,https://www.ncbi.nlm.nih.gov/pubmed/14755253,14755253,,
500,1490388,439533,Drug Gene Interaction database (DGIdb),Taxifolin,,TAXIFOLIN,https://www.dgidb.org/drugs/drugbank:DB02224,,POLI,https://www.dgidb.org/genes/hgnc:9182,,,11201.0,POLI,9606,Homo sapiens (human),,,,,,,,
501,1490389,439533,Drug Gene Interaction database (DGIdb),Taxifolin,,TAXIFOLIN,https://www.dgidb.org/drugs/drugbank:DB02224,,POLH,https://www.dgidb.org/genes/hgnc:9181,,,5429.0,POLH,9606,Homo sapiens (human),,,,,,,,
502,1490390,440004,Comparative Toxicogenomics Database (CTD),"N6,N6-Dimethyladenosine",C021013,"N(6),N(6)-dimethyladenosine",https://ctdbase.org/detail.go?type=chem&acc=C021013,6868,ADAM17,https://ctdbase.org/detail.go?type=gene&acc=6868,,,6868.0,ADAM17,9606,Homo sapiens (human),"N(6),N(6)-dimethyladenosine results in decreased expression of ADAM17 protein|n(6),n(6)-dimethyladenosine inhibits the reaction [cycloheximide results in decreased stability of ADAM17 protein]",,,PMID:36558177,https://www.ncbi.nlm.nih.gov/pubmed/36558177,36558177,,
503,1490391,440004,Comparative Toxicogenomics Database (CTD),"N6,N6-Dimethyladenosine",C021013,"N(6),N(6)-dimethyladenosine",https://ctdbase.org/detail.go?type=chem&acc=C021013,682,BSG,https://ctdbase.org/detail.go?type=gene&acc=682,,,682.0,BSG,9606,Homo sapiens (human),"N(6),N(6)-dimethyladenosine results in decreased expression of BSG protein",,,PMID:36574092,https://www.ncbi.nlm.nih.gov/pubmed/36574092,36574092,,
504,1488914,441336,Comparative Toxicogenomics Database (CTD),Mometasone Furoate,D000068656,Mometasone Furoate,https://ctdbase.org/detail.go?type=chem&acc=D000068656,2908,NR3C1,https://ctdbase.org/detail.go?type=gene&acc=2908,,,2908.0,NR3C1,9606,Homo sapiens (human),Mometasone furoate binds to NR3C1 protein,,,PMID:19422381,https://www.ncbi.nlm.nih.gov/pubmed/19422381,19422381,,
505,1488915,441336,Comparative Toxicogenomics Database (CTD),Mometasone Furoate,D000068656,Mometasone Furoate,https://ctdbase.org/detail.go?type=chem&acc=D000068656,2908,NR3C1,https://ctdbase.org/detail.go?type=gene&acc=2908,,,2908.0,NR3C1,10116,Rattus norvegicus (Norway rat),Mometasone furoate binds to NR3C1 protein,,,PMID:16507850,https://www.ncbi.nlm.nih.gov/pubmed/16507850,16507850,,
506,1488916,441336,Comparative Toxicogenomics Database (CTD),Mometasone Furoate,D000068656,Mometasone Furoate,https://ctdbase.org/detail.go?type=chem&acc=D000068656,2908,NR3C1,https://ctdbase.org/detail.go?type=gene&acc=2908,,,2908.0,NR3C1,9606,Homo sapiens (human),Mometasone furoate binds to NR3C1 protein,,,PMID:12127907,https://www.ncbi.nlm.nih.gov/pubmed/12127907,12127907,,
507,1488917,441336,Comparative Toxicogenomics Database (CTD),Mometasone Furoate,D000068656,Mometasone Furoate,https://ctdbase.org/detail.go?type=chem&acc=D000068656,4306,NR3C2,https://ctdbase.org/detail.go?type=gene&acc=4306,,,4306.0,NR3C2,9606,Homo sapiens (human),Mometasone furoate binds to NR3C2 protein,,,PMID:19422381,https://www.ncbi.nlm.nih.gov/pubmed/19422381,19422381,,
508,1488918,441336,Comparative Toxicogenomics Database (CTD),Mometasone Furoate,D000068656,Mometasone Furoate,https://ctdbase.org/detail.go?type=chem&acc=D000068656,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,9606,Homo sapiens (human),Mometasone furoate binds to and results in increased activity of PGR protein,,,PMID:15189034,https://www.ncbi.nlm.nih.gov/pubmed/15189034,15189034,,
509,1488919,441336,Comparative Toxicogenomics Database (CTD),Mometasone Furoate,D000068656,Mometasone Furoate,https://ctdbase.org/detail.go?type=chem&acc=D000068656,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,9606,Homo sapiens (human),Mometasone furoate binds to PGR protein,,,PMID:19422381,https://www.ncbi.nlm.nih.gov/pubmed/19422381,19422381,,
510,1488920,441336,Comparative Toxicogenomics Database (CTD),Mometasone Furoate,D000068656,Mometasone Furoate,https://ctdbase.org/detail.go?type=chem&acc=D000068656,5241,PGR,https://ctdbase.org/detail.go?type=gene&acc=5241,,,5241.0,PGR,9940,Ovis aries (sheep),Mometasone furoate binds to PGR protein,,,PMID:16507850,https://www.ncbi.nlm.nih.gov/pubmed/16507850,16507850,,
511,1488921,441336,Comparative Toxicogenomics Database (CTD),Mometasone Furoate,D000068656,Mometasone Furoate,https://ctdbase.org/detail.go?type=chem&acc=D000068656,6696,SPP1,https://ctdbase.org/detail.go?type=gene&acc=6696,,,6696.0,SPP1,10090,Mus musculus (house mouse),Mometasone furoate results in increased expression of SPP1 protein,,,PMID:21885873,https://www.ncbi.nlm.nih.gov/pubmed/21885873,21885873,,
512,1488922,441336,Comparative Toxicogenomics Database (CTD),Mometasone Furoate,D000068656,Mometasone Furoate,https://ctdbase.org/detail.go?type=chem&acc=D000068656,6898,TAT,https://ctdbase.org/detail.go?type=gene&acc=6898,,,6898.0,TAT,9606,Homo sapiens (human),Mometasone furoate results in increased activity of TAT protein,,,PMID:19422381,https://www.ncbi.nlm.nih.gov/pubmed/19422381,19422381,,
513,1489424,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,47,ACLY,https://ctdbase.org/detail.go?type=gene&acc=47,,,47.0,ACLY,10116,Rattus norvegicus (Norway rat),Erythromycin estolate results in decreased expression of ACLY mRNA,,,PMID:17522070,https://www.ncbi.nlm.nih.gov/pubmed/17522070,17522070,,
514,1489425,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,2180,ACSL1,https://ctdbase.org/detail.go?type=gene&acc=2180,,,2180.0,ACSL1,10116,Rattus norvegicus (Norway rat),Erythromycin estolate results in decreased expression of ACSL1 mRNA,,,PMID:17522070,https://www.ncbi.nlm.nih.gov/pubmed/17522070,17522070,,
515,1489426,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,216,ALDH1A1,https://ctdbase.org/detail.go?type=gene&acc=216,,,216.0,ALDH1A1,10116,Rattus norvegicus (Norway rat),Erythromycin estolate results in increased expression of ALDH1A1 mRNA,,,PMID:24412560,https://www.ncbi.nlm.nih.gov/pubmed/24412560,24412560,,
516,1489427,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,224,ALDH3A2,https://ctdbase.org/detail.go?type=gene&acc=224,,,224.0,ALDH3A2,10116,Rattus norvegicus (Norway rat),Erythromycin estolate results in decreased expression of ALDH3A2 mRNA,,,PMID:17522070,https://www.ncbi.nlm.nih.gov/pubmed/17522070,17522070,,
517,1491217,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,5166,PDK4,https://ctdbase.org/detail.go?type=gene&acc=5166,,,5166.0,PDK4,10116,Rattus norvegicus (Norway rat),Erythromycin estolate results in decreased expression of PDK4 mRNA,,,PMID:24412560,https://www.ncbi.nlm.nih.gov/pubmed/24412560,24412560,,
518,1491218,441371,Comparative Toxicogenomics Database (CTD),Erythromycin Estolate,D004918,Erythromycin Estolate,https://ctdbase.org/detail.go?type=chem&acc=D004918,5187,PER1,https://ctdbase.org/detail.go?type=gene&acc=5187,,,5187.0,PER1,10116,Rattus norvegicus (Norway rat),Erythromycin estolate results in decreased expression of PER1 mRNA,,,PMID:24412560,https://www.ncbi.nlm.nih.gov/pubmed/24412560,24412560,,
519,1493700,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,998,CDC42,https://ctdbase.org/detail.go?type=gene&acc=998,,,998.0,CDC42,10116,Rattus norvegicus (Norway rat),Propiverine binds to CDC42 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
520,1493868,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,104158,CES1D,https://ctdbase.org/detail.go?type=gene&acc=104158,,,104158.0,Ces1d,10116,Rattus norvegicus (Norway rat),Propiverine binds to CES1D protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
521,1493869,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,55847,CISD1,https://ctdbase.org/detail.go?type=gene&acc=55847,,,55847.0,CISD1,10116,Rattus norvegicus (Norway rat),Propiverine binds to CISD1 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
522,1493870,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,1315,COPB1,https://ctdbase.org/detail.go?type=gene&acc=1315,,,1315.0,COPB1,10116,Rattus norvegicus (Norway rat),Propiverine binds to COPB1 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
523,1493871,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,4513,COX2,https://ctdbase.org/detail.go?type=gene&acc=4513,,,4513.0,COX2,10116,Rattus norvegicus (Norway rat),Propiverine binds to COX2 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
524,1493872,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,1397,CRIP2,https://ctdbase.org/detail.go?type=gene&acc=1397,,,1397.0,CRIP2,10116,Rattus norvegicus (Norway rat),Propiverine binds to CRIP2 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
525,1493873,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,51380,CSAD,https://ctdbase.org/detail.go?type=gene&acc=51380,,,51380.0,CSAD,10116,Rattus norvegicus (Norway rat),Propiverine binds to CSAD protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
526,1493874,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,1460,CSNK2B,https://ctdbase.org/detail.go?type=gene&acc=1460,,,1460.0,CSNK2B,10116,Rattus norvegicus (Norway rat),Propiverine binds to CSNK2B protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
527,1493875,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,1528,CYB5A,https://ctdbase.org/detail.go?type=gene&acc=1528,,,1528.0,CYB5A,10116,Rattus norvegicus (Norway rat),Propiverine binds to CYB5A protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
528,1493876,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,24303,CYP2D3,https://ctdbase.org/detail.go?type=gene&acc=24303,,,24303.0,Cyp2d3,10116,Rattus norvegicus (Norway rat),Propiverine binds to CYP2D3 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
529,1493877,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,1603,DAD1,https://ctdbase.org/detail.go?type=gene&acc=1603,,,1603.0,DAD1,10116,Rattus norvegicus (Norway rat),Propiverine binds to DAD1 protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
530,1495185,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,5478,PPIA,https://ctdbase.org/detail.go?type=gene&acc=5478,,,5478.0,PPIA,10116,Rattus norvegicus (Norway rat),Propiverine binds to PPIA protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
531,1495186,441412,Comparative Toxicogenomics Database (CTD),Propiverine hydrochloride,C015586,propiverine,https://ctdbase.org/detail.go?type=chem&acc=C015586,5479,PPIB,https://ctdbase.org/detail.go?type=gene&acc=5479,,,5479.0,PPIB,10116,Rattus norvegicus (Norway rat),Propiverine binds to PPIB protein,,,PMID:29273565,https://www.ncbi.nlm.nih.gov/pubmed/29273565,29273565,,
532,1494694,442972,Comparative Toxicogenomics Database (CTD),Cyclopamine,C000541,cyclopamine,https://ctdbase.org/detail.go?type=chem&acc=C000541,2735,GLI1,https://ctdbase.org/detail.go?type=gene&acc=2735,,,2735.0,GLI1,10090,Mus musculus (house mouse),Cyclopamine results in decreased expression of GLI1 protein,,,PMID:20395211,https://www.ncbi.nlm.nih.gov/pubmed/20395211,20395211,,
533,1494695,442972,Comparative Toxicogenomics Database (CTD),Cyclopamine,C000541,cyclopamine,https://ctdbase.org/detail.go?type=chem&acc=C000541,2735,GLI1,https://ctdbase.org/detail.go?type=gene&acc=2735,,,2735.0,GLI1,10116,Rattus norvegicus (Norway rat),Cyclopamine inhibits the reaction [resveratrol results in increased expression of GLI1 protein],,,PMID:24464877,https://www.ncbi.nlm.nih.gov/pubmed/24464877,24464877,,
534,1487956,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,154091,SLC2A12,https://ctdbase.org/detail.go?type=gene&acc=154091,,,154091.0,SLC2A12,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of SLC2A12 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
535,1487957,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,144195,SLC2A14,https://ctdbase.org/detail.go?type=gene&acc=144195,,,144195.0,SLC2A14,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of SLC2A14 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
536,1487958,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514.0,SLC2A2,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of SLC2A2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
537,1487959,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514.0,SLC2A2,8078,Fundulus heteroclitus (mummichog),Sodium arsenite affects the expression of SLC2A2 mRNA,,,PMID:20451245,https://www.ncbi.nlm.nih.gov/pubmed/20451245,20451245,,
538,1487960,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514.0,SLC2A2,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of SLC2A2 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
539,1487961,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514.0,SLC2A2,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SLC2A2 protein|ferulic acid inhibits the reaction [sodium arsenite results in decreased expression of SLC2A2 protein],,,PMID:37393015,https://www.ncbi.nlm.nih.gov/pubmed/37393015,37393015,,
540,1487962,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514.0,SLC2A2,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of SLC2A2 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
541,1487963,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514.0,SLC2A2,10090,Mus musculus (house mouse),[sodium arsenite results in increased abundance of arsenite] which results in decreased expression of SLC2A2 protein,,,PMID:35090851,https://www.ncbi.nlm.nih.gov/pubmed/35090851,35090851,,
542,1487964,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514.0,SLC2A2,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of SLC2A2 mRNA,,,PMID:30208560,https://www.ncbi.nlm.nih.gov/pubmed/30208560,30208560,,
543,1487965,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,6514,SLC2A2,https://ctdbase.org/detail.go?type=gene&acc=6514,,,6514.0,SLC2A2,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in decreased expression of SLC2A2 mRNA,,,PMID:35314868,https://www.ncbi.nlm.nih.gov/pubmed/35314868,35314868,,
544,1489071,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,378742,MARC1,https://ctdbase.org/detail.go?type=gene&acc=378742,,,378742.0,marc1,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of MARC1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
545,1489072,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,105009192,MARCH1,https://ctdbase.org/detail.go?type=gene&acc=105009192,,,105009192.0,march1,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of MARCH1 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
546,1489073,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,65108,MARCKSL1,https://ctdbase.org/detail.go?type=gene&acc=65108,,,65108.0,MARCKSL1,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of MARCKSL1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
547,1489074,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,406504,MARCKSL1B,https://ctdbase.org/detail.go?type=gene&acc=406504,,,406504.0,marcksl1b,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of MARCKSL1B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
548,1489250,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,892,CCNC,https://ctdbase.org/detail.go?type=gene&acc=892,,,892.0,CCNC,10116,Rattus norvegicus (Norway rat),Sodium arsenite results in increased expression of CCNC mRNA,,,PMID:11241755,https://www.ncbi.nlm.nih.gov/pubmed/11241755,11241755,,
549,1489251,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8839,CCN5,https://ctdbase.org/detail.go?type=gene&acc=8839,,,8839.0,CCN5,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of CCN5 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
550,1491576,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,729230,CCR2,https://ctdbase.org/detail.go?type=gene&acc=729230,,,729230.0,CCR2,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of CCR2 mRNA,,,PMID:21911445,https://www.ncbi.nlm.nih.gov/pubmed/21911445,21911445,,
551,1491577,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1232,CCR3,https://ctdbase.org/detail.go?type=gene&acc=1232,,,1232.0,CCR3,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of CCR3 mRNA,,,PMID:21911445,https://www.ncbi.nlm.nih.gov/pubmed/21911445,21911445,,
552,1491578,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1233,CCR4,https://ctdbase.org/detail.go?type=gene&acc=1233,,,1233.0,CCR4,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of CCR4 mRNA,,,PMID:36209798|PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/36209798|https://www.ncbi.nlm.nih.gov/pubmed/37682722,36209798|37682722,,
553,1491579,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1233,CCR4,https://ctdbase.org/detail.go?type=gene&acc=1233,,,1233.0,CCR4,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of CCR4 mRNA,,,PMID:21911445,https://www.ncbi.nlm.nih.gov/pubmed/21911445,21911445,,
554,1491580,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1234,CCR5,https://ctdbase.org/detail.go?type=gene&acc=1234,,,1234.0,CCR5,10090,Mus musculus (house mouse),[sodium arsenite results in increased abundance of arsenic] which results in increased expression of CCR5 mRNA,,,PMID:30889423,https://www.ncbi.nlm.nih.gov/pubmed/30889423,30889423,,
555,1491581,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1235,CCR6,https://ctdbase.org/detail.go?type=gene&acc=1235,,,1235.0,CCR6,9606,Homo sapiens (human),Sodium arsenite affects the methylation of CCR6 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
556,1491582,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1235,CCR6,https://ctdbase.org/detail.go?type=gene&acc=1235,,,1235.0,CCR6,10090,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of CCR6 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
557,1491583,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1236,CCR7,https://ctdbase.org/detail.go?type=gene&acc=1236,,,1236.0,CCR7,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of CCR7 mRNA,,,PMID:12676792,https://www.ncbi.nlm.nih.gov/pubmed/12676792,12676792,,
558,1492676,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4064,CD180,https://ctdbase.org/detail.go?type=gene&acc=4064,,,4064.0,CD180,9606,Homo sapiens (human),Sodium arsenite results in increased expression of CD180 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
559,1492677,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4064,CD180,https://ctdbase.org/detail.go?type=gene&acc=4064,,,4064.0,CD180,10090,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of CD180 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
560,1492678,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,4064,CD180,https://ctdbase.org/detail.go?type=gene&acc=4064,,,4064.0,CD180,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of CD180 protein,,,PMID:29044176,https://www.ncbi.nlm.nih.gov/pubmed/29044176,29044176,,
561,1492679,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,930,CD19,https://ctdbase.org/detail.go?type=gene&acc=930,,,930.0,CD19,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of CD19 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
562,1492680,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,909,CD1A,https://ctdbase.org/detail.go?type=gene&acc=909,,,909.0,CD1A,9606,Homo sapiens (human),Sodium arsenite inhibits the reaction [[TNF protein co-treated with CSF2 protein] results in increased expression of CD1A protein],,,PMID:23164666,https://www.ncbi.nlm.nih.gov/pubmed/23164666,23164666,,
563,1492681,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,912,CD1D,https://ctdbase.org/detail.go?type=gene&acc=912,,,912.0,CD1D,9606,Homo sapiens (human),Sodium arsenite results in increased expression of CD1D mRNA,,,PMID:28595984|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/28595984|https://www.ncbi.nlm.nih.gov/pubmed/34032870,28595984|34032870,,
564,1492682,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,12479,CD1D1,https://ctdbase.org/detail.go?type=gene&acc=12479,,,12479.0,Cd1d1,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of CD1D1 mRNA,,,PMID:25270620,https://www.ncbi.nlm.nih.gov/pubmed/25270620,25270620,,
565,1492683,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,914,CD2,https://ctdbase.org/detail.go?type=gene&acc=914,,,914.0,CD2,10090,Mus musculus (house mouse),[sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with cacodylic acid] results in increased expression of CD2 mRNA,,,PMID:34876320,https://www.ncbi.nlm.nih.gov/pubmed/34876320,34876320,,
566,1493517,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,11309,SLCO2B1,https://ctdbase.org/detail.go?type=gene&acc=11309,,,11309.0,SLCO2B1,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of SLCO2B1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
567,1494869,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9308,CD83,https://ctdbase.org/detail.go?type=gene&acc=9308,,,9308.0,CD83,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of CD83 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
568,1494870,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9308,CD83,https://ctdbase.org/detail.go?type=gene&acc=9308,,,9308.0,CD83,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of CD83 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
569,1494871,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,9308,CD83,https://ctdbase.org/detail.go?type=gene&acc=9308,,,9308.0,CD83,9606,Homo sapiens (human),Sodium arsenite results in increased expression of CD83 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
570,1497986,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,25805,BAMBI,https://ctdbase.org/detail.go?type=gene&acc=25805,,,25805.0,BAMBI,9606,Homo sapiens (human),Sodium arsenite results in increased expression of BAMBI mRNA,,,PMID:28595984,https://www.ncbi.nlm.nih.gov/pubmed/28595984,28595984,,
571,1497987,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,8815,BANF1,https://ctdbase.org/detail.go?type=gene&acc=8815,,,8815.0,BANF1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of BANF1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
572,1497988,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,55024,BANK1,https://ctdbase.org/detail.go?type=gene&acc=55024,,,55024.0,BANK1,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of BANK1 mRNA,,,PMID:25879800|PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/25879800|https://www.ncbi.nlm.nih.gov/pubmed/29301061,25879800|29301061,,
573,1498783,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10090,Mus musculus (house mouse),[sulfur dioxide co-treated with sodium arsenite] results in increased expression of BAX mRNA,,,PMID:30195209,https://www.ncbi.nlm.nih.gov/pubmed/30195209,30195209,,
574,1498942,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,83480,PUS3,https://ctdbase.org/detail.go?type=gene&acc=83480,,,83480.0,PUS3,9606,Homo sapiens (human),Sodium arsenite results in increased expression of PUS3 protein,,,PMID:21925251,https://www.ncbi.nlm.nih.gov/pubmed/21925251,21925251,,
575,1498943,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,126789,PUSL1,https://ctdbase.org/detail.go?type=gene&acc=126789,,,126789.0,PUSL1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of PUSL1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
576,1498944,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,58028,PVALB2,https://ctdbase.org/detail.go?type=gene&acc=58028,,,58028.0,pvalb2,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PVALB2 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
577,1498945,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,360208,PVALB8,https://ctdbase.org/detail.go?type=gene&acc=360208,,,360208.0,pvalb8,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PVALB8 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
578,1498946,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5820,PVT1,https://ctdbase.org/detail.go?type=gene&acc=5820,,,5820.0,PVT1,9606,Homo sapiens (human),Sodium arsenite affects the expression of PVT1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
579,1498947,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5820,PVT1,https://ctdbase.org/detail.go?type=gene&acc=5820,,,5820.0,PVT1,9606,Homo sapiens (human),Sodium arsenite results in increased expression of PVT1 mRNA,,,PMID:29301061,https://www.ncbi.nlm.nih.gov/pubmed/29301061,29301061,,
580,1498948,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,11137,PWP1,https://ctdbase.org/detail.go?type=gene&acc=11137,,,11137.0,PWP1,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PWP1 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
581,1498949,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,5822,PWP2,https://ctdbase.org/detail.go?type=gene&acc=5822,,,5822.0,PWP2,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of PWP2 mRNA,,,PMID:20371982,https://www.ncbi.nlm.nih.gov/pubmed/20371982,20371982,,
582,1498950,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,266990,PWP2H,https://ctdbase.org/detail.go?type=gene&acc=266990,,,266990.0,pwp2h,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of PWP2H mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
583,1498951,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,221749,PXDC1,https://ctdbase.org/detail.go?type=gene&acc=221749,,,221749.0,PXDC1,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of PXDC1 mRNA,,,PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/34032870,34032870,,
584,1498952,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,7837,PXDN,https://ctdbase.org/detail.go?type=gene&acc=7837,,,7837.0,PXDN,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of PXDN mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
585,1499423,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,581,BAX,https://ctdbase.org/detail.go?type=gene&acc=581,,,581.0,BAX,10116,Rattus norvegicus (Norway rat),Taurine inhibits the reaction [sodium arsenite results in increased expression of BAX protein],,,PMID:19616567|PMID:20830294,https://www.ncbi.nlm.nih.gov/pubmed/19616567|https://www.ncbi.nlm.nih.gov/pubmed/20830294,19616567|20830294,,
586,1499424,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,58081,BAXA,https://ctdbase.org/detail.go?type=gene&acc=58081,,,58081.0,baxa,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of BAXA mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
587,1499425,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,29994,BAZ2B,https://ctdbase.org/detail.go?type=gene&acc=29994,,,29994.0,BAZ2B,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of BAZ2B mRNA,,,PMID:28595984|PMID:34032870,https://www.ncbi.nlm.nih.gov/pubmed/28595984|https://www.ncbi.nlm.nih.gov/pubmed/34032870,28595984|34032870,,
588,1499426,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,29994,BAZ2B,https://ctdbase.org/detail.go?type=gene&acc=29994,,,29994.0,BAZ2B,9606,Homo sapiens (human),Sodium arsenite results in increased expression of BAZ2B mRNA,,,PMID:17879257,https://www.ncbi.nlm.nih.gov/pubmed/17879257,17879257,,
589,1499427,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,27113,BBC3,https://ctdbase.org/detail.go?type=gene&acc=27113,,,27113.0,BBC3,7955,Danio rerio (zebrafish),Sodium arsenite results in increased expression of BBC3 mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
590,1500038,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1027,CDKN1B,https://ctdbase.org/detail.go?type=gene&acc=1027,,,1027.0,CDKN1B,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of CDKN1B protein,,,PMID:10764629,https://www.ncbi.nlm.nih.gov/pubmed/10764629,10764629,,
591,1500039,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1028,CDKN1C,https://ctdbase.org/detail.go?type=gene&acc=1028,,,1028.0,CDKN1C,10090,Mus musculus (house mouse),Sodium arsenite results in increased expression of CDKN1C mRNA,,,PMID:17451858,https://www.ncbi.nlm.nih.gov/pubmed/17451858,17451858,,
592,1500040,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,399483,CDKN1CA,https://ctdbase.org/detail.go?type=gene&acc=399483,,,399483.0,cdkn1ca,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of CDKN1CA mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
593,1500041,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100151464,CDKN1D,https://ctdbase.org/detail.go?type=gene&acc=100151464,,,100151464.0,cdkn1d,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of CDKN1D mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
594,1500042,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1029,CDKN2A,https://ctdbase.org/detail.go?type=gene&acc=1029,,,1029.0,CDKN2A,9606,Homo sapiens (human),[sodium arsenite co-treated with cadmium chloride co-treated with chromic oxide co-treated with chromous chloride co-treated with lead acetate] results in increased expression of CDKN2A mRNA,,,PMID:12634122,https://www.ncbi.nlm.nih.gov/pubmed/12634122,12634122,,
595,1500043,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1029,CDKN2A,https://ctdbase.org/detail.go?type=gene&acc=1029,,,1029.0,CDKN2A,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of CDKN2A mRNA,,,PMID:11825526|PMID:21820459,https://www.ncbi.nlm.nih.gov/pubmed/11825526|https://www.ncbi.nlm.nih.gov/pubmed/21820459,11825526|21820459,,
596,1500044,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,1029,CDKN2A,https://ctdbase.org/detail.go?type=gene&acc=1029,,,1029.0,CDKN2A,9606,Homo sapiens (human),Sodium arsenite results in decreased expression of CDKN2A mRNA alternative form|sodium arsenite results in decreased expression of CDKN2A protein alternative form,,,PMID:24816914,https://www.ncbi.nlm.nih.gov/pubmed/24816914,24816914,,
597,1500168,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,436806,RAB11FIP4A,https://ctdbase.org/detail.go?type=gene&acc=436806,,,436806.0,rab11fip4a,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of RAB11FIP4A mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
598,1500169,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,100151129,RAB11FIP4B,https://ctdbase.org/detail.go?type=gene&acc=100151129,,,100151129.0,rab11fip4b,7955,Danio rerio (zebrafish),Sodium arsenite results in decreased expression of RAB11FIP4B mRNA,,,PMID:29361514,https://www.ncbi.nlm.nih.gov/pubmed/29361514,29361514,,
599,1500170,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,26056,RAB11FIP5,https://ctdbase.org/detail.go?type=gene&acc=26056,,,26056.0,RAB11FIP5,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of RAB11FIP5 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
600,1500171,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,64284,RAB17,https://ctdbase.org/detail.go?type=gene&acc=64284,,,64284.0,RAB17,9606,Homo sapiens (human),Sodium arsenite affects the methylation of RAB17 gene,,,PMID:28589171,https://www.ncbi.nlm.nih.gov/pubmed/28589171,28589171,,
601,1500172,443495,Comparative Toxicogenomics Database (CTD),Sodium arsenite,C017947,sodium arsenite,https://ctdbase.org/detail.go?type=chem&acc=C017947,64284,RAB17,https://ctdbase.org/detail.go?type=gene&acc=64284,,,64284.0,RAB17,10090,Mus musculus (house mouse),Sodium arsenite results in decreased expression of RAB17 mRNA,,,PMID:37682722,https://www.ncbi.nlm.nih.gov/pubmed/37682722,37682722,,
602,1494539,444266,Comparative Toxicogenomics Database (CTD),Maleic Acid,C030272,maleic acid,https://ctdbase.org/detail.go?type=chem&acc=C030272,10347,ABCA7,https://ctdbase.org/detail.go?type=gene&acc=10347,,,10347.0,ABCA7,9606,Homo sapiens (human),Maleic acid results in increased expression of ABCA7 mRNA,,,PMID:28392987,https://www.ncbi.nlm.nih.gov/pubmed/28392987,28392987,,
603,1494540,444266,Comparative Toxicogenomics Database (CTD),Maleic Acid,C030272,maleic acid,https://ctdbase.org/detail.go?type=chem&acc=C030272,50,ACO2,https://ctdbase.org/detail.go?type=gene&acc=50,,,50.0,ACO2,9823,Sus scrofa (pig),Maleic acid results in decreased activity of ACO2 protein|curcumin inhibits the reaction [maleic acid results in decreased activity of ACO2 protein],,,PMID:25119790,https://www.ncbi.nlm.nih.gov/pubmed/25119790,25119790,,
604,1494541,444266,Comparative Toxicogenomics Database (CTD),Maleic Acid,C030272,maleic acid,https://ctdbase.org/detail.go?type=chem&acc=C030272,116987,AGAP1,https://ctdbase.org/detail.go?type=gene&acc=116987,,,116987.0,AGAP1,9606,Homo sapiens (human),Maleic acid results in increased expression of AGAP1 mRNA,,,PMID:28392987,https://www.ncbi.nlm.nih.gov/pubmed/28392987,28392987,,
605,1494542,444266,Comparative Toxicogenomics Database (CTD),Maleic Acid,C030272,maleic acid,https://ctdbase.org/detail.go?type=chem&acc=C030272,208,AKT2,https://ctdbase.org/detail.go?type=gene&acc=208,,,208.0,AKT2,9606,Homo sapiens (human),Maleic acid results in decreased expression of AKT2 mRNA,,,PMID:28392987,https://www.ncbi.nlm.nih.gov/pubmed/28392987,28392987,,
606,1495016,444266,Comparative Toxicogenomics Database (CTD),Maleic Acid,C030272,maleic acid,https://ctdbase.org/detail.go?type=chem&acc=C030272,8339,H2BC8,https://ctdbase.org/detail.go?type=gene&acc=8339,,,8339.0,H2BC8,9606,Homo sapiens (human),Maleic acid results in decreased expression of H2BC8 mRNA,,,PMID:28392987,https://www.ncbi.nlm.nih.gov/pubmed/28392987,28392987,,
607,1495017,444266,Comparative Toxicogenomics Database (CTD),Maleic Acid,C030272,maleic acid,https://ctdbase.org/detail.go?type=chem&acc=C030272,26762,HAVCR1,https://ctdbase.org/detail.go?type=gene&acc=26762,,,26762.0,HAVCR1,10116,Rattus norvegicus (Norway rat),Maleic acid results in increased expression of HAVCR1 protein|curcumin inhibits the reaction [maleic acid results in increased expression of HAVCR1 protein],,,PMID:25119790,https://www.ncbi.nlm.nih.gov/pubmed/25119790,25119790,,
608,1495018,444266,Comparative Toxicogenomics Database (CTD),Maleic Acid,C030272,maleic acid,https://ctdbase.org/detail.go?type=chem&acc=C030272,3162,HMOX1,https://ctdbase.org/detail.go?type=gene&acc=3162,,,3162.0,HMOX1,10116,Rattus norvegicus (Norway rat),Maleic acid affects the expression of HMOX1 mRNA,,,PMID:22954530,https://www.ncbi.nlm.nih.gov/pubmed/22954530,22954530,,
609,1495019,444266,Comparative Toxicogenomics Database (CTD),Maleic Acid,C030272,maleic acid,https://ctdbase.org/detail.go?type=chem&acc=C030272,3479,IGF1,https://ctdbase.org/detail.go?type=gene&acc=3479,,,3479.0,IGF1,9606,Homo sapiens (human),Maleic acid results in increased expression of IGF1 mRNA,,,PMID:28392987,https://www.ncbi.nlm.nih.gov/pubmed/28392987,28392987,,
610,1488122,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5349,FXYD3,https://ctdbase.org/detail.go?type=gene&acc=5349,,,5349.0,FXYD3,9606,Homo sapiens (human),Trichostatin A results in increased expression of FXYD3 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
611,1488123,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,53827,FXYD5,https://ctdbase.org/detail.go?type=gene&acc=53827,,,53827.0,FXYD5,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FXYD5 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
612,1488124,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,53827,FXYD5,https://ctdbase.org/detail.go?type=gene&acc=53827,,,53827.0,FXYD5,9606,Homo sapiens (human),Trichostatin A results in increased expression of FXYD5 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
613,1488125,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,199920,FYB2,https://ctdbase.org/detail.go?type=gene&acc=199920,,,199920.0,FYB2,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of FYB2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
614,1488126,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,199920,FYB2,https://ctdbase.org/detail.go?type=gene&acc=199920,,,199920.0,FYB2,9606,Homo sapiens (human),Trichostatin A results in decreased expression of FYB2 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
615,1488127,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2534,FYN,https://ctdbase.org/detail.go?type=gene&acc=2534,,,2534.0,FYN,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of FYN mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
616,1489861,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,84691,GARIN1B,https://ctdbase.org/detail.go?type=gene&acc=84691,,,84691.0,GARIN1B,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GARIN1B mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
617,1490381,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,79815,NIPAL2,https://ctdbase.org/detail.go?type=gene&acc=79815,,,79815.0,NIPAL2,9606,Homo sapiens (human),Trichostatin A results in increased expression of NIPAL2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
618,1490382,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,25836,NIPBL,https://ctdbase.org/detail.go?type=gene&acc=25836,,,25836.0,NIPBL,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NIPBL mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
619,1490383,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,25836,NIPBL,https://ctdbase.org/detail.go?type=gene&acc=25836,,,25836.0,NIPBL,9606,Homo sapiens (human),Trichostatin A results in decreased expression of NIPBL mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
620,1493019,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10681,GNB5,https://ctdbase.org/detail.go?type=gene&acc=10681,,,10681.0,GNB5,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GNB5 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
621,1493020,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10681,GNB5,https://ctdbase.org/detail.go?type=gene&acc=10681,,,10681.0,GNB5,9606,Homo sapiens (human),Trichostatin A results in decreased expression of GNB5 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
622,1493021,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2790,GNG10,https://ctdbase.org/detail.go?type=gene&acc=2790,,,2790.0,GNG10,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GNG10 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
623,1493022,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2790,GNG10,https://ctdbase.org/detail.go?type=gene&acc=2790,,,2790.0,GNG10,9606,Homo sapiens (human),Trichostatin A results in decreased expression of GNG10 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
624,1493023,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2791,GNG11,https://ctdbase.org/detail.go?type=gene&acc=2791,,,2791.0,GNG11,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GNG11 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
625,1493024,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2791,GNG11,https://ctdbase.org/detail.go?type=gene&acc=2791,,,2791.0,GNG11,9606,Homo sapiens (human),Trichostatin A results in increased expression of GNG11 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
626,1493518,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2908,NR3C1,https://ctdbase.org/detail.go?type=gene&acc=2908,,,2908.0,NR3C1,9606,Homo sapiens (human),Trichostatin A results in increased expression of NR3C1 mRNA alternative form|trichostatin A results in decreased expression of NR3C1 mRNA alternative form|trichostatin A results in decreased expression of NR3C1 protein alternative form|trichostatin A results in increased expression of NR3C1 protein alternative form,,,PMID:17498915,https://www.ncbi.nlm.nih.gov/pubmed/17498915,17498915,,
627,1493519,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2908,NR3C1,https://ctdbase.org/detail.go?type=gene&acc=2908,,,2908.0,NR3C1,9606,Homo sapiens (human),Trichostatin A results in increased expression of NR3C1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
628,1493520,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2908,NR3C1,https://ctdbase.org/detail.go?type=gene&acc=2908,,,2908.0,NR3C1,10116,Rattus norvegicus (Norway rat),Trichostatin A inhibits the reaction [HSP90AA1 protein binds to NR3C1 protein]|trichostatin A inhibits the reaction [dexamethasone affects the localization of NR3C1 protein],,,PMID:31778773,https://www.ncbi.nlm.nih.gov/pubmed/31778773,31778773,,
629,1493521,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,3164,NR4A1,https://ctdbase.org/detail.go?type=gene&acc=3164,,,3164.0,NR4A1,9606,Homo sapiens (human),Fenretinide promotes the reaction [trichostatin A results in increased expression of NR4A1 protein]|nr4a1 protein promotes the reaction [trichostatin A results in increased cleavage of CASP3 protein]|trichostatin A affects the localization of NR4A1 protein|trichostatin A results in increased expression of NR4A1 protein|rarb protein promotes the reaction [fenretinide promotes the reaction [trichostatin A results in increased expression of NR4A1 protein]]|trichostatin A results in increased expression of NR4A1 mrna|[fenretinide co-treated with trichostatin A] affects the localization of NR4A1 protein|rarb protein promotes the reaction [trichostatin A results in increased expression of NR4A1 protein]|trichostatin A promotes the reaction [fenretinide results in increased expression of NR4A1 mrna]|fenretinide promotes the reaction [trichostatin A results in increased expression of NR4A1 mrna],,,PMID:21319187,https://www.ncbi.nlm.nih.gov/pubmed/21319187,21319187,,
630,1493522,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,4929,NR4A2,https://ctdbase.org/detail.go?type=gene&acc=4929,,,4929.0,NR4A2,9606,Homo sapiens (human),Trichostatin A results in increased expression of NR4A2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
631,1493523,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2516,NR5A1,https://ctdbase.org/detail.go?type=gene&acc=2516,,,2516.0,NR5A1,9606,Homo sapiens (human),Trichostatin A results in increased expression of NR5A1 mrna|trichostatin A inhibits the reaction [nicotine results in decreased expression of NR5A1 mrna],,,PMID:24709674,https://www.ncbi.nlm.nih.gov/pubmed/24709674,24709674,,
632,1493524,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2494,NR5A2,https://ctdbase.org/detail.go?type=gene&acc=2494,,,2494.0,NR5A2,8355,Xenopus laevis (African clawed frog),Trichostatin A results in decreased expression of NR5A2 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
633,1493525,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,399449,NR5A2.L,https://ctdbase.org/detail.go?type=gene&acc=399449,,,399449.0,nr5a2.L,8355,Xenopus laevis (African clawed frog),Trichostatin A results in decreased expression of NR5A2.L mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
634,1493526,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2649,NR6A1,https://ctdbase.org/detail.go?type=gene&acc=2649,,,2649.0,NR6A1,9606,Homo sapiens (human),Trichostatin A affects the expression of NR6A1 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
635,1493701,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55105,GPATCH2,https://ctdbase.org/detail.go?type=gene&acc=55105,,,55105.0,GPATCH2,9606,Homo sapiens (human),Trichostatin A results in decreased expression of GPATCH2 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
636,1493702,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55105,GPATCH2,https://ctdbase.org/detail.go?type=gene&acc=55105,,,55105.0,GPATCH2,9606,Homo sapiens (human),Trichostatin A results in increased expression of GPATCH2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
637,1493703,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55668,GPATCH2L,https://ctdbase.org/detail.go?type=gene&acc=55668,,,55668.0,GPATCH2L,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPATCH2L mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
638,1493704,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55668,GPATCH2L,https://ctdbase.org/detail.go?type=gene&acc=55668,,,55668.0,GPATCH2L,9606,Homo sapiens (human),Trichostatin A results in increased expression of GPATCH2L mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
639,1493705,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54865,GPATCH4,https://ctdbase.org/detail.go?type=gene&acc=54865,,,54865.0,GPATCH4,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPATCH4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
640,1493706,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54865,GPATCH4,https://ctdbase.org/detail.go?type=gene&acc=54865,,,54865.0,GPATCH4,9606,Homo sapiens (human),Trichostatin A results in increased expression of GPATCH4 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
641,1493707,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,221914,GPC2,https://ctdbase.org/detail.go?type=gene&acc=221914,,,221914.0,GPC2,9606,Homo sapiens (human),Trichostatin A affects the expression of GPC2 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
642,1493708,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2719,GPC3,https://ctdbase.org/detail.go?type=gene&acc=2719,,,2719.0,GPC3,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPC3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
643,1493709,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2719,GPC3,https://ctdbase.org/detail.go?type=gene&acc=2719,,,2719.0,GPC3,9606,Homo sapiens (human),Trichostatin A results in decreased expression of GPC3 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
644,1493710,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2239,GPC4,https://ctdbase.org/detail.go?type=gene&acc=2239,,,2239.0,GPC4,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GPC4 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
645,1494543,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,221294,NT5DC1,https://ctdbase.org/detail.go?type=gene&acc=221294,,,221294.0,NT5DC1,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NT5DC1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
646,1494544,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,221294,NT5DC1,https://ctdbase.org/detail.go?type=gene&acc=221294,,,221294.0,NT5DC1,9606,Homo sapiens (human),Trichostatin A results in decreased expression of NT5DC1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
647,1494545,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,4907,NT5E,https://ctdbase.org/detail.go?type=gene&acc=4907,,,4907.0,NT5E,9606,Homo sapiens (human),Trichostatin A results in increased expression of NT5E mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
648,1494546,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,4908,NTF3,https://ctdbase.org/detail.go?type=gene&acc=4908,,,4908.0,NTF3,9606,Homo sapiens (human),Trichostatin A results in decreased expression of NTF3 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
649,1494547,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,50863,NTM,https://ctdbase.org/detail.go?type=gene&acc=50863,,,50863.0,NTM,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NTM mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
650,1494548,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,50863,NTM,https://ctdbase.org/detail.go?type=gene&acc=50863,,,50863.0,NTM,9606,Homo sapiens (human),Trichostatin A results in decreased expression of NTM mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
651,1494549,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,50863,NTM,https://ctdbase.org/detail.go?type=gene&acc=50863,,,50863.0,NTM,9606,Homo sapiens (human),Trichostatin A results in increased expression of NTM mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
652,1495020,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,84955,NUDCD1,https://ctdbase.org/detail.go?type=gene&acc=84955,,,84955.0,NUDCD1,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUDCD1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
653,1495021,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,84955,NUDCD1,https://ctdbase.org/detail.go?type=gene&acc=84955,,,84955.0,NUDCD1,9606,Homo sapiens (human),Trichostatin A results in decreased expression of NUDCD1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
654,1495022,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55190,NUDT11,https://ctdbase.org/detail.go?type=gene&acc=55190,,,55190.0,NUDT11,9606,Homo sapiens (human),Trichostatin A results in increased expression of NUDT11 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
655,1495023,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,83594,NUDT12,https://ctdbase.org/detail.go?type=gene&acc=83594,,,83594.0,NUDT12,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NUDT12 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
656,1495024,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,83594,NUDT12,https://ctdbase.org/detail.go?type=gene&acc=83594,,,83594.0,NUDT12,9606,Homo sapiens (human),Trichostatin A results in decreased expression of NUDT12 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
657,1495025,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,25961,NUDT13,https://ctdbase.org/detail.go?type=gene&acc=25961,,,25961.0,NUDT13,9606,Homo sapiens (human),Trichostatin A results in increased expression of NUDT13 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
658,1495026,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55270,NUDT15,https://ctdbase.org/detail.go?type=gene&acc=55270,,,55270.0,NUDT15,9606,Homo sapiens (human),Trichostatin A affects the expression of NUDT15 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
659,1495647,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2913,GRM3,https://ctdbase.org/detail.go?type=gene&acc=2913,,,2913.0,GRM3,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GRM3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
660,1495648,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2913,GRM3,https://ctdbase.org/detail.go?type=gene&acc=2913,,,2913.0,GRM3,9606,Homo sapiens (human),Trichostatin A results in decreased expression of GRM3 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
661,1495649,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2896,GRN,https://ctdbase.org/detail.go?type=gene&acc=2896,,,2896.0,GRN,8355,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of GRN mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
662,1495650,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2922,GRP,https://ctdbase.org/detail.go?type=gene&acc=2922,,,2922.0,GRP,9606,Homo sapiens (human),Trichostatin A results in increased expression of GRP mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
663,1495651,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54103,GSAP,https://ctdbase.org/detail.go?type=gene&acc=54103,,,54103.0,GSAP,9606,Homo sapiens (human),Trichostatin A results in decreased expression of GSAP mrna|trichostatin A results in increased expression of GSAP mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
664,1495652,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,145258,GSC,https://ctdbase.org/detail.go?type=gene&acc=145258,,,145258.0,GSC,8355,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of GSC mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
665,1495653,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55876,GSDMB,https://ctdbase.org/detail.go?type=gene&acc=55876,,,55876.0,GSDMB,9606,Homo sapiens (human),Trichostatin A affects the expression of GSDMB mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
666,1495654,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,2950,GSTP1,https://ctdbase.org/detail.go?type=gene&acc=2950,,,2950.0,GSTP1,7955,Danio rerio (zebrafish),Trichostatin A results in increased expression of GSTP1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
667,1495655,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,1687,GSDME,https://ctdbase.org/detail.go?type=gene&acc=1687,,,1687.0,GSDME,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of GSDME mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
668,1496170,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7520,XRCC5,https://ctdbase.org/detail.go?type=gene&acc=7520,,,7520.0,XRCC5,9606,Homo sapiens (human),Trichostatin A results in increased acetylation of XRCC5 protein,,,PMID:27064363,https://www.ncbi.nlm.nih.gov/pubmed/27064363,27064363,,
669,1496171,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55130,ODAD2,https://ctdbase.org/detail.go?type=gene&acc=55130,,,55130.0,ODAD2,9606,Homo sapiens (human),Trichostatin A results in decreased expression of ODAD2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
670,1496172,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,115948,ODAD3,https://ctdbase.org/detail.go?type=gene&acc=115948,,,115948.0,ODAD3,9606,Homo sapiens (human),Trichostatin A affects the expression of ODAD3 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
671,1496173,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,115948,ODAD3,https://ctdbase.org/detail.go?type=gene&acc=115948,,,115948.0,ODAD3,9606,Homo sapiens (human),Trichostatin A results in increased expression of ODAD3 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
672,1496174,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,4953,ODC1,https://ctdbase.org/detail.go?type=gene&acc=4953,,,4953.0,ODC1,7955,Danio rerio (zebrafish),Trichostatin A results in increased expression of ODC1 mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
673,1496175,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,4953,ODC1,https://ctdbase.org/detail.go?type=gene&acc=4953,,,4953.0,ODC1,9606,Homo sapiens (human),Trichostatin A results in increased expression of ODC1 mRNA,,,PMID:19606018,https://www.ncbi.nlm.nih.gov/pubmed/19606018,19606018,,
674,1496176,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57489,ODF2L,https://ctdbase.org/detail.go?type=gene&acc=57489,,,57489.0,ODF2L,9606,Homo sapiens (human),Trichostatin A results in increased expression of ODF2L mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
675,1496177,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,57489,ODF2L,https://ctdbase.org/detail.go?type=gene&acc=57489,,,57489.0,ODF2L,8355,Xenopus laevis (African clawed frog),Trichostatin A results in increased expression of ODF2L mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
676,1496178,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,8481,OFD1,https://ctdbase.org/detail.go?type=gene&acc=8481,,,8481.0,OFD1,9606,Homo sapiens (human),Trichostatin A results in increased expression of OFD1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
677,1496179,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,10724,OGA,https://ctdbase.org/detail.go?type=gene&acc=10724,,,10724.0,OGA,9606,Homo sapiens (human),Trichostatin A affects the expression of OGA mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
678,1496180,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,55239,OGFOD1,https://ctdbase.org/detail.go?type=gene&acc=55239,,,55239.0,OGFOD1,9606,Homo sapiens (human),Trichostatin A results in decreased expression of OGFOD1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
679,1496355,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,563972,GSTT1A,https://ctdbase.org/detail.go?type=gene&acc=563972,,,563972.0,gstt1a,7955,Danio rerio (zebrafish),Trichostatin A results in increased expression of GSTT1A mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
680,1496356,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,79712,GTDC1,https://ctdbase.org/detail.go?type=gene&acc=79712,,,79712.0,GTDC1,9606,Homo sapiens (human),Trichostatin A results in decreased expression of GTDC1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
681,1496784,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,80228,ORAI2,https://ctdbase.org/detail.go?type=gene&acc=80228,,,80228.0,ORAI2,9606,Homo sapiens (human),Trichostatin A results in decreased expression of ORAI2 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
682,1496785,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,80228,ORAI2,https://ctdbase.org/detail.go?type=gene&acc=80228,,,80228.0,ORAI2,9606,Homo sapiens (human),Trichostatin A results in increased expression of ORAI2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
683,1496786,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,93129,ORAI3,https://ctdbase.org/detail.go?type=gene&acc=93129,,,93129.0,ORAI3,9606,Homo sapiens (human),Trichostatin A results in decreased expression of ORAI3 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
684,1496787,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5000,ORC4,https://ctdbase.org/detail.go?type=gene&acc=5000,,,5000.0,ORC4,9606,Homo sapiens (human),Trichostatin A affects the expression of ORC4 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
685,1496788,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,5004,ORM1,https://ctdbase.org/detail.go?type=gene&acc=5004,,,5004.0,ORM1,9606,Homo sapiens (human),Trichostatin A results in decreased expression of ORM1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
686,1496789,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,29095,ORMDL2,https://ctdbase.org/detail.go?type=gene&acc=29095,,,29095.0,ORMDL2,9606,Homo sapiens (human),Trichostatin A affects the expression of ORMDL2 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
687,1496790,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,94103,ORMDL3,https://ctdbase.org/detail.go?type=gene&acc=94103,,,94103.0,ORMDL3,9606,Homo sapiens (human),Trichostatin A affects the expression of ORMDL3 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
688,1496974,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,375513,GUSBP4,https://ctdbase.org/detail.go?type=gene&acc=375513,,,375513.0,GUSBP4,9606,Homo sapiens (human),Trichostatin A results in decreased expression of GUSBP4 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
689,1497386,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23264,ZC3H7B,https://ctdbase.org/detail.go?type=gene&acc=23264,,,23264.0,ZC3H7B,9606,Homo sapiens (human),Trichostatin A results in increased expression of ZC3H7B mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
690,1497387,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,84524,ZC3H8,https://ctdbase.org/detail.go?type=gene&acc=84524,,,84524.0,ZC3H8,9606,Homo sapiens (human),Trichostatin A results in increased expression of ZC3H8 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
691,1497388,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,56829,ZC3HAV1,https://ctdbase.org/detail.go?type=gene&acc=56829,,,56829.0,ZC3HAV1,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZC3HAV1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
692,1497389,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,56829,ZC3HAV1,https://ctdbase.org/detail.go?type=gene&acc=56829,,,56829.0,ZC3HAV1,9606,Homo sapiens (human),Trichostatin A affects the expression of ZC3HAV1 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
693,1497390,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,56829,ZC3HAV1,https://ctdbase.org/detail.go?type=gene&acc=56829,,,56829.0,ZC3HAV1,9606,Homo sapiens (human),Trichostatin A results in increased expression of ZC3HAV1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
694,1497391,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,92092,ZC3HAV1L,https://ctdbase.org/detail.go?type=gene&acc=92092,,,92092.0,ZC3HAV1L,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZC3HAV1L mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
695,1497392,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,92092,ZC3HAV1L,https://ctdbase.org/detail.go?type=gene&acc=92092,,,92092.0,ZC3HAV1L,9606,Homo sapiens (human),Trichostatin A results in increased expression of ZC3HAV1L mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
696,1497393,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23174,ZCCHC14,https://ctdbase.org/detail.go?type=gene&acc=23174,,,23174.0,ZCCHC14,9606,Homo sapiens (human),Trichostatin A affects the expression of ZCCHC14 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
697,1497394,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,51538,ZCCHC17,https://ctdbase.org/detail.go?type=gene&acc=51538,,,51538.0,ZCCHC17,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZCCHC17 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
698,1497395,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,51538,ZCCHC17,https://ctdbase.org/detail.go?type=gene&acc=51538,,,51538.0,ZCCHC17,9606,Homo sapiens (human),Trichostatin A affects the expression of ZCCHC17 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
699,1497684,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,80336,PABPC1L,https://ctdbase.org/detail.go?type=gene&acc=80336,,,80336.0,PABPC1L,9606,Homo sapiens (human),Trichostatin A results in increased expression of PABPC1L mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
700,1497685,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,379896,PABPC1.S,https://ctdbase.org/detail.go?type=gene&acc=379896,,,379896.0,pabpc1.S,8355,Xenopus laevis (African clawed frog),Trichostatin A results in decreased expression of PABPC1.S mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
701,1497686,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,132430,PABPC4L,https://ctdbase.org/detail.go?type=gene&acc=132430,,,132430.0,PABPC4L,9606,Homo sapiens (human),Trichostatin A results in increased expression of PABPC4L mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
702,1497687,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,140886,PABPC5,https://ctdbase.org/detail.go?type=gene&acc=140886,,,140886.0,PABPC5,9606,Homo sapiens (human),Trichostatin A results in increased expression of PABPC5 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
703,1497688,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,29993,PACSIN1,https://ctdbase.org/detail.go?type=gene&acc=29993,,,29993.0,PACSIN1,9606,Homo sapiens (human),Trichostatin A affects the expression of PACSIN1 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
704,1497689,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,29993,PACSIN1,https://ctdbase.org/detail.go?type=gene&acc=29993,,,29993.0,PACSIN1,9606,Homo sapiens (human),Trichostatin A results in increased expression of PACSIN1 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
705,1498307,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23022,PALLD,https://ctdbase.org/detail.go?type=gene&acc=23022,,,23022.0,PALLD,9606,Homo sapiens (human),Trichostatin A results in decreased expression of PALLD mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
706,1498308,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,445815,PALM2AKAP2,https://ctdbase.org/detail.go?type=gene&acc=445815,,,445815.0,PALM2AKAP2,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PALM2AKAP2 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
707,1498309,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,445815,PALM2AKAP2,https://ctdbase.org/detail.go?type=gene&acc=445815,,,445815.0,PALM2AKAP2,9606,Homo sapiens (human),Trichostatin A results in increased expression of PALM2AKAP2 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
708,1498310,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,54873,PALMD,https://ctdbase.org/detail.go?type=gene&acc=54873,,,54873.0,PALMD,8355,Xenopus laevis (African clawed frog),Trichostatin A results in decreased expression of PALMD mRNA,,,PMID:15901671,https://www.ncbi.nlm.nih.gov/pubmed/15901671,15901671,,
709,1498311,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,64398,PALS1,https://ctdbase.org/detail.go?type=gene&acc=64398,,,64398.0,PALS1,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PALS1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
710,1498312,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,64398,PALS1,https://ctdbase.org/detail.go?type=gene&acc=64398,,,64398.0,PALS1,9606,Homo sapiens (human),Trichostatin A results in decreased expression of PALS1 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
711,1498313,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,51678,PALS2,https://ctdbase.org/detail.go?type=gene&acc=51678,,,51678.0,PALS2,9606,Homo sapiens (human),Trichostatin A results in increased expression of PALS2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
712,1498314,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,25891,PAMR1,https://ctdbase.org/detail.go?type=gene&acc=25891,,,25891.0,PAMR1,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PAMR1 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
713,1498315,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,25891,PAMR1,https://ctdbase.org/detail.go?type=gene&acc=25891,,,25891.0,PAMR1,9606,Homo sapiens (human),Trichostatin A results in decreased expression of PAMR1 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
714,1498637,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,80829,ZFP91,https://ctdbase.org/detail.go?type=gene&acc=80829,,,80829.0,ZFP91,9606,Homo sapiens (human),Trichostatin A affects the expression of ZFP91 mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
715,1498638,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,23414,ZFPM2,https://ctdbase.org/detail.go?type=gene&acc=23414,,,23414.0,ZFPM2,9606,Homo sapiens (human),Trichostatin A results in decreased expression of ZFPM2 mrna|trichostatin A results in increased expression of ZFPM2 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
716,1498639,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,51663,ZFR,https://ctdbase.org/detail.go?type=gene&acc=51663,,,51663.0,ZFR,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZFR mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
717,1499244,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,64393,ZMAT3,https://ctdbase.org/detail.go?type=gene&acc=64393,,,64393.0,ZMAT3,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of ZMAT3 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
718,1499245,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,64393,ZMAT3,https://ctdbase.org/detail.go?type=gene&acc=64393,,,64393.0,ZMAT3,9606,Homo sapiens (human),Trichostatin A results in increased expression of ZMAT3 mRNA,,,PMID:24935251|PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/24935251|https://www.ncbi.nlm.nih.gov/pubmed/26272509,24935251|26272509,,
719,1500034,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7570,ZNF22,https://ctdbase.org/detail.go?type=gene&acc=7570,,,7570.0,ZNF22,9606,Homo sapiens (human),"[NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of ZNF22 mRNA",,,PMID:27188386,https://www.ncbi.nlm.nih.gov/pubmed/27188386,27188386,,
720,1500035,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7570,ZNF22,https://ctdbase.org/detail.go?type=gene&acc=7570,,,7570.0,ZNF22,9606,Homo sapiens (human),Trichostatin A results in decreased expression of ZNF22 mRNA,,,PMID:26272509,https://www.ncbi.nlm.nih.gov/pubmed/26272509,26272509,,
721,1500036,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7767,ZNF224,https://ctdbase.org/detail.go?type=gene&acc=7767,,,7767.0,ZNF224,9606,Homo sapiens (human),Trichostatin A results in increased expression of ZNF224 mRNA,,,PMID:24935251,https://www.ncbi.nlm.nih.gov/pubmed/24935251,24935251,,
722,1500037,444732,Comparative Toxicogenomics Database (CTD),trichostatin A,C012589,trichostatin A,https://ctdbase.org/detail.go?type=chem&acc=C012589,7582,ZNF33B,https://ctdbase.org/detail.go?type=gene&acc=7582,,,7582.0,ZNF33B,9606,Homo sapiens (human),Trichostatin A affects the expression of ZNF33B mRNA,,,PMID:28542535,https://www.ncbi.nlm.nih.gov/pubmed/28542535,28542535,,
723,1488117,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1107,CHD3,https://ctdbase.org/detail.go?type=gene&acc=1107,,,1107.0,CHD3,9606,Homo sapiens (human),Tretinoin results in decreased expression of CHD3 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
724,1488118,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1108,CHD4,https://ctdbase.org/detail.go?type=gene&acc=1108,,,1108.0,CHD4,9606,Homo sapiens (human),Tretinoin results in decreased expression of CHD4 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
725,1488119,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,57680,CHD8,https://ctdbase.org/detail.go?type=gene&acc=57680,,,57680.0,CHD8,9606,Homo sapiens (human),Tretinoin results in increased expression of CHD8 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
726,1488120,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,80205,CHD9,https://ctdbase.org/detail.go?type=gene&acc=80205,,,80205.0,CHD9,9606,Homo sapiens (human),Tretinoin results in increased expression of CHD9 mRNA,,,PMID:23724009|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/23724009|https://www.ncbi.nlm.nih.gov/pubmed/33167477,23724009|33167477,,
727,1488121,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55349,CHDH,https://ctdbase.org/detail.go?type=gene&acc=55349,,,55349.0,CHDH,9606,Homo sapiens (human),Tretinoin results in decreased expression of CHDH mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
728,1488923,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1141,CHRNB2,https://ctdbase.org/detail.go?type=gene&acc=1141,,,1141.0,CHRNB2,9031,Gallus gallus (chicken),Tretinoin results in increased expression of CHRNB2 protein|tretinoin results in increased expression of CHRNB2 mrna|tretinoin inhibits the reaction [epibatidine binds to [CHRNA4 protein binds to CHRNB2 protein]],,,PMID:17203487,https://www.ncbi.nlm.nih.gov/pubmed/17203487,17203487,,
729,1488924,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1145,CHRNE,https://ctdbase.org/detail.go?type=gene&acc=1145,,,1145.0,CHRNE,9606,Homo sapiens (human),Tretinoin results in increased expression of CHRNE mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
730,1489428,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10519,CIB1,https://ctdbase.org/detail.go?type=gene&acc=10519,,,10519.0,CIB1,9606,Homo sapiens (human),Tretinoin results in increased expression of CIB1 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
731,1489429,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10518,CIB2,https://ctdbase.org/detail.go?type=gene&acc=10518,,,10518.0,CIB2,9606,Homo sapiens (human),Tretinoin results in decreased expression of CIB2 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
732,1489430,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,130106,CIB4,https://ctdbase.org/detail.go?type=gene&acc=130106,,,130106.0,CIB4,9606,Homo sapiens (human),Tretinoin results in increased expression of CIB4 mRNA,,,PMID:23830798,https://www.ncbi.nlm.nih.gov/pubmed/23830798,23830798,,
733,1489431,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,137392,CIBAR1,https://ctdbase.org/detail.go?type=gene&acc=137392,,,137392.0,CIBAR1,9606,Homo sapiens (human),Tretinoin results in decreased expression of CIBAR1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
734,1489432,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1149,CIDEA,https://ctdbase.org/detail.go?type=gene&acc=1149,,,1149.0,CIDEA,10090,Mus musculus (house mouse),Tretinoin results in increased expression of CIDEA mRNA,,,PMID:16604517|PMID:16788091,https://www.ncbi.nlm.nih.gov/pubmed/16604517|https://www.ncbi.nlm.nih.gov/pubmed/16788091,16604517|16788091,,
735,1489433,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,4261,CIITA,https://ctdbase.org/detail.go?type=gene&acc=4261,,,4261.0,CIITA,9606,Homo sapiens (human),Tretinoin results in increased expression of CIITA mRNA,,,PMID:17229644,https://www.ncbi.nlm.nih.gov/pubmed/17229644,17229644,,
736,1489434,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,440836,CIMAP1B,https://ctdbase.org/detail.go?type=gene&acc=440836,,,440836.0,CIMAP1B,9606,Homo sapiens (human),Tretinoin results in increased expression of CIMAP1B mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
737,1489851,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,548596,CKMT1A,https://ctdbase.org/detail.go?type=gene&acc=548596,,,548596.0,CKMT1A,9606,Homo sapiens (human),Tretinoin results in decreased expression of CKMT1A mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
738,1489852,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1163,CKS1B,https://ctdbase.org/detail.go?type=gene&acc=1163,,,1163.0,CKS1B,9606,Homo sapiens (human),Tretinoin results in decreased expression of CKS1B mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
739,1489853,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1164,CKS2,https://ctdbase.org/detail.go?type=gene&acc=1164,,,1164.0,CKS2,9606,Homo sapiens (human),Tretinoin results in decreased expression of CKS2 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
740,1489854,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,23122,CLASP2,https://ctdbase.org/detail.go?type=gene&acc=23122,,,23122.0,CLASP2,9606,Homo sapiens (human),Tretinoin results in increased expression of CLASP2 mRNA,,,PMID:23724009|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/23724009|https://www.ncbi.nlm.nih.gov/pubmed/33167477,23724009|33167477,,
741,1489855,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,122616,CLBA1,https://ctdbase.org/detail.go?type=gene&acc=122616,,,122616.0,CLBA1,9606,Homo sapiens (human),Tretinoin results in decreased expression of CLBA1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
742,1489856,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1178,CLC,https://ctdbase.org/detail.go?type=gene&acc=1178,,,1178.0,CLC,9606,Homo sapiens (human),Tretinoin results in increased expression of CLC mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
743,1489857,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1181,CLCN2,https://ctdbase.org/detail.go?type=gene&acc=1181,,,1181.0,CLCN2,9606,Homo sapiens (human),Tretinoin results in decreased expression of CLCN2 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
744,1489858,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1183,CLCN4,https://ctdbase.org/detail.go?type=gene&acc=1183,,,1183.0,CLCN4,9606,Homo sapiens (human),Tretinoin results in decreased expression of CLCN4 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
745,1489859,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1183,CLCN4,https://ctdbase.org/detail.go?type=gene&acc=1183,,,1183.0,CLCN4,10090,Mus musculus (house mouse),Tretinoin results in increased expression of CLCN4 mRNA,,,PMID:16604517,https://www.ncbi.nlm.nih.gov/pubmed/16604517,16604517,,
746,1489860,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1184,CLCN5,https://ctdbase.org/detail.go?type=gene&acc=1184,,,1184.0,CLCN5,9606,Homo sapiens (human),Tretinoin results in decreased expression of CLCN5 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
747,1490032,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,5010,CLDN11,https://ctdbase.org/detail.go?type=gene&acc=5010,,,5010.0,CLDN11,9606,Homo sapiens (human),Tretinoin results in decreased expression of CLDN11 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
748,1490033,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,436897,CLDN11A,https://ctdbase.org/detail.go?type=gene&acc=436897,,,436897.0,cldn11a,7955,Danio rerio (zebrafish),Tretinoin results in decreased expression of CLDN11A mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
749,1490034,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,23562,CLDN14,https://ctdbase.org/detail.go?type=gene&acc=23562,,,23562.0,CLDN14,8364,Xenopus tropicalis (tropical clawed frog),Tretinoin results in increased expression of CLDN14 mRNA,,,PMID:28689802,https://www.ncbi.nlm.nih.gov/pubmed/28689802,28689802,,
750,1490035,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1365,CLDN3,https://ctdbase.org/detail.go?type=gene&acc=1365,,,1365.0,CLDN3,10090,Mus musculus (house mouse),[bisphenol F co-treated with tretinoin] results in decreased expression of CLDN3 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
751,1490036,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1364,CLDN4,https://ctdbase.org/detail.go?type=gene&acc=1364,,,1364.0,CLDN4,9615,Canis lupus familiaris (dog),CYP26A1 protein inhibits the reaction [tretinoin results in increased expression of CLDN4 mrna]|tretinoin results in increased expression of CLDN4 protein|tretinoin results in increased expression of CLDN4 mRNA,,,PMID:17035595,https://www.ncbi.nlm.nih.gov/pubmed/17035595,17035595,,
752,1490037,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1364,CLDN4,https://ctdbase.org/detail.go?type=gene&acc=1364,,,1364.0,CLDN4,10090,Mus musculus (house mouse),[bisphenol A co-treated with tretinoin] results in decreased expression of CLDN4 mrna|[bisphenol F co-treated with tretinoin] results in decreased expression of CLDN4 mrna|[bis(4-hydroxyphenyl)sulfone co-treated with tretinoin] results in decreased expression of CLDN4 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
753,1490038,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1364,CLDN4,https://ctdbase.org/detail.go?type=gene&acc=1364,,,1364.0,CLDN4,10090,Mus musculus (house mouse),Tretinoin results in increased expression of CLDN4 mRNA,,,PMID:16236135,https://www.ncbi.nlm.nih.gov/pubmed/16236135,16236135,,
754,1492491,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1300,COL10A1,https://ctdbase.org/detail.go?type=gene&acc=1300,,,1300.0,COL10A1,10116,Rattus norvegicus (Norway rat),Tretinoin results in increased expression of COL10A1 mRNA,,,PMID:24977338,https://www.ncbi.nlm.nih.gov/pubmed/24977338,24977338,,
755,1492492,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1301,COL11A1,https://ctdbase.org/detail.go?type=gene&acc=1301,,,1301.0,COL11A1,9606,Homo sapiens (human),Tretinoin results in decreased expression of COL11A1 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
756,1492493,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1301,COL11A1,https://ctdbase.org/detail.go?type=gene&acc=1301,,,1301.0,COL11A1,10090,Mus musculus (house mouse),Tretinoin results in decreased expression of COL11A1 mRNA,,,PMID:18703560,https://www.ncbi.nlm.nih.gov/pubmed/18703560,18703560,,
757,1492494,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1302,COL11A2,https://ctdbase.org/detail.go?type=gene&acc=1302,,,1302.0,COL11A2,9606,Homo sapiens (human),Tretinoin results in decreased expression of COL11A2 mRNA,,,PMID:15498508,https://www.ncbi.nlm.nih.gov/pubmed/15498508,15498508,,
758,1492495,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1302,COL11A2,https://ctdbase.org/detail.go?type=gene&acc=1302,,,1302.0,COL11A2,10090,Mus musculus (house mouse),Tretinoin results in increased expression of COL11A2 mrna|[tretinoin binds to RXRB protein] which binds to COL11A2 enhancer,,,PMID:15206905,https://www.ncbi.nlm.nih.gov/pubmed/15206905,15206905,,
759,1492496,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1303,COL12A1,https://ctdbase.org/detail.go?type=gene&acc=1303,,,1303.0,COL12A1,9606,Homo sapiens (human),Tretinoin results in increased expression of COL12A1 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
760,1492497,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1303,COL12A1,https://ctdbase.org/detail.go?type=gene&acc=1303,,,1303.0,COL12A1,10090,Mus musculus (house mouse),[bisphenol F co-treated with tretinoin] results in decreased expression of COL12A1 mrna|[bisphenol A co-treated with tretinoin] results in decreased expression of COL12A1 mrna|[bis(4-hydroxyphenyl)sulfone co-treated with tretinoin] results in decreased expression of COL12A1 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
761,1492498,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1305,COL13A1,https://ctdbase.org/detail.go?type=gene&acc=1305,,,1305.0,COL13A1,9606,Homo sapiens (human),Tretinoin results in decreased expression of COL13A1 mRNA,,,PMID:23830798,https://www.ncbi.nlm.nih.gov/pubmed/23830798,23830798,,
762,1494178,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,23412,COMMD3,https://ctdbase.org/detail.go?type=gene&acc=23412,,,23412.0,COMMD3,9606,Homo sapiens (human),Tretinoin results in increased expression of COMMD3 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
763,1494179,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,170622,COMMD6,https://ctdbase.org/detail.go?type=gene&acc=170622,,,170622.0,COMMD6,9606,Homo sapiens (human),Tretinoin results in decreased expression of COMMD6 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
764,1494180,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1312,COMT,https://ctdbase.org/detail.go?type=gene&acc=1312,,,1312.0,COMT,9606,Homo sapiens (human),Tretinoin results in increased expression of COMT mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
765,1494872,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1340,COX6B1,https://ctdbase.org/detail.go?type=gene&acc=1340,,,1340.0,COX6B1,7955,Danio rerio (zebrafish),Tretinoin results in decreased expression of COX6B1 mRNA,,,PMID:20530235,https://www.ncbi.nlm.nih.gov/pubmed/20530235,20530235,,
766,1494873,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1347,COX7A2,https://ctdbase.org/detail.go?type=gene&acc=1347,,,1347.0,COX7A2,9606,Homo sapiens (human),Tretinoin results in increased expression of COX7A2 mRNA,,,PMID:17218384,https://www.ncbi.nlm.nih.gov/pubmed/17218384,17218384,,
767,1494874,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1349,COX7B,https://ctdbase.org/detail.go?type=gene&acc=1349,,,1349.0,COX7B,9606,Homo sapiens (human),Tretinoin results in increased expression of COX7B mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
768,1494875,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1351,COX8A,https://ctdbase.org/detail.go?type=gene&acc=1351,,,1351.0,COX8A,10090,Mus musculus (house mouse),[bisphenol F co-treated with tretinoin] results in decreased expression of COX8A mrna|[bis(4-hydroxyphenyl)sulfone co-treated with tretinoin] results in decreased expression of COX8A mrna|[bisphenol A co-treated with tretinoin] results in decreased expression of COX8A mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
769,1494876,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1356,CP,https://ctdbase.org/detail.go?type=gene&acc=1356,,,1356.0,CP,9606,Homo sapiens (human),Tretinoin results in increased expression of CP mRNA,,,PMID:21934132|PMID:23830798|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/23830798|https://www.ncbi.nlm.nih.gov/pubmed/33167477,21934132|23830798|33167477,,
770,1494877,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,51200,CPA4,https://ctdbase.org/detail.go?type=gene&acc=51200,,,51200.0,CPA4,9606,Homo sapiens (human),Tretinoin results in decreased expression of CPA4 mRNA,,,PMID:23830798,https://www.ncbi.nlm.nih.gov/pubmed/23830798,23830798,,
771,1494878,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,57094,CPA6,https://ctdbase.org/detail.go?type=gene&acc=57094,,,57094.0,CPA6,9606,Homo sapiens (human),Tretinoin results in decreased expression of CPA6 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
772,1494879,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1360,CPB1,https://ctdbase.org/detail.go?type=gene&acc=1360,,,1360.0,CPB1,9606,Homo sapiens (human),Tretinoin results in decreased expression of CPB1 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
773,1495320,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,55313,CPPED1,https://ctdbase.org/detail.go?type=gene&acc=55313,,,55313.0,CPPED1,9606,Homo sapiens (human),Tretinoin results in increased expression of CPPED1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
774,1495321,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1373,CPS1,https://ctdbase.org/detail.go?type=gene&acc=1373,,,1373.0,CPS1,9606,Homo sapiens (human),Tretinoin results in decreased expression of CPS1 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
775,1495322,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,51692,CPSF3,https://ctdbase.org/detail.go?type=gene&acc=51692,,,51692.0,CPSF3,9606,Homo sapiens (human),Tretinoin results in decreased expression of CPSF3 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
776,1495323,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10898,CPSF4,https://ctdbase.org/detail.go?type=gene&acc=10898,,,10898.0,CPSF4,9606,Homo sapiens (human),Tretinoin results in decreased expression of CPSF4 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
777,1495324,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,79869,CPSF7,https://ctdbase.org/detail.go?type=gene&acc=79869,,,79869.0,CPSF7,9606,Homo sapiens (human),Tretinoin results in decreased expression of CPSF7 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
778,1495325,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1374,CPT1A,https://ctdbase.org/detail.go?type=gene&acc=1374,,,1374.0,CPT1A,9606,Homo sapiens (human),Tretinoin results in decreased expression of CPT1A mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
779,1495326,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1374,CPT1A,https://ctdbase.org/detail.go?type=gene&acc=1374,,,1374.0,CPT1A,10090,Mus musculus (house mouse),Tretinoin results in increased expression of CPT1A mRNA,,,PMID:16840543,https://www.ncbi.nlm.nih.gov/pubmed/16840543,16840543,,
780,1495327,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1375,CPT1B,https://ctdbase.org/detail.go?type=gene&acc=1375,,,1375.0,CPT1B,7955,Danio rerio (zebrafish),Tretinoin results in decreased expression of CPT1B mRNA,,,PMID:20530235|PMID:32553615,https://www.ncbi.nlm.nih.gov/pubmed/20530235|https://www.ncbi.nlm.nih.gov/pubmed/32553615,20530235|32553615,,
781,1495328,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1375,CPT1B,https://ctdbase.org/detail.go?type=gene&acc=1375,,,1375.0,CPT1B,9606,Homo sapiens (human),Tretinoin results in increased expression of CPT1B mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
782,1495329,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1375,CPT1B,https://ctdbase.org/detail.go?type=gene&acc=1375,,,1375.0,CPT1B,10090,Mus musculus (house mouse),Tretinoin results in increased expression of CPT1B mRNA,,,PMID:16840543,https://www.ncbi.nlm.nih.gov/pubmed/16840543,16840543,,
783,1495330,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,126129,CPT1C,https://ctdbase.org/detail.go?type=gene&acc=126129,,,126129.0,CPT1C,9606,Homo sapiens (human),Tretinoin results in decreased expression of CPT1C mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
784,1497541,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,51084,CRYL1,https://ctdbase.org/detail.go?type=gene&acc=51084,,,51084.0,CRYL1,9606,Homo sapiens (human),Tretinoin results in decreased expression of CRYL1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
785,1497542,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,51084,CRYL1,https://ctdbase.org/detail.go?type=gene&acc=51084,,,51084.0,CRYL1,9606,Homo sapiens (human),Tretinoin results in increased expression of CRYL1 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
786,1497543,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1428,CRYM,https://ctdbase.org/detail.go?type=gene&acc=1428,,,1428.0,CRYM,9606,Homo sapiens (human),Tretinoin results in increased expression of CRYM mRNA,,,PMID:21934132|PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/23724009,21934132|23724009,,
787,1497544,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1429,CRYZ,https://ctdbase.org/detail.go?type=gene&acc=1429,,,1429.0,CRYZ,9606,Homo sapiens (human),Tretinoin results in decreased expression of CRYZ mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
788,1497545,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1431,CS,https://ctdbase.org/detail.go?type=gene&acc=1431,,,1431.0,CS,9606,Homo sapiens (human),Tretinoin results in decreased expression of CS mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
789,1497546,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1434,CSE1L,https://ctdbase.org/detail.go?type=gene&acc=1434,,,1434.0,CSE1L,9606,Homo sapiens (human),Thiophenes analog promotes the reaction [tretinoin results in decreased expression of CSE1L mrna],,,PMID:16140955,https://www.ncbi.nlm.nih.gov/pubmed/16140955,16140955,,
790,1497547,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1434,CSE1L,https://ctdbase.org/detail.go?type=gene&acc=1434,,,1434.0,CSE1L,9606,Homo sapiens (human),Tretinoin results in decreased expression of CSE1L mRNA,,,PMID:16140955|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/16140955|https://www.ncbi.nlm.nih.gov/pubmed/33167477,16140955|33167477,,
791,1497548,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1435,CSF1,https://ctdbase.org/detail.go?type=gene&acc=1435,,,1435.0,CSF1,9606,Homo sapiens (human),Tretinoin results in increased expression of CSF1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
792,1497549,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1436,CSF1R,https://ctdbase.org/detail.go?type=gene&acc=1436,,,1436.0,CSF1R,9606,Homo sapiens (human),TNF protein promotes the reaction [tretinoin results in increased expression of CSF1R mrna]|bucladesine promotes the reaction [tretinoin results in increased expression of CSF1R mrna],,,PMID:8445950,https://www.ncbi.nlm.nih.gov/pubmed/8445950,8445950,,
793,1498135,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1459,CSNK2A2,https://ctdbase.org/detail.go?type=gene&acc=1459,,,1459.0,CSNK2A2,9606,Homo sapiens (human),Tretinoin results in decreased expression of CSNK2A2 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
794,1498136,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1460,CSNK2B,https://ctdbase.org/detail.go?type=gene&acc=1460,,,1460.0,CSNK2B,9606,Homo sapiens (human),Tretinoin results in decreased expression of CSNK2B mRNA,,,PMID:17218384,https://www.ncbi.nlm.nih.gov/pubmed/17218384,17218384,,
795,1498137,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,10675,CSPG5,https://ctdbase.org/detail.go?type=gene&acc=10675,,,10675.0,CSPG5,9606,Homo sapiens (human),Tretinoin results in decreased expression of CSPG5 mRNA,,,PMID:21934132|PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/21934132|https://www.ncbi.nlm.nih.gov/pubmed/33167477,21934132|33167477,,
796,1498138,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,79848,CSPP1,https://ctdbase.org/detail.go?type=gene&acc=79848,,,79848.0,CSPP1,9606,Homo sapiens (human),Tretinoin results in decreased expression of CSPP1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
797,1498139,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,64651,CSRNP1,https://ctdbase.org/detail.go?type=gene&acc=64651,,,64651.0,CSRNP1,9606,Homo sapiens (human),Tretinoin results in increased expression of CSRNP1 mRNA,,,PMID:33167477,https://www.ncbi.nlm.nih.gov/pubmed/33167477,33167477,,
798,1498140,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,64651,CSRNP1,https://ctdbase.org/detail.go?type=gene&acc=64651,,,64651.0,CSRNP1,10090,Mus musculus (house mouse),[bisphenol F co-treated with tretinoin] results in decreased expression of CSRNP1 mRNA,,,PMID:30951980,https://www.ncbi.nlm.nih.gov/pubmed/30951980,30951980,,
799,1498141,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,81566,CSRNP2,https://ctdbase.org/detail.go?type=gene&acc=81566,,,81566.0,CSRNP2,9606,Homo sapiens (human),Tretinoin results in increased expression of CSRNP2 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
800,1498142,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,80034,CSRNP3,https://ctdbase.org/detail.go?type=gene&acc=80034,,,80034.0,CSRNP3,9606,Homo sapiens (human),Tretinoin results in increased expression of CSRNP3 mRNA,,,PMID:23724009,https://www.ncbi.nlm.nih.gov/pubmed/23724009,23724009,,
801,1498143,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1465,CSRP1,https://ctdbase.org/detail.go?type=gene&acc=1465,,,1465.0,CSRP1,9606,Homo sapiens (human),Tretinoin results in increased expression of CSRP1 mRNA,,,PMID:15498508|PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/15498508|https://www.ncbi.nlm.nih.gov/pubmed/21934132,15498508|21934132,,
802,1498144,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1466,CSRP2,https://ctdbase.org/detail.go?type=gene&acc=1466,,,1466.0,CSRP2,9606,Homo sapiens (human),Tretinoin results in decreased expression of CSRP2 mRNA,,,PMID:21934132,https://www.ncbi.nlm.nih.gov/pubmed/21934132,21934132,,
803,1498145,444795,Comparative Toxicogenomics Database (CTD),Tretinoin,D014212,Tretinoin,https://ctdbase.org/detail.go?type=chem&acc=D014212,1466,CSRP2,https://ctdbase.org/detail.go?type=gene&acc=1466,,,1466.0,CSRP2,10090,Mus musculus (house mouse),Tretinoin results in decreased expression of CSRP2 mRNA,,,PMID:16604517,https://www.ncbi.nlm.nih.gov/pubmed/16604517,16604517,,
804,1488765,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5328,PLAU,https://ctdbase.org/detail.go?type=gene&acc=5328,,,5328.0,PLAU,9606,Homo sapiens (human),Resveratrol inhibits the reaction [lysophosphatidic acid results in increased expression of PLAU mrna]|resveratrol inhibits the reaction [EGF protein results in increased expression of PLAU mrna]|gefitinib promotes the reaction [resveratrol inhibits the reaction [EGF protein results in increased expression of PLAU mrna]]|resveratrol promotes the reaction [gefitinib inhibits the reaction [lysophosphatidic acid results in increased expression of PLAU mrna]]|gefitinib promotes the reaction [resveratrol inhibits the reaction [lysophosphatidic acid results in increased expression of PLAU mrna]]|resveratrol promotes the reaction [gefitinib inhibits the reaction [EGF protein results in increased expression of PLAU mrna]],,,PMID:23127547,https://www.ncbi.nlm.nih.gov/pubmed/23127547,23127547,,
805,1488766,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5328,PLAU,https://ctdbase.org/detail.go?type=gene&acc=5328,,,5328.0,PLAU,9606,Homo sapiens (human),Resveratrol results in decreased expression of and results in decreased activity of PLAU protein|pyrazolanthrone promotes the reaction [resveratrol results in decreased expression of PLAU protein]|resveratrol inhibits the reaction [SP1 protein binds to PLAU promoter],,,PMID:23437203,https://www.ncbi.nlm.nih.gov/pubmed/23437203,23437203,,
806,1488767,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5328,PLAU,https://ctdbase.org/detail.go?type=gene&acc=5328,,,5328.0,PLAU,9606,Homo sapiens (human),Resveratrol results in decreased activity of PLAU protein,,,PMID:25605016,https://www.ncbi.nlm.nih.gov/pubmed/25605016,25605016,,
807,1488768,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5328,PLAU,https://ctdbase.org/detail.go?type=gene&acc=5328,,,5328.0,PLAU,9606,Homo sapiens (human),Resveratrol results in decreased expression of PLAU mRNA,,,PMID:22199285|PMID:23437203|PMID:26537190,https://www.ncbi.nlm.nih.gov/pubmed/22199285|https://www.ncbi.nlm.nih.gov/pubmed/23437203|https://www.ncbi.nlm.nih.gov/pubmed/26537190,22199285|23437203|26537190,,
808,1488769,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5328,PLAU,https://ctdbase.org/detail.go?type=gene&acc=5328,,,5328.0,PLAU,9606,Homo sapiens (human),Resveratrol results in decreased expression of PLAU protein,,,PMID:26537190,https://www.ncbi.nlm.nih.gov/pubmed/26537190,26537190,,
809,1488770,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5328,PLAU,https://ctdbase.org/detail.go?type=gene&acc=5328,,,5328.0,PLAU,10116,Rattus norvegicus (Norway rat),[resveratrol co-treated with streptozocin] results in increased expression of PLAU mRNA,,,PMID:25905778,https://www.ncbi.nlm.nih.gov/pubmed/25905778,25905778,,
810,1488771,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5329,PLAUR,https://ctdbase.org/detail.go?type=gene&acc=5329,,,5329.0,PLAUR,9606,Homo sapiens (human),Resveratrol results in decreased expression of PLAUR mRNA,,,PMID:22199285|PMID:26537190,https://www.ncbi.nlm.nih.gov/pubmed/22199285|https://www.ncbi.nlm.nih.gov/pubmed/26537190,22199285|26537190,,
811,1488772,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5329,PLAUR,https://ctdbase.org/detail.go?type=gene&acc=5329,,,5329.0,PLAUR,9606,Homo sapiens (human),Resveratrol results in decreased expression of PLAUR protein,,,PMID:26537190,https://www.ncbi.nlm.nih.gov/pubmed/26537190,26537190,,
812,1488773,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5331,PLCB3,https://ctdbase.org/detail.go?type=gene&acc=5331,,,5331.0,PLCB3,9606,Homo sapiens (human),"Resveratrol inhibits the reaction [15-hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic acid results in increased expression of PLCB3 protein modified form]",,,PMID:18291361,https://www.ncbi.nlm.nih.gov/pubmed/18291361,18291361,,
813,1489565,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,10733,PLK4,https://ctdbase.org/detail.go?type=gene&acc=10733,,,10733.0,PLK4,9606,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of PLK4 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
814,1491208,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,55703,POLR3B,https://ctdbase.org/detail.go?type=gene&acc=55703,,,55703.0,POLR3B,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of POLR3B mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
815,1491209,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,10621,POLR3F,https://ctdbase.org/detail.go?type=gene&acc=10621,,,10621.0,POLR3F,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of POLR3F mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
816,1491210,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9883,POM121,https://ctdbase.org/detail.go?type=gene&acc=9883,,,9883.0,POM121,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of POM121 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
817,1491211,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,100101267,POM121C,https://ctdbase.org/detail.go?type=gene&acc=100101267,,,100101267.0,POM121C,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of POM121C mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
818,1491212,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,646074,POM121L10P,https://ctdbase.org/detail.go?type=gene&acc=646074,,,646074.0,POM121L10P,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of POM121L10P mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
819,1491213,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,285877,POM121L12,https://ctdbase.org/detail.go?type=gene&acc=285877,,,285877.0,POM121L12,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of POM121L12 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
820,1491214,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5443,POMC,https://ctdbase.org/detail.go?type=gene&acc=5443,,,5443.0,POMC,10090,Mus musculus (house mouse),"Resveratrol inhibits the reaction [lipopolysaccharide, escherichia coli O111 B4 inhibits the reaction [POMC protein modified form results in increased secretion of corticosterone]]",,,PMID:27052214,https://www.ncbi.nlm.nih.gov/pubmed/27052214,27052214,,
821,1491215,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,84892,POMGNT2,https://ctdbase.org/detail.go?type=gene&acc=84892,,,84892.0,POMGNT2,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of POMGNT2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
822,1491216,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,51371,POMP,https://ctdbase.org/detail.go?type=gene&acc=51371,,,51371.0,POMP,10090,Mus musculus (house mouse),Resveratrol results in increased expression of POMP protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
823,1491400,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),Resveratrol results in increased expression of PON1 mRNA,,,PMID:15458977|PMID:20228421|PMID:21199573,https://www.ncbi.nlm.nih.gov/pubmed/15458977|https://www.ncbi.nlm.nih.gov/pubmed/20228421|https://www.ncbi.nlm.nih.gov/pubmed/21199573,15458977|20228421|21199573,,
824,1491401,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,9606,Homo sapiens (human),Resveratrol results in increased expression of PON1 protein,,,PMID:21199573,https://www.ncbi.nlm.nih.gov/pubmed/21199573,21199573,,
825,1491402,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,10090,Mus musculus (house mouse),[resveratrol results in increased abundance of homocysteine] which results in decreased activity of PON1 protein,,,PMID:19028542,https://www.ncbi.nlm.nih.gov/pubmed/19028542,19028542,,
826,1491403,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5444,PON1,https://ctdbase.org/detail.go?type=gene&acc=5444,,,5444.0,PON1,10090,Mus musculus (house mouse),Resveratrol results in increased expression of PON1 mrna|resveratrol results in increased expression of PON1 protein,,,PMID:18930334,https://www.ncbi.nlm.nih.gov/pubmed/18930334,18930334,,
827,1491404,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5445,PON2,https://ctdbase.org/detail.go?type=gene&acc=5445,,,5445.0,PON2,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of PON2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
828,1491405,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,51367,POP5,https://ctdbase.org/detail.go?type=gene&acc=51367,,,51367.0,POP5,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of POP5 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
829,1491406,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5447,POR,https://ctdbase.org/detail.go?type=gene&acc=5447,,,5447.0,POR,10090,Mus musculus (house mouse),"Resveratrol inhibits the reaction [POR protein affects the reaction [benzo(a)pyrene results in increased chemical synthesis of benzo(a)pyrene-7,8-dihydrodiol-9,10-epoxide-DNA]]",,,PMID:28111842,https://www.ncbi.nlm.nih.gov/pubmed/28111842,28111842,,
830,1491407,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5447,POR,https://ctdbase.org/detail.go?type=gene&acc=5447,,,5447.0,POR,10090,Mus musculus (house mouse),Resveratrol results in increased expression of POR protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
831,1496647,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,10887,PROKR1,https://ctdbase.org/detail.go?type=gene&acc=10887,,,10887.0,PROKR1,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of PROKR1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
832,1496648,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,128674,PROKR2,https://ctdbase.org/detail.go?type=gene&acc=128674,,,128674.0,PROKR2,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of PROKR2 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
833,1496649,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,150696,PROM2,https://ctdbase.org/detail.go?type=gene&acc=150696,,,150696.0,PROM2,9606,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in decreased expression of PROM2 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
834,1496650,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5626,PROP1,https://ctdbase.org/detail.go?type=gene&acc=5626,,,5626.0,PROP1,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of PROP1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
835,1496651,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,67939,PRORSD1,https://ctdbase.org/detail.go?type=gene&acc=67939,,,67939.0,Prorsd1,10090,Mus musculus (house mouse),Resveratrol results in increased expression of PRORSD1 protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
836,1496652,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5627,PROS1,https://ctdbase.org/detail.go?type=gene&acc=5627,,,5627.0,PROS1,9606,Homo sapiens (human),Resveratrol results in decreased expression of PROS1 mRNA,,,PMID:20926118,https://www.ncbi.nlm.nih.gov/pubmed/20926118,20926118,,
837,1496653,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5627,PROS1,https://ctdbase.org/detail.go?type=gene&acc=5627,,,5627.0,PROS1,9823,Sus scrofa (pig),[dietary fats co-treated with resveratrol] results in increased expression of PROS1 mRNA,,,PMID:21852083,https://www.ncbi.nlm.nih.gov/pubmed/21852083,21852083,,
838,1496654,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,148137,PROSER3,https://ctdbase.org/detail.go?type=gene&acc=148137,,,148137.0,PROSER3,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of PROSER3 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
839,1496655,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5629,PROX1,https://ctdbase.org/detail.go?type=gene&acc=5629,,,5629.0,PROX1,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in decreased expression of PROX1 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
840,1496791,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,8559,PRPF18,https://ctdbase.org/detail.go?type=gene&acc=8559,,,8559.0,PRPF18,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of PRPF18 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
841,1496792,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,27339,PRPF19,https://ctdbase.org/detail.go?type=gene&acc=27339,,,27339.0,PRPF19,9606,Homo sapiens (human),[plant extracts co-treated with resveratrol] results in increased expression of PRPF19 mRNA,,,PMID:23557933,https://www.ncbi.nlm.nih.gov/pubmed/23557933,23557933,,
842,1496793,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9129,PRPF3,https://ctdbase.org/detail.go?type=gene&acc=9129,,,9129.0,PRPF3,10090,Mus musculus (house mouse),Resveratrol results in decreased expression of PRPF3 protein,,,PMID:25505154,https://www.ncbi.nlm.nih.gov/pubmed/25505154,25505154,,
843,1496794,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,9128,PRPF4,https://ctdbase.org/detail.go?type=gene&acc=9128,,,9128.0,PRPF4,9606,Homo sapiens (human),[coumestrol co-treated with resveratrol] results in increased expression of PRPF4 mRNA,,,PMID:19167446,https://www.ncbi.nlm.nih.gov/pubmed/19167446,19167446,,
844,1500162,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090,Mus musculus (house mouse),Resveratrol inhibits the reaction [acrolein results in increased expression of PTGS2 protein],,,PMID:34813903,https://www.ncbi.nlm.nih.gov/pubmed/34813903,34813903,,
845,1500163,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090,Mus musculus (house mouse),Resveratrol inhibits the reaction [azoxymethane results in increased expression of PTGS2 mrna]|resveratrol inhibits the reaction [azoxymethane results in increased expression of PTGS2 protein],,,PMID:21355597,https://www.ncbi.nlm.nih.gov/pubmed/21355597,21355597,,
846,1500164,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090,Mus musculus (house mouse),Resveratrol inhibits the reaction [cadmium chloride results in increased expression of PTGS2 protein],,,PMID:27279585,https://www.ncbi.nlm.nih.gov/pubmed/27279585,27279585,,
847,1500165,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090,Mus musculus (house mouse),Resveratrol inhibits the reaction [dextran sulfate results in increased expression of PTGS2 mrna],,,PMID:19940103,https://www.ncbi.nlm.nih.gov/pubmed/19940103,19940103,,
848,1500166,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090,Mus musculus (house mouse),Resveratrol inhibits the reaction [dextran sulfate results in increased expression of PTGS2 protein],,,PMID:20132809|PMID:30844440,https://www.ncbi.nlm.nih.gov/pubmed/20132809|https://www.ncbi.nlm.nih.gov/pubmed/30844440,20132809|30844440,,
849,1500167,445154,Comparative Toxicogenomics Database (CTD),Resveratrol,D000077185,Resveratrol,https://ctdbase.org/detail.go?type=chem&acc=D000077185,5743,PTGS2,https://ctdbase.org/detail.go?type=gene&acc=5743,,,5743.0,PTGS2,10090,Mus musculus (house mouse),Resveratrol inhibits the reaction [dietary fats results in increased expression of PTGS2 mrna],,,PMID:24812660,https://www.ncbi.nlm.nih.gov/pubmed/24812660,24812660,,
850,1490641,448537,Drug Gene Interaction database (DGIdb),Diethylstilbestrol,,DIETHYLSTILBESTROL,https://www.dgidb.org/drugs/rxcui:3390,,ESR1,https://www.dgidb.org/genes/hgnc:3467,,,2099.0,ESR1,9606,Homo sapiens (human),,,,,,,,
851,1490642,448763,DrugBank,Methyl-phe-pro-amino-cyclohexylglycine,DB08187,N-Methylphenylalanyl-N-[(trans-4-aminocyclohexyl)methyl]-L-prolinamide,https://www.drugbank.ca/drugs/DB08187,BE0000048,Prothrombin,https://www.drugbank.ca/bio_entities/BE0000048,P00734,Prothrombin,2147.0,F2,9606,Homo sapiens (human),,,,PMID:10592235,https://www.ncbi.nlm.nih.gov/pubmed/10592235,10592235,,
852,1490643,448769,Therapeutic Target Database (TTD),Carbazole butanoic acid,D05JAH,4-Carbazol-9-yl-butyric acid,https://idrblab.net/ttd/data/drug/details/D05JAH,T07217,Fatty acid-binding protein 4 (FABP4),https://idrblab.net/ttd/data/target/details/T07217,P15090,"Fatty acid-binding protein, adipocyte",2167.0,FABP4,9606,Homo sapiens (human),Inhibitor,,,,,,,
853,1490644,448769,Therapeutic Target Database (TTD),Carbazole butanoic acid,D05JAH,4-Carbazol-9-yl-butyric acid,https://idrblab.net/ttd/data/drug/details/D05JAH,T21507,Fatty acid-binding protein 5 (FABP5),https://idrblab.net/ttd/data/target/details/T21507,Q01469,Fatty acid-binding protein 5,2171.0,FABP5,9606,Homo sapiens (human),Inhibitor,,,,,,,
854,1490645,448780,BindingDB,"3'-3""-Dichlorophenol-1,8-3H-benzo[DE]isochromen-1-one",18763,"1,8-naphthalein derivative, 10",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18763,1875,Dihydrofolate reductase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1875,P00374,Dihydrofolate reductase,1719.0,DHFR,9606,Homo sapiens (human),,Ki (nM),5200,PMID:17004711|DOI:10.1021/jm051187d,https://www.ncbi.nlm.nih.gov/pubmed/17004711|https://doi.org/10.1021/jm051187d,17004711,10.1021/jm051187d,
855,1490646,448780,BindingDB,"3'-3""-Dichlorophenol-1,8-3H-benzo[DE]isochromen-1-one",18763,"1,8-naphthalein derivative, 10",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18763,1934,Thymidylate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1934,P00469,Thymidylate synthase,,,1582,Lacticaseibacillus casei,,Ki (nM),700,PMID:17004711|DOI:10.1021/jm051187d,https://www.ncbi.nlm.nih.gov/pubmed/17004711|https://doi.org/10.1021/jm051187d,17004711,10.1021/jm051187d,
856,1490647,448780,BindingDB,"3'-3""-Dichlorophenol-1,8-3H-benzo[DE]isochromen-1-one",18763,"1,8-naphthalein derivative, 10",https://www.bindingdb.org/rwd/bind/chemsearch/marvin/MolStructure.jsp?monomerid=18763,1933,Thymidylate synthase,https://www.bindingdb.org/rwd/jsp/dbsearch/PrimarySearch_ki.jsp?tag=pol&polymerid=1933,P0A884,Thymidylate synthase,83579666.0,,83333,Escherichia coli K-12,,Ki (nM),600,PMID:17004711|DOI:10.1021/jm051187d,https://www.ncbi.nlm.nih.gov/pubmed/17004711|https://doi.org/10.1021/jm051187d,17004711,10.1021/jm051187d,
857,1490919,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,5244,ABCB4,https://ctdbase.org/detail.go?type=gene&acc=5244,,,5244.0,ABCB4,9606,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [colforsin results in decreased expression of ABCB4 mrna],,,PMID:12926078,https://www.ncbi.nlm.nih.gov/pubmed/12926078,12926078,,
858,1490920,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,9606,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [bucladesine results in increased expression of ABCC2 protein],,,PMID:26049102,https://www.ncbi.nlm.nih.gov/pubmed/26049102,26049102,,
859,1490921,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,1244,ABCC2,https://ctdbase.org/detail.go?type=gene&acc=1244,,,1244.0,ABCC2,10116,Rattus norvegicus (Norway rat),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [ursodeoxycholic acid inhibits the reaction [ethinyl estradiol results in decreased expression of ABCC2 mrna]]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [chenodeoxycholic acid inhibits the reaction [ethinyl estradiol results in decreased expression of ABCC2 mrna]],,,PMID:27743861,https://www.ncbi.nlm.nih.gov/pubmed/27743861,27743861,,
860,1491408,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,466,ATF1,https://ctdbase.org/detail.go?type=gene&acc=466,,,466.0,ATF1,9606,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [dinoprostone results in increased phosphorylation of ATF1 protein],,,PMID:12164941,https://www.ncbi.nlm.nih.gov/pubmed/12164941,12164941,,
861,1491409,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,9606,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [dinoprostone results in increased expression of ATF3 protein],,,PMID:30409902,https://www.ncbi.nlm.nih.gov/pubmed/30409902,30409902,,
862,1491410,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,467,ATF3,https://ctdbase.org/detail.go?type=gene&acc=467,,,467.0,ATF3,10116,Rattus norvegicus (Norway rat),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [isoproterenol results in increased expression of ATF3 protein],,,PMID:25136830,https://www.ncbi.nlm.nih.gov/pubmed/25136830,25136830,,
863,1492177,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,2488,FSHB,https://ctdbase.org/detail.go?type=gene&acc=2488,,,2488.0,FSHB,10116,Rattus norvegicus (Norway rat),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [FSHB protein results in increased phosphorylation of TSC2 protein],,,PMID:17510244,https://www.ncbi.nlm.nih.gov/pubmed/17510244,17510244,,
864,1493340,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,200186,CRTC2,https://ctdbase.org/detail.go?type=gene&acc=200186,,,200186.0,CRTC2,10090,Mus musculus (house mouse),[N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide co-treated with SB 203580] inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of CRTC2 protein]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [perfluorooctane sulfonic acid results in decreased expression of CRTC2 protein]|[n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide co-treated with SB 203580] inhibits the reaction [perfluorooctane sulfonic acid inhibits the reaction [[CRTC2 protein binds to CREB1 protein modified form] which binds to STAR promoter]]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [perfluorooctane sulfonic acid inhibits the reaction [[CRTC2 protein binds to CREB1 protein modified form] which binds to STAR promoter]],,,PMID:33359577,https://www.ncbi.nlm.nih.gov/pubmed/33359577,33359577,,
865,1493341,449241,Comparative Toxicogenomics Database (CTD),N-(2-(4-Bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,C063509,N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide,https://ctdbase.org/detail.go?type=chem&acc=C063509,1499,CTNNB1,https://ctdbase.org/detail.go?type=gene&acc=1499,,,1499.0,CTNNB1,9606,Homo sapiens (human),N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [lithium chloride affects the localization of CTNNB1 protein modified form]|n-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [lithium chloride affects the localization of CTNNB1 protein],,,PMID:22493441,https://www.ncbi.nlm.nih.gov/pubmed/22493441,22493441,,
